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Abstract
The Effect of Health Information Technology on Hospital Quality of Care
by
Ruirui Sun
Advisor: Professor Partha Deb
Health Information Technology (Health IT) is designed to store patients records safely
and clearly, to reduce input errors and missing records, and to make communications more
efficiently. Concerned with the relatively lower adoption rate among the US hospitals com-
pared to most developed countries, the Bush Administration set up the Office of National
Coordinator for Health Information Technology in 2006 to mandate the Health IT implemen-
tation with $25.9 billion subsidies to eligible hospitals starting 2009. Underlying the huge
subsidy is the belief that Health IT can reduce hospital cost by improving efficiency and
quality, and can help reduce total health expenditure. Yet researchers from both medical
field and economics field have been struggling to find evidence on such implications for years.
In my dissertation I conduct empirical analysis to investigate the causal effect of Health
IT on US hospitals efficiency and quality, and to examine whether such effects vary across
different patient groups or hospital types. The rich study sample consists of two datasets: the
2002-2008 National Inpatient Sample (NIS) and State Inpatient Database (SID) generated
by Agency for Healthcare Research and Quality (AHRQ), and the HIMSS Analytics data.
v
The NIS is a nationally representative patient level discharge data set, which includes about
20% of the total US inpatient discharges annually. The HIMSS Analytics is a survey data set
that reports about 5000 US hospitals Health IT adoption status and history, together with
hospital characteristics. The SID comes from four states: CA, FL, NY, and WA, with almost
100% discharge information available. It also gives the benefit of linking multiple discharge
records to the same initial visit record, and therefore can be used to identify readmissions
to hospitals.
The first chapter is a in depth literature review on the studies of Health IT and its
impact on hospital outcomes. The second chapter is an empirical paper that uses nationally
representative data to study how IT system affect patients’ Length of Stay, by adopting Finite
Mixture Model method. The third chapter empirically analyzes IT’s impact on readmissions,
and particularly for five conditions that are also of Center for Medicare and Medicaid Services
(CMS) focuses in determining hospital quality.
This dissertation finds empirical evidence that supports Health IT’s contribution. It also
establishes how Finite Mixture Model method can be used in healthcare research. Results
show that not all patients or hospitals are expected to receive the same degree of benefit from
Health IT adoption. In fact, majority of the populations are not shown to be affected. Still,
studies from this dissertation illustrate the potential of Health IT systems, as the analyses
so far are only conducted in the hospital setting. On a broader sense, Health IT is supposed
to support all aspects of healthcare deliveries and coordinations.
Acronyms used in this dissertation are listed in Appendix table A1
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Chapter 1
Health Information Technology
Utilization and Its Effect on Hospital
Quality of Inpatient Care in the US:
a Literature Review
1.1 Introduction
In economics, innovation in technology is seen as a way to increase production and improve
efficiency. It is certainly true in the health care market, which is highly information intensive
and thus would highly benefit from good information management. For example, advances
in information technology allow for the near-immediate adjudication of claims at pharma-
cies(Goldman and Lakdawalla, 2011). Health information technology (Health IT) is one of
the most important innovation in the health care industry, due to its potential advantage
at lowering cost, monitoring and surveillance, and reducing medical errors. The adoption
rate in US hospitals is much lower than most EU countries. More and more researchers and
policy makers are beginning to take great interest at this low adoption pace issue.
Health care information technology consists of various categories. The most common and
widely discussed ones include the Electronic Medical Record (EMRs). It contains digital
format of patients’ medical information, for example medical history, medication, laboratory
test results and other clinical data. EMRs is to replace traditional paper-based handwritten
medical record, which makes it easier to read and keep track of patients’ history information.
Moreover, digital record can be transferred between care providers more convenient and
1
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faster. Within the EMRs category, there are several particular applications. Healthcare
Information and Management Systems Society (HIMSS) Foundation define in their Health
IT dataset since 2005 of EMRs as consisting of Clinical Data Repository, Clinical Decision
Support System (CDSS), Computerized Practitioner Order Entry (CPOE), Order Entry
(Includes Order Communications), Physician Documentation, and Physician Portal.
In this paper, I am reviewing previous literature with topic of the adoption of general
Health IT and EMRs, and its correlation with quality of care. Literatures are taken from
economics, medical and health fields. The next section of this paper illustrate the method of
my study collection. The third and fourth sections are my reviews for literatures. I will cover
two main topics: the adoption in US hospitals and Health IT effect on hospital quality of
care. The first topic will discuss the rate and barriers of adoption in US hospitals. Reviews
for the second topic mostly come from health and medical journals.
1.2 Method
Studies from 1996 till April 2016 were identified by searching EBSCOhost and Google scholar.
Criteria of inclusion of research papers are: published English-language peer-reviewed jour-
nal papers from top 50 (according to Journal Influence Index, ranked within each field)
economics journals, medical journals, and health journals. Widely cited working papers are
also considered during the searching process. Topics must be related to the US hospital
Health IT utilization and inpatient care, except for section 3 of the paper where I study
the evidence of Health IT from other countries. I also consider reports from WHO, NIS
and Agency for Health Research and Quality (AHRQ). Keywords used include: electronic
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medical record, electronic health record1, electronic patient record, computerized physician
order entry, clinical decision support, health information technology, Health IT, quality, and
hospital.
Over 600 papers appeared at the initial search. After applying the criteria, 68 papers
were selected and reviewed, among which 36 paper were about Health IT adoption. For all
papers, 33 are from medical journals, 27 are from health service journals, and 8 are from
economics journals.
1.3 Health IT adoption in the US hospitals
1.3.1 Timeline for Health IT adoption
Health IT was originally developed during 1960s, initially designed to provide billing and
financial services. Later on it grew into drug interaction controls, laboratory quality controls,
and indices of patient’s radiology histories (Collen, 1995; Dorenfest, 1997) . In the 1970s,
Health IT developed into Electronic Medical Record (EMRs) and Computerized Physician
Order Entry (CPOE). In later years it became to be utilized for monitoring purposes, es-
pecially to catch medical errors, transfer patients’ record between health care institutes,
etc.
During 1980s, the Dorenfest institute began to collect Health IT data in the entire US
healthcare industry. It is one of the most comprehensive datasets available in the US so
far for Health IT adoption, not only for hospitals’ record, but also for other care providers
(i.e. Home Health, Ambulatory, etc). Later on, the American Hospital Association (AHA)
1Most studies use the word EMRs and EHR interchangeably. However, EMRs should be considered as a
data source for EHR since EMRs is collected within a single care provider institute, i.e. a hospital or clinical
office, whereas EHR contains information from multiple or all care deliver organizations (Kierkegaard, 2011).
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conducted its own Hospital IT Adoption Database, covering over 3600 hospitals per year.
In 2000, the Institute of Medicine (IOM) published a book called “To err is human:
building a safer health system” (Kohn et al., 2000). This book establishes concepts of
constructing a better health care system and promoting Health IT. The authors also advocate
for government policy support in these promotions. Since then, researchers began to study
the cost and benefit analysis for adopting Health IT, and to advocate government intervention
in adopting Health IT (Wang et al., 2003; Zlabek et al., 2011; Coye and Bernstein, 2003;
Goldsmith et al., 2003; Hersh, 2004; Bower, 2005; Middleton, 2005; Fonkych and Taylor,
2005; DesRoches et al., 2010). The need for federal support is partially due to the high
initial set up cost of information system. Financial burden is one of the biggest barriers
in adoption, which is discussed in the next sub-setion. Besides examining the financial
incentive, these papers also advocate establishing national standards on EMRs and other
systems’ coding, to promote inter-institution information exchange (Silverstein, 2009). This
is especially important for patients who receive health care from more than one hospital.
In 2004, President Bush set up the office of National Coordinator for Health Informa-
tion Technology, aiming to coordinate nationwide implementation and usage of Health IT.
This office is legislatively mandated in the Health Information Technology for Economic and
Clinical Health Act (HITECH), which started since 2009. HITECH is part of the American
Recovery and Reinvestment Act (ARRA). The US Department of Health and Human Ser-
vices is spending $25.9 billion to promote and expand the adoption of Health IT. Hospitals
and doctors who fail to achieve a meaningful adoption (aka meaningful use, or MU) and
usage of Health IT will face a reduction in Medicare reimbursement. The standard of MU
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is defined by Centers for Medicare & Medicaid Services (CMS) (CMS, 2013). Agency for
Health Research and Quality (AHRQ) also have their different projects in promoting the
Health IT adoption, such as funding, grants etc. According to Lee et al. (2012), as of 2007,
less than 50% of the US hospitals had adopted EMRs, and only about 20% had adopted
CPOE. By using 2009 AHA health IT survey, Blavin et al. (2010) show that 11.4% of hos-
pitals met all and 48.3% met half or more of the core criteria that are included in both the
AHA IT survey and the final “meaningful-use”. Jha et al. (2011) use 2900 hospitals from
2010 AHA health IT survey to show that approximately two-thirds of them plan to apply
for meaningful use before 2013.
1.3.2 Adoption barriers
It is important to understand why some hospitals or care providers feel reluctant to imple-
ment Health IT system even though such technology has been advocated for a long time.
Studies in literatures that investigate this topic often involves case study, survey and/or
interviews. There are 3 barriers from studies that are discussed most frequently.
• High financial cost.
Financial barrier is one of the most important barriers that prevent a care provider
from adopting Health IT. This financial burden not only exists in the initial set up, but
also persists during the entire future period for maintenance. According to an onsite
study conducted through 2004 to 2005 in six Community Health Centers (CHCs),
the initial EMRs costs on average $54,000 per Full-Time-Equivalent (FTE) physician
(number of FTE physicians of each of the six centers ranges from 40 to 200), including
purchasing and installing and other productivity loss. Average ongoing costs per FTE
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physician per year is $26,610, including hardware and software maintenance, staff and
contractors training, and so forth(Miller and West, 2007).
Ho and Pakes (2011) point out that physician incentives (mainly from managed care)
have an effect on hospitals’ cost control, and therefore affect technology adoptions.
However, there is uncertainty about the financial benefit, so that there is not enough
incentive to purchase and set up the system. In fact, the adoption of Health IT are
too often viewed as primarily directed at health systems, payers and patients, with
much less direct benefit appreciated by the physicians themselves (Shortliffe, 2005).
Miller and Sim (2004) conducted nearly 90 interviews from 2000 to 2002 with 30
physician organizations with EMRs implemented, and very few interviewees reported
any financial incentives for quality. Some of them facing additional costs due to the
fact that they are seeing fewer patients during the EMRs transition period. In another
survey plus interview study of 3606 medical groups, conducted by Gans et al. (2005),
those medical groups with EMRs implemented have a greater concern about loss of
productivity during transition to EMRs. A substantial fraction (which is unfortunately
not disclosed in this study) of practices experience a reduction in practice productivity
during implementation of 10-15 percent for at least several months. Interview results
also show that for most practices, actual costs of implementation were higher than
they had expected, with cost overruns averaging about 25 percent over the venders’
estimate.
This is an even bigger issue for hospitals in rural areas. The EMRs adoption process is
currently in a deadlock where payers and purchasers do not want to provide incentives
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unless benefits and interoperability of EHRs are assured. Health care providers do
not want to buy until costs and risks are lower and incentives are higher, and vendors
cannot bring down the costs until providers adoption accelerates. (Bahensky et al.,
2008)
• High initial physician time costs.
Physicians as well as nurses need to learn and be comfortable with operating the infor-
mation system. This requires great investment in training, which involves both finance
support and time devoted. However, this is not an easy process. Some physicians re-
port they are spending more time per patient even years after EMRs adoption (Miller
and Sim, 2004; Friedrich MJ, 2009).
• Difficult complementary changes and inadequate support.
Health IT cannot work alone without complementary changes, which again involves
lots of physicians’ time. They have to redesign their work flow, as pointed out in
the survey done by Miller and Sim (2004). In their study sample, physicians had to
work with their staffs to summarize and enter patient information from existing paper
based record into EMRs. This causes very strong resistance towards new technology
adoption.
In 2009, Abramson et al. (2012) surveyed 148 hospitals in New York State on the topic
of EMRs adoption and health information exchange. Only 2 of them reported full
implementation of the system. Over 40% of the hospitals that have not adopted EMRs
system cite “lack of adequate IT staff and resources for training staff in basic computer
skills” as a major barrier to the adoption.
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1.3.3 Issues related to Health IT adoption
Health IT is not a perfect technology that operates without any problems. Some issues have
been realized even with successfully installed Health IT system, and these will discourage
healthcare workers’ willingness towards Health IT adoption. First of all, Health IT will
not reach its full potential usage if used in isolation. Frisse (1999) analogized the usage of
Health IT to supply chain. They are similar in the way that both healthcare and businesses
like Walmart see it as their goal to reach effective provision of a desired set of goods and
services with the least possible overhead. Frisse identified that successful businesses like
Walmart and Amazon.com make effective use of technology by putting the resources at
inventory control. And the inventory in healthcare market is time. Health IT can help save
time in medical records searching and analyzing, and reducing patients’ waiting time and
thus improve patient flow. Frisse indicated in his work that Health IT itself cannot be of
great usage if the managed care system cannot provide support. Like in businesses such as
Walmart or Amazon.com, where companies use inventory management systems to increase
efficiency, health care IT system needs to be utilized with the interactions of physicians,
nurses and all other care providers.
Secondly, Health IT can change medical care workers’ working process. Banner and Olney
(2009) conducted a case study in a central Florida hospital that prepared to adopt EMRs
system. He shows that there is a significant increase in time that nurses spent documenting
after the implementation of information system. Dowding et al. (2012) did a case study of
nursing care in Kaiser Permanente healthcare organization, which consists of 29 hospitals
in Northern and Southern California. The study was done from period 2003 to 2009, using
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time series analysis. Results show that EMRs has a substantial impact on nursing care
process (increased workflow in documentation). In the main time, physicians can become
self-aware that they are not comfortable at operating required skill (such as computer skills),
that they need clearer EMRs usage process instructions. This problem appears more in rural
area. Laramee et al. (2011) interviewed health care professionals in a rural academic medical
center, where interviewees even show self-blame when EMRs did not work correctly.
Thirdly, regardless of the extra time put into work with technology, the actual records
put into EMRs consist of many copy-paste words, which might be efficient but not useful.
Case studies show that sign out and progress notes appear to be redundant, with more
than half of the information duplicated from previous documents. There is also significant
information duplication between document types, such as from admission notes to progress
report (Wrenn et al., 2010; Hartzband and Groopman, 2008).
Safety is another issue that bothers patients most regarding Health IT adoption. Cush-
man (1997) shows that patients will withhold information from physicians in case it might
result in legal issues and discrimination. At the same time, physicians may feel forced into
keeping some type of data including sensitive information. Such incomplete or inaccurate
records (including those redundant copy-pasted records) may contaminate the knowledge
base for outcome or surveillance. Miller and Tucker (2009) shows that state privacy laws
restrict the transfer of medical information between hospitals. In the basis of instrumental
variable estimation techniques, they find that in states without hospital privacy laws, one
hospital’s adoption increases the propensity of other area hospitals to adopt by 6 percent.
Miller and Tucker (2014) again study State-level rules and regulations that defer hospitals’
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implementation decision. In this paper, the authors study how the prospect of electronic
data being used in court affects the decisions of US hospitals to adopt EMRs systems. They
show that the use of electronic evidence in discovery are associated with one-third decrease
in adoption of EMRs by hospitals.
Lastly, the lack of an Health IT standard remains a big problem. Information system
vendors belong to different companies, each with their own EMRs standards in documenta-
tion. It is hard to pull information from different systems. This is a challenge especially in
the case of patients transferring between hospitals. This issue has been constantly raised in
papers that advocate federal support of adoption. Keenan et al. (2013) show that sometimes
this is even an issue within an healthcare institute. The authors use a qualitative method
to identify the existence of variation in nurse documentation and communication. They also
advocate a centralized care overview in patients’ EMRs so that the entire care team can get
access, such as standard reporting format, content, and words, just to make sure it is easily
accessible to all team members. This centralization may not require more financial input
and therefore should not add a burden to healthcare providers. Rather, it calls for more time
input into the training of EMRs usage. On the other hand, vendors who provide information
system have been found to conceal from users the fuller knowledge of serious faults in their
system, which will further cause communication inefficiency (Koppel and Kreda, 2009).
1.4 Health IT effect on hospital quality of care
“The biggest mistake we could make right now would be to give a lot of money to indi-
vidual vendors to buy a bunch of IT systems and then find they don’t connect, they don’t
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interoperate, they’re not driven to performance,” said Don Detmer, MD, MA, president and
CEO of the American Medical Informatics Association (Doolan and Bates, 2002). One of
the biggest potential benefits from Health IT is the improvement of quality of care and there
are many excellent papers trying to answer if Health IT generates any improvement.
Health IT studies published in medical journals used randomized control trials to inves-
tigate the effect. Overhage et al. (1996) conducted a RCT on the general medicine inpatient
service in an urban, university-affiliated public hospital. This study investigated whether
computer reminders increase the provision of inpatient preventive care. The idea of this
experiment is that hospitalizations provide good opportunity for preventive care, so that the
computer reminders will notify physicians of daily rounds reports about preventive care for
which their patients were eligible, and suggest orders. There were 78 house staff rotating
on 6 general medicine service. However the results show no significant differences between
controlled group and the intervention group in compliance with preventive care guidelines.
A probable reason for this result is that these inpatient physicians are not patients’ primary
care doctors. It is also possible that such reminders are not effective and therefore that more
intensive intervention are needed. The authors suggest a direct linkage between inpatient
and outpatient care providers, which is part of the health information exchange activities.
This study shed a light on the fact the health information needs to be accessible and utilized
across different care providers. EMRs is just a starting point of information sharing.
Overhage et al. (1997) studied the errors of omissions in a public teaching hospital using
a randomized control trial of six independent services. The idea of this study came from the
fact that physicians often fail to order tests or treatments needed to monitor the effect of
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other tests or treatments. The authors tried to see if EMRs can help prevent such omission of
errors from happening. This trial went on for 30 weeks in 1992. Results showed a significant
difference in the number of orders physicians placed: treatment group physicians ordered
46.3% of instances when they received a reminder, while there was 21.9% compliance by
control group physicians. This study also showed a slight increase in cost where EMRs is
adopted, due to the increasing number of orders placed. However, patients in this research
were not formally randomly assigned to services, but were admitted in sequence so that all
services had equal numbers of admissions. There was no evidence of significant differences
in patients’ demographics, clinical characteristics. Nor for severity of illness.
Over the years of Health IT implementation and its related research on how it can
help improve health care quality, some large hospitals have become a target for before-after
outcome comparison and randomize control trials. Brigham and Women’s Hospital in Boston
is one of such care providers. Study topics cover several aspects of Health IT:
1. Medical Error:
Bates et al. (1998) studied whether Health IT can prevent serious medication errors
that may result in adverse drug events. There were essentially 2 randomly assigned
treatment groups: one group with Health IT (physician order entry), and another one
with both Health IT and a team intervention, which included changing the role of
pharmacists so that they were more on site and available for questions. There were
in total 6711 admissions during the 6-month study period. Before-after comparisons
showed that Health IT implementation is related to 55% decline in serious medication
errors. When compared with Health IT-alone group, the Health IT plus team interven-
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tion showed no significant improvement. However, this study cannot randomly assign
a control group, where physicians still use paper-based medical record input, therefore
the before-after comparison cannot identify the true treatment effect of Health IT.
Shojania et al. (1998) used randomized control trial to study how can Health IT help
with the overuse of intravenous vancomycin, which is an important cause of nosocomial
infection. The experiment was done again in Brigham and Women’s Hospital, involved
96 physicians and 1798 patients. The computerized physician order entry in this ex-
periment shows guidelines from the Centers for Disease Control and Prevention, which
will help physicians making decisions when making orders. The result indeed shows
treatment group physicians order 32% fewer orders. However, this paper’s conclusion
comes from the specific design of their IT system. It is not guaranteed that it would
be the same design for all systems made by all vendors. Also, this reduction of over
usage in this case does not necessarily apply to all other treatment. It is still primarily
depend on how physicians acted when making order entries. One problem associated
with it is that physicians can keep making orders in their old way regardless of the
existence of Health IT. How to prevent this from happening can be challenging.
Jha et al. (1998) conducted research in the same hospital to study adverse drug events
(ADE). The goal for this paper is to see if computer based monitor can help identifying
ADE. The role of Health IT in this study is to suggest whether an ADE might be
present. Then a trained reviewer examine the records to determine what actions should
be taken. There are 2 other comparison groups: a group with nurses and pharmacists
that stimulate voluntary report, and a group with nurses doing intensive chart review.
CHAPTER 1. LITERATURE REVIEW 14
This study shows that nurses doing intensive chart reviews prevents the most ADE.
Health IT based monitor does better than stimulated voluntary report.
Bates et al. (1999b) did another study based on cases in Brigham and Women’s Hospi-
tal, where they study the effect of Computerized Physician Order Entry on medication
error prevention. This is a 4-period (year) time series study. During the study, the non-
missed-dose medication error rate fell 81 percent, from 142 per 1,000 patient-days in
the baseline period to 26.6 per 1,000 patient-days in the final period. Non-intercepted
serious medication errors (those with the potential to cause injury) fell 86 percent from
baseline to period 3, the final period. However, it may be hard to justify this decline
as a causal effect due to the fact that there was no proper control group for this study.
The decline they found might be a correlation in time, where other diagnosis techniques
are improving or better trained physicians are hired.
Teich et al. (2000) collected one-year time series data from Brigham and Women’s
Hospital and studied the prescribing behavior of physicians, and found that the pro-
portion of doses that exceeded the recommended maximum decreased from 2.1% before
implementation of computerized physician order entry to 0.6% afterward. This study
involves in total 14000 of orders. Chertow et al. (2001) did experiments from 1997 to
1998 on optimizing prescribing behavior. Within total of 7490 patients that suffer from
renal insufficiency, more appropriate doses were deemed after Health IT implementa-
tion (67% after adoption vs 54% before). There is a statistically significant decrease
in the mean length of stay from 4.5 days to 4.3 days.
2. Improved Efficiency:
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The study of Bates et al. (1999a) is to determine the impact of EMRs on reducing
redundant laboratory test. This randomized control trials involved a 4-month experi-
ment, with in total 77609 tests (of 5700 patients). 939 of these tests were redundant.
In treatment group, 27% of ordered redundant tests were performed, whereas in control
group 51% were performed. Results show an annual saving in lab charges for $35,000.
Wang et al. (2003) studied the financial cost and benefit per primary care physician
in Brigham and Women’s Hospital for over 5 years. The estimated net benefit from
EMRs over the five years was $86,400 per provider. These net benefits were primary
from the savings of drug expenditures, improved utilization of radiology tests, better
capture of charges and decreased billing errors.
3. Others:
Kuperman et al. (1999) analyzed trend data in Brigham and Women’s Hospital over
five years and find EMRs decrease compliance to allergy alert. In Kucher et al. (2005)
study, 2506 patients were assigned into a randomized control trial, to investigate if
computer alert program can encourage prophylaxis and therefore reduce the frequency
of deep-vein thrombosis among high-risk hospitalized patients. The results show that
10% of patients in treatment group received mechanical prophylaxis, whereas only 1.5%
in control group. Hazard survival regression shows treatment group is associated with
41% decrease in the 90-day risk of deep-vein thrombosis.
What needs to be noticed is that Brigham and Women’s Hospital is a large tertiary care
provider in Boston, with 726 beds at the time of study. The majority of the US hospitals
are much smaller, and therefore it would be hard to make the same conclusion in other
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hospitals’ setting. Adoption of Health IT in a hospital can be associated with the number
of physicians and their behaviors. Elnahal et al. (2011) showed this situation by using 2006
Hospital Quality Alliance (HQA) dataset with logit regressions. They found that hospitals
with performance in the top decile nationally (defined by the HQA dataset) were more likely
to adopt.
Beside Brigham and Women’s Hospital, other academic hospitals have also become tar-
geted experiment sites. Dexter et al. (2004) developed a randomized control trial at the
Indiana University Medical Center from 1998 to 1999, with 3777 general medicine patients.
The treatment group was equipped with computerized standing order systems, which is de-
signed to identify inpatients who were eligible for influenza and pneumococcal vaccination.
This study shows that the patients in the computerized standing order systems group receive
vaccination more often than control group (42% vs 30%, respectively). Evans et al. (1998)
tried to see if Health IT can help achieve optimal use of antibiotics and other anti-infective
agents. They conducted a before-after comparison at LDS hospital in Salt Lake city, with
545 patients in the post-adoption period and 1136 patients in the pre-adoption period. This
study shows a decline in number of orders for drugs that patients had reported allegies, from
146 to 35. It also shows reduction in excess drug dosage from 405 to 87. Zlabek et al. (2011)
obtained longitudinal data from Gunderson Lutheran Medical Center. Data was collected
one year before the adoption of EMRs and one year after. They find a decrease in lab test
per week after the implementation, and decrease in medical errors too. However one should
not take these results and interpret them as the causal effect from Health IT implementation,
due to the fact that these are not randomized trials. There could have been great changes in
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patients’ and physicians’ characteristics over the study periods and without a proper control
group the results could only be seen as correlation.
Health IT has the potential to improve healthcare in public health setting even though
not many reports have been published from this perspective. Paneth-Pollak et al. (2010)
report the effect of EMRs on decision making in ten New York City clinics that are part of
the NYC Department of Health and Mental Hygiene (DOHMH) Bureau of STD Control.
The EMRs implemented in these clinics are called “Express Visits” that can assess the utility
of an on-site clinical test, identify the need for combined services and evaluate new clinic visit
option. There is an increase in the percentage of patients who are treated with chlamydia or
gonorrhea after the EMRs implementation. Yet again, this study can only show correlations
rather than causal effects.
There are also studies that focused on population based research, and these researches
studied general quality related incidents instead of particular diseases. Athey and Stern
(2002b) approached the impact of Health IT from a mortality perspective. The study is
focused on emergency response systems (known as 911 centers) in Pennsylvania from 1994
to 1996. The authors use emergency room cardiac patients’ mortality as the outcome vari-
able, to see if the IT systems adopted by 911 centers have any effect in improving it. The
model is a difference-in-difference setup, where treatment group is the counties that have
adopted Health IT during the study period, and the control group is all other counties in
Pennsylvania. Patients’ information is obtained through hospital discharge data. With over
15,000 observations, the cox hazard model show that the adoption of Health IT significantly
decrease both 6-hour mortality (by over 60%) and 48-hour mortality (by 35%). Although
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cardiac cases only account for a small fraction of the entire emergency calls, and this PA
EMS dataset used here is not population based, this study shows that it is important to
efficiently obtaining health information to improve healthcare outcome. Linder et al. (2007)
established their research under a nationally representative setup. They use 2003 and 2004
National Ambulatory Medical Care Survey to estimate the relationship between EMRs usage
and 17 ambulatory quality indicators, using cross-sectional logit regression, controlling for
patients’ age, sex and race. Sample size varies across different quality indicators, ranging
from 368 to 22,770. Only 3 out of the 17 indicators show significant association with EMRs
adoption.
Parente and McCullough (2009) explored the effect of Health IT on patients’ safety,
with the outcome variables defined as patients’ safety indicators. They use 1999 to 2002
medicare patient data and fixed effect model to see whether Health IT systems help improve
inpatients’ safety. They have three types of Health IT to investigate: the EMRs, the picture
archiving and communications systems (PACs), and Clinical/Nursing IT (which facilitate
the creation, modification and evaluation of patient care plans). The final sample includes
80 million patients and 2707 hospitals. Their panel analysis shows that only EMRs system
is associated with a significant improvement in outcome. However, even though the authors
used one-year lagged Health IT adoption indicator to account for the fact that it takes time
for care providers to fully utilize the techniques, the time span may still be too short for them
to identify significant improvement. Also the study did not show heterogeneous effects of
Health IT among hospitals. It is possible that smaller or less famous hospitals improved more
in quality after the adoption of EMRs than the larger and famous ones did. Or academic
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hospitals may gain more from EMRs adoption than nonacademic ones (as McCullough et al.
(2010) found so in their paper). Furthermore, if Health IT adopters also at the same time
established quality improvement activities (such as associated with more and better trained
physicians and nurses), their results might be overestimating the effect. Nevertheless, this
paper well addressed the endogeneity issue in Health IT adoption while exploring its effect.
McCullough et al. (2010) set up a similar analysis structure. They again used Medicare
data and conducted panel analysis. The authors search for effect of computerized physician
order entry on process quality. Their sample includes 3401 hospitals from 2004 to 2007. A
fixed effect model was estimated for the entire full sample and then for academic hospitals
only. They find significant improvement in pneumococcal vaccination and most appropriate
antibiotic in both model setups.
Miller and Tucker (2011a) use instrumental variable analysis to estimate the effect of
EMRs adoption on neonatal mortality. They use confidential birth records over 11 years from
1995, and find that EMRs adoption is associated with a reduction of 7 to 80 neonatal deaths
per 100,000 live births. Their instrument variables to address the endogenous adoption of
EMRs are the state privacy law. Due to the easy-sharing characteristics of EMRs, some
states restrict the sharing of patients’ information, which therefore reduce the incentive for
hospitals to implement the technology. But the state law does not directly affect neonatal
death, therefore it validates the exogeneity requirement for the instrument.
Appari et al. (2012) used 2006-2010 Hospital Compare data to construct a panel analysis
of meaningful use adoption of EMRs on hospital process care, with a a total of 3921 hospi-
tals. There are four levels of EMRs adoption according to the “meaningful use” defined by
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CMS, and four categories of process quality indicators. Results show that quality indicators
improve most from level 2 to level 3. However moving from level 3 to level 4 is associated
with a decrease in quality. One explanation could be that the time span is not long enough
for researchers to detect positive improvement. It could also be the case that it is important
to notice that EMRs have its limit in certain areas. For example, one of the decrease of
quality happened to acute myocardial infarction, which has an average of 94.89 out of 100
score in terms of quality. With such a high quality process, space for improvement is small.
McCullough et al. (2016) study the effect of Health IT and the related labor coordination
on Medicare patients’ outcomes, using 2002-2007 MEDPAR data. They use Difference-
in-Difference models and check carefully for robustness and falsification tests for causal
inference. They find that Health IT improve outcomes (30-day post-acute care mortality) for
patients with complex, high-severity diagnoses, and no effect for the average patients. This
paper shows that Health IT’s heterogeneous effects exist across patients’ medical severity
levels.
Surveys and interviews are also another type of qualitative research method. Koppel
(2005) interviewed 261 house staff regarding the usage of computerized physician order entry
and whether it causes medication errors. The study shows there are 22 types of medication
error risks reported from the interviews; for example, pharmacy inventory displays being
mistaken for dosage guidelines, or ignoring antibiotic renewal notices. Interviewees indicate
that such errors occur at least weekly. Kutney-Lee and Kelly (2011) used 2006 to 2007
multi-state nursing care and patient safety survey to investigate EMRs’ role in the quality
of nursing care improvement. The sample includes 316 hospitals from four states in the US,
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with a total of 16,352 nurses being interviewed. Results show that nurses reports that fewer
poor patient safety and quality outcomes had occurred after the implementation of EMRs.
However this study does suffer from a issue that stems from survey questionnaires, that the
questions asked in the survey is too vague and subjective. For example, it asked the nurses
to indicate true or false for some statements such as “frequent medication errors”. Such
survey questions can hardly provide the objective measurement, and interviewees may not
be illustrating their real attitudes towards EMRs.
Not all studies are optimistic about the Health IT’s effect on care quality improvement.
A recent study by Goodwin et al. (2013) found that length of stay decreased by 0.11% but
30-day re-hospitalization increased by 0.19% after adoption of EMRs, by using generalized
linear models (GLM) method on 2000-2007 5% Medicare Provider Analysis and Review
(MEDPAR) dataset. Jones et al. (2010) used 2004 - 2007 Hospital Compare, with a sample
of 3971 hospitals. They used a Difference-in-Difference set up for their regressions of acute
myocardial infarction, heart failure and pneumonia care. Results show basic EMRs related
to an improvement for heart failure care, but advanced EMRs (basic EMRs plus CPOE)
related to a decline in quality. However this study’s result may be biased in the sense that
the treatment and control groups are not matching well enough for DID analysis. As the
authors pointed out in their table 2, which is a summary statistics of treatment (EMRs
adopted) and control groups (no EMRs), these two groups are fundamentally different in
size, teaching status, urbanization, and health care system affiliation. Agha (2014) perform
detailed empirical analysis of the Health IT’s impact on Medicare inpatient outcomes from
1998 to 2005, using 20% Medicare claims data and fixed-effect model. This is a project that
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examines the IT’s impact in a nationally representative setting. It shows that Health IT is
associated with a 1.3% increase in billed charges, and there is no evidence of cost savings
even five years after adoption. It also shows there is no correlation in reducing inpatient
mortality, adverse drug events and readmission rates. This paper is among the first studies
that report higher charges associated with the implementation of Health IT system. However
in this study, causal interpretation of coefficients cannot be established.
1.5 Conclusions
In this chapter I introduce the development and adoption trend of Health IT in the US
healthcare market. I then review studies about adoption barriers and problems, and about
the effect of Health IT on hospital quality.
Startup cost which includes both financial burden and time taken away from physician
practice is one of the biggest barrier to Health IT adoption. Whether Health IT has helped
reduced hospital costs remains uncertain from the existing research. Studies have shown
inconsistent results. Most of the published studies have shown improvements in hospital
care quality after the adoptions of certain types of EMRs. However these research either
come from studies in a particular hospital, or fail to accompany with proper control groups
to address the endogeneity of Health IT adoption.
Health IT will remain a big topic that worth exploring in healthcare industry, especially
when it is involved with millions of dollars each year. Future studies on the EMRs adoption
and its impact after the health care reform would be desirable to see if it helps improve the
healthcare quality, both from an efficiency perspectives, and to ease the financial burden
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on hospitals (which might be ultimately transferred to patients). More population based
studies are desired, and so are studies that explore heterogeneity effects among hospitals
and patients.
Chapter 2
Heterogeneous Treatment Effects of
Electronic Medical Records on
Hospital Efficiency
2.1 Introduction
Health care market is highly information intensive. Care providers must make medical de-
cisions and provide services based on available medical information of patients, and would
benefit from good information management technologies. Economists view technology in-
novation as a way to increase production (Solow, 1957) and improve efficiency (Bresnahan
et al., 1999). Health Information Technology (Health IT) has been suggested greatly to re-
duce medical errors and to lower costs and improve healthcare efficiency. While the concept
and expectation of the IT system has been accepted widely across the health care sector,
existing literature provides little nationwide empirical evidence. Moreover, the scope and
disparities of how the Health IT system affects patients has rarely been empirically examined.
The lack of empirical evidence does not necessarily indicate a shortfall of the IT system.
Rather, this might be merely an indication that Health IT studies may easily fall into an
“IT Paradox” trap, where empirical evidence of IT system is hard to find (discussed further
in section 2.2). This paper studies one of the foundation of Health IT system, the Electronic
Medical Records (EMRs), and finds definite evidence of its impact of reducing inpatient
Length of Stay (LOS). I use variation in hospital competitors’ IT adoption rates to identify
the effect on LOS two years after adoption of the EMRs by the focal hospital. The model
24
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is estimated using two-sample non-linear instrumental variable, which allows me to obtain
the consistent causal effect of IT system. The study sample covers 23 millions of patients
discharge information from 1271 hospitals nationwide, which is extracted from National
Inpatient Sample from 2002 to 2008. The sample contains data from patients of various age
group, geographic areas, gender and races, disease types and severity level, while allowing
for enough variation in hospital EMRs adoption behaviors. Results show that Computerized
Physician Order Entry (CPOE) along with Enterprise EMRs can reduce LOS by as much
as 16% for the total study population.
I propose that there are two levels of heterogeneous treatment effects. The first level
is based on patients’ observable heterogeneity, while the second level is identified by the
variation left in residuals from mean estimates. I observed that the first level of heterogeneity
is the patients diagnostic categories. To estimate the second level of heterogeneous treatment
effects I introduced the Finite Mixture Model (FMM) method, which has been widely used in
medical literature to examine mixtures among average treatment effect, in order to estimate
the potential heterogeneity within the average effect. The model identifies two types of
EMRs effects on patients’ LOS, and it is further able to link the observable patients and
hospitals characteristics to the heterogeneous effect identified. I also show that there is mixed
IT effects within inpatient population, where 20% - 30% of the patients experience greater
reduction in LOS due to EMRs than the rest of the patients. The model predicts that these
20% - 30% patients are the ones have more severe medical conditions, with concomitantly
longer LOS to start with, and their hospital characteristics are not shown to be significantly
different to those that are not affected greatly by EMRs.
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This study relates to both the economics literature of IT implementation and Health
IT literature that studies the effectiveness of information system on population health care
quality. In relation to economics literature, this paper takes advantage of the rich patient
discharge data and addresses the importance of heterogeneous effect, which has been argued
in the literature both theoretically and empirically as a way to tackle the IT paradox. In
theory, researchers may have failed to identify information system due to redistribution of
output. It is possible that the effect linked with information system can sometimes be pos-
itive and sometimes negative, with an overall sum of zero effect. Empirically, aggregated
statistics may have overlooked any potential impact of IT system because it fails to iden-
tify heterogeneity in the effect. In relation to the Health IT literature, my analysis results
support the theoretical understanding of EMRs’ working mechanisms. By design, with treat-
ment guidelines embedded within the system, EMRs may inform care providers with alerts
regarding testing, monitoring and interventions. This feature may result in the patients’ dis-
parities in receiving EMRs effects, based on diagnoses, patients’ medical complexity or the
complementary of doctors’ interactions with the system. Therefore it is expected that EMRs
has more potential for complex cases than for moderate cases, and my empirical analysis
supports this hypothesis.
The Finite Mixture Model offers a special property when analyzing heterogeneity by
avoiding the sharp dichotomy between the “moderate condition” and the “severe medical
complexity”, or between different hospital types. In understanding of the EMRs mechanism,
the underlying unobserved heterogeneity which splits the inpatient population into latent
classes is assumed to be based the person’s latent degree of medical severity. The observed
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health conditions and hospital types, etc., may be combined together to reflect the true
heterogeneity, therefore simply stratifying the sample may fail to identify this combination.
On the other hand, the Finite Mixture Model consists of two-step estimation that captures
this combination and therefore gives more flexibility than traditional methods.
The next section of this paper will discuss more information on the “IT Paradox” from
both theoretical and empirical perspectives, and then establish three main hypotheses that
are tested in this study, followed by data description, statistical models and empirical esti-
mation results.
2.2 The Paradox and Heterogeneity Hypotheses
2.2.1 The “IT Paradox”
Nobel Laureate economist Robert Solow first brought up the notion of information system
paradox on the nation level productivity back in 1987, stating that “You can see the com-
puter age everywhere but in the productivity statistics.” This references to the problem that
researchers had failed to find empirical evidence to support the realization of IT benefit on
the economy as a whole. Such difficulty exists regardless of the industries that researchers
have examined. Brynjolfsson (1993) reviews a handful of studies and summarizes this em-
pirical challenge and raises four theoretical explanations for this difficulty: (a) measurement
error of outputs and inputs; (b) mismanagement of the technology by managers; (c) time lags
in the pay-offs to IT; and (d) redistribution, which may result in heterogeneous output levels
or benefit among firms without adding to the total outcome. In particular, Brynjoflsson
explains the hypothesis of redistribution as rearranging “the shares of pie without making
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it any bigger”. Therefore, the redistribution hypothesis essentially identifies and states the
possible heterogeneous effects of IT system among firms or products.
The theory of redistribution brings up two points that need to be considered when con-
ducting empirical analysis. First, the identification of such heterogeneous effect variations
requires usage of disaggregated level data. Brynjolfsson and Hitt (1996) conducted empirical
analysis that found IT system yields strong positive output (a marginal return of $2.62 with
every dollar spent). Their research takes into account of time lag of IT adoption, and utilizes
detailed firm level information rather than industry level data, which they argue reveals the
variations of output among firms. Secondly, redistribution gives a theoretical foundation for
the existence of heterogeneous IT treatment effect. According to this theory, it is reasonable
to believe that IT system contribute to firms differently: some firms are better adapted to
the computerized work environment with improvements in work flow or procedures, while
others may not be able to corporate with the new change. Therefore, an estimation of mean
response of all users can be misleading because the average effect is a mixture of substantial
benefit for some, little or no benefit (or even harm) for others.
While the “IT Paradox” existed in studies of many other industries, Lapointe et al.
(2011) summarize how theoretical foundations of this problem are particularly apparent in
health care services. Lapointe et al. emphasize that currently in Health IT research area
the issue of redistribution is given little consideration, and that maybe Health IT fosters
quality care in some sectors while not in others. However this paper focused more on the
perspective of institutions where task redistribution occurs, rather than patient outcomes;
therefore there is a lack of discussion on EMRs impact on patients themselves. While this
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theoretical study did not provide more analysis about where the heterogeneous IT effect
on patient outcome occurs, other empirical researchers have reported similar assumptions
according to observable characteristics available in data. McCullough et al. (2013) explored
the heterogeneous effect of Health IT on Medicare inpatient mortality based on patient types
and severity, while Miller and Tucker (2011a) examined the heterogeneity of Health IT effect
on neonatal outcome based on mothers’ observable demographic difference, such as education
and race.
2.2.2 Hypotheses and Heterogeneous Treatment Effect
Health IT is designed to store patients records safely and clearly, to reduce input errors and
missing records, and to make communications more efficient. Among various categories of
Health IT, the most basic and widely discussed include the Electronic Medical Records1. The
EMRs contain digitally formatted patients’ medical information, including medical history,
medication, laboratory test results and other clinical data. EMRs is designed to replace
traditional paper-based handwritten medical records, to make records easier to read and
to better track patient history. Moreover, digital records can be transferred between care
providers more convenient and quickly under certain conditions. Another system that is
advised to be used in combination with basic EMRs system is the Computerized Physician
Order Entry (CPOE), where care providers can enter medical orders into a computer system.
It is to replace traditional methods of placing medication orders such as written prescription
and fax. Same as the basic EMRs system, utilization of CPOE is also expected to reduce
1Another related concept is the Electronic Health Records (EHRs). EMRs contains the standard data
gathered in one provider’s office, whereas EHRs includes more comprehensive medical and clinical history
that goes behind the information collected within the provider’s office.
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communication costs and medical errors and improve efficiency.
The computerized storage of patients’ data can lower the communication costs within
the hospital. For example, IT allows physicians and nurses to access patients’ record more
quickly, without going through piles of paper-based files. This can lead to improvement in
timeliness of treatment and precision (e.g., no unclear handwritten notes, or missing files).
Therefore it is expected to see that Length of Stay (LOS) will be shortened due to improved
efficiency and precision of Health IT’s data.
One might argue that with an expensive IT system investment, a hospital may have the
reason to provide more services to pay for these investments and that this behavior may
actually result in longer LOS to cover the IT financial costs. However regardless of whether
such inefficiency exists, the payment system in the US discourages prolonged LOS, since
more private insurance as well as Medicare is changing to prospective payment according to
diagnosis-related-groups (DRGs). Under such reimbursement strategy to hospital, hospitals
are not paid based on the number of days the patients stayed, but rather the acuity of the
patient’s needs defined by DRGs codes. Therefore there is often little financial incentive to
keep patients for long period of time.
Yet there is limited evidence in literature that shows the impact of EMRs on reducing
LOS. Parente and Van Horn (2006) finds no effect of Clinical IT (including EMRs) on LOS
in not-for-profit hospitals, and a marginally significant 1% drop in LOS (at 10% significant
level) in for-profit hospitals. However this study is based on hospital level average LOS anal-
ysis, which cannot capture the long tailed distribution of LOS found with individual level
data. Aggregated analysis of technology improvement may thus fall into the “IT productivity
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paradox” trap, which refers to the situation in empirical studies where the benefit of infor-
mation system cannot be found in aggregate output statistics. This can be again attributed
to the problem of “IT Paradox”, as Brynjolfsson has argued about the aggregated level data
missing the variation on disaggregated level issue. In this paper I analyze discharge level
data, which provides details across patient types and characteristics and their outcome.
Hypothesis 1. EMRs lead to faster discharge of patients from hospitals.
Hypothesis 1 discusses the potential average effect of EMRs on patients. However, un-
derstanding the potential heterogeneous EMRs effects helps in evaluating the impact of the
adoption of the IT system in health care sector. Patients not only differ in their observable
characteristics, but also may respond variously to technology improvement. EMRs treat-
ment effect may vary according to individual’s observed characteristics such as demographic
information and admission reasons. Furthermore, heterogeneous effect should be expected if
redistribution of outcome from Health IT indeed exists. The question is, where do heteroge-
neous effects happen. There has been lack of formal discussion in literature about the source
of heterogeneity of EMRs impact. In this paper I investigate this issue from two levels.
The first level of heterogeneous effects is based on observable patient characteristics.
I propose two aspects here: admission type and diagnosis. Admission types (Emergency
Room admission or not) and primary diagnosis can result in different procedures and care
processes, and thereby lead to different levels of IT impact. For example, Emergency Room
(ER) admissions generally occur under more acute situations and would benefit from a more
comprehensive medical background of the patients. One such case is that an ER admission
with stroke requires the physician to identify the types of stroke: clotting or bleeding, each
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of which calls for distinct treatment procedures. These treatments can be counterproductive
or even fatal if used interchangeably (Bhattacharya et al., 2013). Under such emergent cir-
cumstances, a hospital that can access the patient’s past medical history quickly and more
accurately will likely be able to provide a faster and more precise diagnosis and more time to
save a life. However, this scenario would only work provided that the patient has been ad-
mitted to the hospital before and has his/her medical background information electronically
stored. Besides the differences in admission types, patient medical conditions can also be
identified into various Major Diagnostic Categories, with biologically driven responsiveness
to treatment. Therefore it is reasonable to believe that EMRs can benefit patients differently
based on their diagnoses. Athey and Stern (2002a) find IT adoption for emergency response
system improves the patients’ health status through improvement in timeliness, using panel
data set of Pennsylvania counties during 1994-1996. McCullough et al. (2013) use medicare
data on patient level with Diff-in-Diff analysis setup and show that IT’s effect on Medicare
patient outcome varies across four types of disease: pneumonia (PN), congestive heart failure
(CHF), coronary atherosclerosis (CA) and acute myocardial infarction (AMI). In this paper,
I take into consideration of all possible diagnostic categories.
Hypothesis 2. Individual’s admission types and major diagnosis may lead to different
treatment procedures and care processes, and thus patients end up receiving different levels
of EMRs benefit.
Beyond Hypothesis 2, there are still reasons to believe that heterogeneous effect of EMRs
exists within each subgroup of patients defined by their admission types and diagnosis, hence
the second level of heterogeneous effect. Statistically, the mean estimates within each sub-
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population of patients express only the average magnitude of EMRs effect, while there is
still variation left in the residual.
First, EMRs treatment effect may vary according to individual’s medical conditions.
The role of EMRs includes not only storing information electronically, but also organizing
such data to improve treatment decisions. For conditions that require constant monitoring
and tests, EMRs can help monitor by generating large volume of data to be evaluated by
providers. Patients with more severe medical conditions such as diabetes, hypertension or
other high comorbidity measure may therefore benefit more from the IT utilization. Also,
patients that require services from multiple clinical specialists can have their physicians
exchange information and communicate with each other more easily and quickly with the
help of EMRs and CPOE. Such benefits will be less obvious among patients with lower
medical complexity (McCullough et al., 2013). So the average treatment effect within each
subsample by disease types can still be mixture of substantial benefits for some, little or
no benefit (or even harm, if human errors occur during operating the system, such as copy-
pasting information without discretionary) for other patients.
Secondly, the potential heterogeneous treatment effects of EMRs adoption may happen
differently in different types of hospitals. For example, it may be reasonable to believe that
for-profit hospitals will try to reduce LOS after EMRs adoption, due to cost minimizing
concern, whereas such issue is less of concern to non-profit hospitals. Or teaching hospitals
may have better trained physicians and nurses who are more adaptable to new technology
implementation, than those non-teaching hospitals, therefore greater reduction in LOS might
be expected. Moreover, IT complementary labor input and process adaption within an
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institute also plays an important part in the utilization of an IT system, hence an additional
source of potential heterogeneity at the hospital level.
Thirdly, heterogeneity may appear as a distributional treatment effect. As mentioned
above, IT system use can lead to improvement in timeliness by reducing communication cost.
Therefore it is reasonable to assume that individuals may be affected by EMRs differently
based on their LOS. An individual who is admitted to hospital with tww-night stays may
be discharged from hospital a few hours faster with EMRs shortening paperwork time. An
individual who is on the longer end of inpatient stay may be experiencing much faster
discharge than one who is admitted for only two days, because he/she has a longer LOS to
begin with to receive improvement. Therefore any improvement for the patient with a short
LOS may be minimal compared to those with long LOS, especially when LOS in the data
set is coded in days rather than hours. Yet again, one can argue that the distribution-based
variations in treatment effect can be just reflecting the variations caused by patients’ health
condition. Those who has longer LOS are often the ones with more severe medical conditions
than those who stay for a short time.
Because of the first two reasons for the existence of heterogeneous effects, individual
medical conditions and hospital types, one can conduct analysis on sub-samples based on
observable medical conditions or hospital types. However there are two flaws to such a study
design. On the one hand, since observed medical conditions measure may not fully represent
the true complexity and severity of the patient’s medical status. On the other hand, observed
medical conditions can be correlated with demographic background or hospital types, it is
hard to verify whether the result is based on medical conditions or other factors. For example,
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being admitted to a large teaching hospital in a metropolitan area can be seen to indicate
that the patient is in a substantially severe condition.
For the third reason illustrated above, quantile regression for treatment effect estimation
may be applicable for distribution-based heterogeneous effect. Yet the correlation across
different quantiles that each individual test statistic at different quantile relies on, makes
it difficult to understand the treatment estimates. Moreover, Fink et al. (2014) finds that
analysis using either interactions or quantile regressions for heterogeneous effect analysis
suffer from the problem of over-rejecting the null hypothesis using traditional standard errors
and p-values for testings. They argue that each interaction term represents a separate
hypothesis beyond the original experimental design, resulting in a substantially increased
type I error, and individual test results for each percentile group may suffer from the issue
of reusing the same data, as argued by White (2000).
Therefore, not only the true underlying mechanism that causes variability of EMRs effect
is unknown (I listed three possibilities of the sources above), but it is also difficult to incorpo-
rate a traditional estimation strategy for heterogeneous effect. I propose a new way to think
about the origination of heterogeneous treatment effect, which is the Finite Mixture Model
(FMM). The FMM consists of two steps. On the first step, the model identifies the presence
of unobserved heterogeneity and on the second step, it takes into account all known charac-
teristics to explain the heterogeneous effects, if any are found. This contributes to my third
hypothesis, which is that there is a second level of heterogeneous effects. What differentiates
this paper from previous Health IT studies is that, in this analysis, all of the patients’ and
hospitals’ characteristics are taken into account without having to make assumptions of how
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to divide up the study sample. In fact, there is no need to stratify the sample and I utilize
all available information. The strategy to test for this hypothesis is detailed in section 2.4.
Hypothesis 3. EMRs heterogeneous effects exist within each admission types and major
diagnosis group.
2.3 Data Description
There are two main sources of data used for the present analysis. The first one is obtained
from the 2008 Healthcare Information and Management Systems Society (HIMSS) Analytics.
The HIMSS Foundation conducts annual survey questions to over 3000 hospitals in the US
about information on Health IT adoption. Hospitals included in this database are those
that are part of certain integrated health delivery systems. This database contains detailed
information on Health IT adoption on hospital level, including the type of applications,
adoption date, operating status, and adoption plans.
The second source of data comes from the 2002 to 2008 National Inpatient Sample (NIS),
which is part of the Healthcare Cost and Utilization Project conducted by Agency for Health-
care Research and Quality (AHRQ). NIS is the largest inpatient health care database in the
United States, yielding national estimates of hospital inpatient stays. It is a repeated cross-
sectional dataset that resamples every year to represent about 20% of the US acute care
hospitals each year. The dataset contains discharge level medical information, and demo-
graphic information. Medical information includes admission time, length of stay, up to 25
diagnosis records and up to 15 procedure records for each patient. It also includes patients’
insurance or Medicare/Medicaid status, and total out-of-pocket charges. These discharge
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variables allow me to generate patients’ Charlson Comorbidity Index, which is a measure
of medical severity2. Hospital Referral Region dataset from Dartmouth Atlas, and one year
American Hospital Association (AHA) dataset are also used to capture industry market
structure hospital characteristics.
There are some potential sample selection issues to this study. First, to make usage of
the two major data sets, I need to use AHA ID to link them. However in the NIS data, some
states prohibit the identification of hospitals and therefore information from such states
are not available for analysis. Secondly, HIMSS only survey the hospitals that belong to
integrated systems, thus small and independent stand-alone hospitals are not included in
this analysis. Because these problems that may cause bias in the analysis, I restrict my
study sample only to hospitals from states that are available to analyze in all years.
On the patient side, it is important to notice that there are fundamental differences in
patients background. First of all, patients who are transferred into a hospital from other
health care facilities may have more severe health situation and need more intensive care.
Secondly, child birth as the primary reason for a hospital stay should not be viewed as
the same as those who were admitted due to disease. Therefore I drop discharges that are
transferred from other care providers or of birth giving to make sure the final sample consists
of patients who are comparable to each other. I also exclude deaths during inpatient stay.
The final sample consists of 23,852,189 discharges over the seven years. There are in total
1271 hospitals from 21 states. Figure 2.1 shows the geographic coverage of hospitals studied.
As shown in the graph, the final sample consists mostly of states with high population
2Charlson Comorbidity Index, developed by Charlson et al. (1987), is a adjusted-risk weighted sum of 17
comorbidity conditions; the higher the score the more likely the predicted outcome will result in mortality
or higher resource use.
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density. About one third of the hospitals (450) appear only once in all seven years, another
one third appear twice (414), and the rest appear at least three times during the study
period.
The variable of interest is patients’ Length of Stay, measured in days. Same-day dis-
charge is coded as having LOS equals to one. The controlled variables are categorized into
three groups (plus year and state fixed effect). The first group is demographic information,
including age, gender, race, zip code income level, and patients’ payer types. The second
part is health status, which includes two variables: total Charlson Comorbidity Index and
an indicator of Emergency Room Admission. The third group is hospital characteristics,
including hospital size, ownership types and other indicators. Summary statistics are shown
in table 2.1. On average, LOS is longer in hospitals with IT adoptions (4.540 versus 4.459
for Enterprise EMRs and 4.56 versus 4.474 for EMRs + CPOE), and patients in IT imple-
mented hospitals tend to have higher Charlson Comorbidity Index (1.046 versus 1.018 for
Enterprise EMRs and 1.042 versus 1.028 for EMRs + CPOE). On hospital level, hospitals
with EMRs implemented tend to be the ones that are larger (in terms of bed size), with
various affiliations, belonging to health care delivery systems, and teaching hospitals.
2.3.1 Definition of EMRs
The definition of EMRs was unclear during the past few years, so it results in inconsis-
tent measure in literature. For example, Fonkych and Taylor (2005) define two stages of
EMRs adoption in their analysis: a basic EMRs system that contains Computerized Patient
Records, Clinical Data Repository and Clinical Decision Support; whereas a advanced EMRs
is the basic EMRs plus Computerized Physician Order Entry. Miller and Tucker (2011a)
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defined their basic EMRs as having adopted “Enterprise EMR” together with other clinical
support. 3
I adapt two measure of EMRs in my analysis, one is the “Enterprise EMR” as basic
EMRs, and the other one is “basic EMRs plus CPOE”. Due to the structure of HIMSS
questionnaire4, the EMRs is coded in a similar fashion to those used in the work by Miller and
Tucker (2011a). Hospitals are coded as having an EMRs system one year after their initial
“Enterprise EMRs” contract year, and the system is reported as “Live and Operational”.
Similar method applies to the coding of “EMRs plus CPOE”. There are two reasons to
add the CPOE into EMRs definition. First, in theory, CPOE can help shorten Length of
Stay since it is designed to reduced medical errors, to record and transfer information faster.
This means fewer potential hospital stays for patients, so that they do not have to stay
for a longer period waiting for further corrections and communications from care providers.
Second, CPOE utilization has been assigned as the goal of Stage I of the Meaningful Use
by The Health Information Technology for Economic and Clinical Health (HITECH) Act.
Therefore it has essential policy implication to understand the magnitude of CPOE’s impact.
2.4 Identification Strategy
2.4.1 Basic Model
The basic model seeks to find whether last year’s EMRs adoption has any effect on current
year’s Length of Stay, after controlling for hospital characteristics (membership, teaching
3Starting 2009, HIMSS Analytics changes the IT components’ definition in their questionnaire. EMRs
in HIMSS database is now a categorical variable that includes six types of applications, where “Enterprise
EMR” is dropped.
4Since the HIMSS dataset is a survey questionnaire, there are inevitable measurement errors in recording
the information. Researchers have indicated that the status of hospitals IT adoption can be inconsistent
across years, due to the error made by respondents who were filling out the survey.
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status, bed size, ownership etc), patient demographics (age, gender, race, zip code income
level, payer type etc), and patient severity (measured by Charlson Index). The model is
estimated using the negative binomial distribution due to the long tail distribution of LOS.
Therefore the estimation specification is
E(yikt) = f(β0 + β1EMRsk,t−1 +Xiβ2 + Siβ3 +Hkβ4 + λs + φt), (2.1)
where i indicate each discharge unit, and k indicates hospitals at each t period, Xi stands for
demographic characteristic of the discharge, Si is the observable severity of the discharge, Hk
is the observable hospital characteristic, and λs and φt indicate state and year fixed effect,
respectively. Particularly, β1 is the estimator of interest in this analysis. I estimate the effect












where θ indicate all the parameters as stated in equation (2.1), α is the parameter of the
negative binomial distribution that will be estimated.
One of the biggest challenge is that the EMRs adoption decision is endogenously made.
If hospitals decided to implement EMRs and at the same time practicing more on treatments
for patients that acquire longer LOS and services, then the naive estimates β1 in equation
(2.1) should not be interpreted as causal. As pointed out in Elnahal et al. (2011), high
quality adopters acquire more and faster Health IT. In literature, most studies on detecting
EMRs effect on hospital quality of care were conducted within a certain hospital (e.g. Bates
et al. (1999a), Dexter et al. (2004)). In a few studies that aim to capture national results,
researchers tend to use panel data to control for hospital fixed effect (e.g.McCullough et al.
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(2010)). Miller and Tucker (2011a) use privacy laws in each state as an instrument for
EMRs adoption, because hospitals in states where patients record were under strict sharing
permissions were more resistant to adopt information sharing based technology. However,
this instrument is invalid for use in my study because none of the states in my sample except
for North Carolina had a strict privacy law during the study period, hence the low variation
in state legislation for identification in the first stage regression.
2.4.2 Two Sample Instrumental Variable (IV) Model
In this study, I use a different instrument for the EMRs adoption, which is the one-year
lagged EMRs adoption rate of a hospital’s competitors. Suppose hospital i is facing the
decision whether to implement EMRs or not. If it sees more of its competitors in the market
installing the system, then it will be more inclined to adopt the technology. This is the same
rationale as described in the paper of banking market, where banks decide to implement
information system just to keep up with their competitors (Prasad and Harker, 1997). The
assumption implies that the IT adoption decision is closely correlated with competitors’
behavior, yet competitors don’t affect the outcome of a focal hospital directly. The idea
of using competitors relationship in an industry as an instrument is not a completely new
idea in Industrial Organization literature. For example, Evans et al. (1993) use this idea
in airline industries, where they combine instrumental variable method in a fixed-effect
model to eliminate bias. Their instrumental variable is a one-year lagged firm indicator
(Route Herfindahl, to indicator a firm’s ranking position in the industry). Davis (2005)
utilizes this method for movie theater industry, where he uses two-quarter lagged values
of market structure to instrument for current market structure (variations come from the
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movement in competitor’s ranking among movie theaters). In health economics research,
Dafny et al. (2009) study whether the competitiveness in the health care market causes
changes in insurance premiums. In this study, they used market-specific shocks induced by
a large national merger as an instrument for changes in market concentration. The results
show unbiased estimates that the mean increase in local market HHI during 1998-2006 raised
premiums by roughly 7 percent.
The exogeneity assumption of IV methods states that the instrumental variables only
affect the outcome variable indirectly through the endogenous variable. For competing hos-
pitals’ adoption rate to work as a proper instrument, I am imposing the assumption that
competitors’ EMRs adoption does not directly improve the focal hospital’s patients benefit.
There are several reasons to believe that such assumption on the EMRs network externali-
ties is valid. First, hospitals adopt different plans from numerous IT providers, which makes
the inter-hospital health information exchange difficult. The EMRs are primarily installed
to enhance communications within the hospital system itself, rather than the transferring
usage. Secondly, very few hospitals exchange patients’ health records with competitors.
Besides, under state privacy law and the HIPPA regulation, inter-hospital information shar-
ing is strongly restricted (Miller and Tucker, 2009). Furthermore, in my analysis I exclude
transferred patients from the sample. Therefore competitor’s EMRs adoption should not
directly affect focal hospital’s service. Some evidence is available, such as Lee et al. (2013b)
conducted production function estimation of Health IT adoption and found no evidence of
network externalities on hospitals’ productivity. McCullough et al. (2013) tested the hy-
pothesis of EMRs spillover effect in a Diff-and-Diff setting. Results show that neighboring
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EMRs and CPOE adoption does not influence the focal hospital’s magnitude of IT impact.
This IV strategy is valid as long as market shocks to patient outcomes are not corre-
lated with the IT adoption. I find no evidence suggesting that hospital EMRs adoption is
endogenous to time varying unobservables. The first possible threat to this identification
strategy is that health IT adoption could alter the distribution of patient composition such
as severity and diagnoses types. Competitors’ implementation of the EMRs system may al-
ter the patient composition in the market and therefore affect focal hospital’s inpatient care
outcome. I analyze the patient composition trend by adoption status throughout the 7-year
study period and didn’t find significant disparities between the adopters and non-adopters
(see table B1 and table B2).
The second threat to the identification strategy is that there might exist quality invest-
ment correlated to outcome yet unobserved to me, e.g., an exogenous shock in the market
to initiate hospital efficiency improvement. However, if the instrumental variable is picking
up such unobservables, then we should see improvement in quality of care across the entire
inpatient population, not only for patients who should be affected by EMRs. To address this
threat, I present an analysis on Acute Myocardial Infarction (AMI) patients as a placebo
test. According to McCullough et al. (2013), AMI is a common condition with widely ac-
cepted diagnostic and treatment guidelines. The treatments are so standardized that AMI
patients are expected to receive little impact from EMRs system. This is particularly true
for emergent ST-elevated myocardial infarctions (STEMIs) without secondary diagnoses of
Coronary Atherosclerosis (CA) or Congestive Heart Failure (CHF) where rapid repercussion
therapy is the standard of care. Therefore EMRs is expected to have little effect on AMI
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and STEMIs patients. The placebo test is presented in table B3, which indeed shows that
neither Enterprise EMRs nor EMRs + CPOE shows a statistically significant impact. This
placebo test does not indicate that there are other unobserved investment to be attributed
to the efficiency change.
Due to sample selection and my restrictions on the states to be included, the merged
dataset (discharge level) is only showing a subsample of the hospital population. Yet it is to
be believed that the correlation of EMRs adoption and previous years’ competitors’ adoption
rate is happening across the entire hospital population. Therefore I am adopting the two
sample IV (TSIV) method brought up by Angrist and Krueger (1992), which illustrate that
TSIV can still yield consistent estimates. The first stage regression is based on the HIMSS
dataset only, which contains the entire system-related hospitals for each year (hospital level).
Therefore the first stage logit regression model is as follows:
P (EMRs adoptionk,t|Hk, w) =
1
1 + exp(−(w0 + w1Competitors’ EMRs ratek,t−1 +Hw2 + φt))
, (2.3)
where the significance of w1 estimator is of interest. Since the second stage regression is
parameterized into the non-linear negative binomial distribution, traditional two-stage IV
method yields inconsistency (for comprehensive illustration of such inconsistency, please
review Terza et al. (2008)). As a result I adopt the residual included control function method,
where both the variable of interest (in this case, the last year EMRs adoption decision) and
the residuals from first stage regression are inserted into second stage regression, instead of
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the predicted value of last year EMRs decision.
E(yikt) =
f(β0 + β1EMRsk,t−1 + γF.S.residualk,t−1 +Xiβ2 + Siβ3 +Hkβ4 + λs + φt), (2.4)
The residual inclusion idea was first suggested by Hausman (1978) in linear models to test
for endogeneity. Similarly in a non-linear set up, if the residual coefficient is significant in
the second stage regression, then it suggests the existence of endogeneity.
2.4.3 Heterogeneous Effect Models
It is important for economists to identify the heterogeneous effect of any intervention, to
understand how different populations are impacted. As mentioned in the Hypotheses, there
are two levels of heterogeneous treatment effect of EMRs. On the first level, EMRs can
affect patients within different disease types differently. On the second level, even within
each subsample of patients grouped according to the diagnoses, patients are still expected to
affected heterogeneously based on their health status, which is indicated by a latent variable.
For analysis on the first level of EMRs heterogeneous treatment effect, I split the full
sample into subsamples based on the admission types and patients’ major diagnostic cate-
gory. Then the model is estimated using the Two Sample Instrumental Variables method to
obtain consistent estimates.
To establish the estimation second level of heterogeneous effect, I estimate a Finite Mix-
ture Model. As discussed in previous section, FMM is a suitable way to integrate all observed
differences in variables, using all available information in the sample, without manually split-
ting the sample into different categories. The theoretical derivation of mixture of densities
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has been established in the statistics literature for decades (e.g. see McLachlan and Basford
(1988)), and Lindsay (1995) has provided more recent in-depth discussions of the utilization
of FMM. The mixture model is also widely used in medical research studies. For example,
Schlattmann (2009) discussed numerous applications of the FMM method, including anal-
ysis of gene expression data, pharmacokinetics, toxicology, and meta-analysis of published
work. In econometrics, Heckman and Singer (1984) demonstrated the mixture model anal-
ysis for duration data, and estimated the distribution function of the unobservables. Deb
and Trivedi (1997) published the first work utilizing a FMM analysis on a binomial count
model in the health economics field, where they estimate the demand for medical care based
on unobserved health status of the elderly.
According to my proposed hypotheses, I begin with the assumption that there are at
least two different groups in the population, the more severe patients and the less severe
ones. To show this in the mixture model concept, it means there are two sub-populations
in the whole population. The identification of these two components is based on the latent
variable that indicating health conditions. I do not put any constraint on how to separate
these two populations based on observed characteristics. I am letting the model to do this
separation, through maximizing likelihood method.
A typical FMM contains two stages of analysis. The first stage model with C components
(in my study here with the assumption mentioned above, C = 2) looks like this:




where 0 < πj < 1 and
∑C
j=1 πj = 1, θj is parameter of x, j indicates different components
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in the model, and πj is the predicted share/percentage of component j among the entire
population. In other words, the log-likelihood is the sum of each component’s log-likelihood,
weighted by the probability. More specifically, LOS is modeled by Negative Binomial distri-
bution. Thus for the Negative Binomial density for each observation i















where αj ≥ 0 is referred to as the index or dispersion parameter. When αj → 0, the
distribution converges to Poisson distribution. The subscript j of αj indicates that each
component of the mixture follows its own distribution density. At this stage, the model
predicts C types of heterogeneous effects (again, in this paper, C = 2) of EMRs on LOS.
At the same time, the model will predict πj, the predicted share of the components. Notice
that all shares of the components should sum to 1. That is,
C∑
j=1
πj = 1 (2.7)
0 < πj < 1 (2.8)
Parameters of the finite mixture distributions for LOS are estimated by maximum likelihood.
The second stage of FMM relates the predicted heterogeneous groups to each observation.
Although the class probabilities, πj, are not informative for individual-level assignment of
observations into classes, Bayes’ theorem can be used to estimate the posterior probability
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that observation i belongs to component c:




After the two-stage FMM analysis, the model does not yet relate the predicted heterogeneity
to the observable characteristics of each inpatient record to understand how the estimated
sub groups differ. I use the estimates of the posterior probabilities of class-membership to
assign individuals in the sample to a unique class and use these classifications to explore
the determinants and correlates of class membership. This process is estimated using OLS
regression.
2.5 Results
2.5.1 Basic Model and First Level Heterogeneous Treatment Ef-
fect
Figure 2.2 shows the adoption of Enterprise EMRs and EMRs + CPOE across years. The
adoption of Enterprise reaches above 40% by 2008, whereas the adoption of CPOE is much
lower, with slightly more than 20%. The adoption rates are consistent with the information
provided in Dranove et al. (2012), which shows the implementation of CPOE to be about
22% in 2008.
Table 2.2 reports the first stage of IV regression. The instrument (one-year lagged EMRs
adoption rate from competitors in the same HRR area as focal hospitals) shows strong corre-
lation with the EMRs adoption of each focal hospital. This is true for both Enterprise EMRs
and EMRs + CPOE adopters, which supports the correlation requirement of the instrument
to the endogenous variable. Hospital ownership type shows significant correlation to adop-
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tion decisions. Compared to for-profit hospitals, government owned or non-profit hospitals
are more likely to invest in the IT technology, probably because the financial pressure at
the beginning of the adoption process is too heavy and does not meet profit-maximization
criteria for a for-profit hospital. Belonging to a health care delivery system is significantly
associated with IT adoption, which may be explained by the incentive gained from IT for
easier inner system communication, or by the larger bargaining power in negotiating prices.
At the same time, hospitals accredited by or affiliated to other organizations do not show
significant associations to the EMRs adoption behavior for CPOE adoption.
The first two columns of table 2.3a and 2.3b show both the Enterprise EMRs and EMRs
+ CPOE adoption effect on LOS respectively, under Negative Binomial regressions. Notice
the model also controls for patients’ Major Diagnosis Category (MDCs) that is not reported
in the tables. The remaining four columns study the heterogeneous effect of EMRs based
on discharges’ admission types. All of the estimated coefficients show negative sign, which
corresponds to Hypothesis 1 that EMRs reduce LOS. Across the two sub-tables, coefficients
in table 2.3b are greater than those in table 2.3a, indicating that LOS is reduced more with
added CPOE to EMRs than Enterprise EMRs alone.
Furthermore, results also show a consistent pattern in the size of effect within each
sub-table. The point estimates of IV estimators are all larger than the naive estimators,
and under the CPOE + EMRs implementation, IT’s effect is all statistically significant.
When ignoring endogeneity under naive regression (column 1, 3, and 5), the one-year lagged
EMRs adoption shows a drop LOS by about 1.4% to 2%. When controlling for endogeneity
(column 2, 4, and 6) using Two Sample IV, LOS are shown to be reduced by 11% by
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using Enterprise EMRs and by 16% by using EMRs + CPOE. In other words, while the
residuals from first stage regression pull away any unobserved factors in EMRs adoption
decision making, the coefficient on lagged EMRs variable is expected to be showing the true
treatment effect. Along with this result, we see that patients’ demographic information and
their severity (Charlson Index) show significant correlation to the hospital staying length,
along with several hospital characteristics. LOS increases with the increase of age; black
patients tend to have longer LOS compared to white non-Hispanic patients, while Hispanic
patients have shorter stays; Female patients stay for fewer days compared to male patients;
a higher Charlson Index is correlated with longer LOS, while patients admitted through ER
are staying with longer LOS than those that are not ER admissions.
In response to Hypothesis 2, results show that the first level of heterogeneous treatment
effect that is based on patients admission types is not significant. Under Enterprise EMRs
setting, neither sub-sample based on ER/non-ER admission shows significant impact from
the IT system. Also the effect on non-ER admitted sample shows smaller EMRs effect
than the ER admitted sample, and the significance drops for non-ER patients under a naive
estimation approach. Under EMRs + CPOE setting however, non-ER admitted patients
receive significant 15.8% drop in LOS, whereas ER admitted patients receive significant
10.2% drop. Moreover, table 2.3a shows that residual from first stage is insignificant, whereas
in table 2.3b they are significant except for ER admissions. This suggests that for ER
discharges under EMRs + CPOE setting, there is little to no endogeneity detected. The point
estimates on ER admission are lower than non-ER in both Health IT settings, although not
statistically significant. In theory, it is plausible to assume that patients with ER admission
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may expect to benefit more from IT system than those who are not, because ER admissions in
general reflects more complicated situations that require constant monitoring and immediate
response. Yet the lack of empirical results to support this theory may be due to the fact
that in some emergency cases, IT system can fulfill its potential only if the patient has
been admitted to this same hospital before or there are patient records on file already to be
extracted. Since I cannot identify the readmission using this particular dataset I was not
able to further investigate this possibility.
Figure 2.3 reports IV estimation results from eight Major Diagnosis Categories. The drop
of LOS due to Enterprise EMRs implementation ranges from 6.4% (Digestive, Hepatobiliary,
and Pancreas disease) to 45.4% (Injuries, Poison, Burns, Toxic and Trauma). This confirms
Hypothesis 2 that heterogeneous EMRs effects can be found across different diagnostic types.
And once more the combination of EMRs + CPOE shows greater effect than the Enterprise
EMRs setting.
EMRs with CPOE adopted shows greater effect than Enterprise EMRs alone. This
should not be a surprise, for CPOE allows providers to interact with patients’ medical data
stored through EMRs and make decisions in real time and use it to place medical orders.
Therefore it is expected that EMRs and CPOE will show a greater effect when combined
together. Besides, the definition of Enterprise EMRs in HIMSS database is not very clear
in its measurement. Survey respondents may be responding for this IT system but referring
to other types of IT system they have implemented, since the word “Enterprise EMRs”
seems to cover a range of IT system instead of just one application. CPOE is also the first
stage requirement of HITECH Meaningful Use regulation, which once more emphasize its
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importance.
2.5.2 Second Level Heterogeneous Treatment Effect
Sub-tables (a) and (b) of table 2.4 show the results from FMM first stage regressions for
consistent estimation, where the FMM model is automatically identifying two types of ob-
servations that are receiving different EMRs effects based on unobserved latent class. 5
According to the result, there are about 77% “component 1” (“C 1” as in the column title)
observations and 23% “component 2” (“C 2” as in the column title) observations. For Enter-
prise EMRs, patients in component 1 experience an insignificant drop of LOS by 3.3%, 3.9%
and 0.5% (all discharges, ER admissions and non-ER admissions, respectively), whereas the
component 2 patients are significantly affected by EMRs adoption, with the magnitude of
effect much higher than that of component 1: 18.2%, 12% and 18.3% drop in LOS under
EMRs adoption (all discharges, ER admissions and Non-ER admissions, respectively).
For Enterprise EMRs plus CPOE, patients in component 1 experience an insignificant
decrease in LOS by 3.1%, 2.0% and 7.1%, whereas the component 2 patients also are sig-
nificantly affected by CPOE added EMRs, with the magnitude of effect being much larger
than that of component 1: 20.5%, 17.4% and 19.8% drop in LOS under EMRs adoption (all
discharges, ER admissions and non-ER admissions, respectively). Once more, added CPOE
cause greater reduction in LOS than Enterprise EMRs alone. And notice the significance
power is increased in the analysis of EMRs + CPOE setting, which again emphasizes the
importance of CPOE added to EMRs. All together, component 2 patients received much
higher impact by EMRs than did component 1.
5Just a reminder that the second stage of FMM analysis is to estimate the probabilities of each observation
belonging to different heterogeneous component, therefore the result is not reported in tables here.
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So far the results only distinguish the two heterogeneous groups. But who are those
component 1 and 2 patients? To what degree are they different? To answer these questions,
I first checked the distributions of LOS in each component. The densities are shown in figure
2.4. All four graphs tell a similar story: that patients belonging to component 1 have on
average a shorter LOS while those in component 2 on average have a longer LOS, with longer
right tails in the distribution. To summarize, those who on average stay in hospitals for a
longer period of time see a larger drop in LOS with the implementation of EMRs.
I then impose the model to regress the posterior probability of being in “component
1” on demographic and hospital characteristics, time and state fixed effect, and on patient
acuity. Results are shown in table 2.5. Age, gender and race have some significant effects on
assigning patients into each component: older patients and black patients are more likely to
be assigned to component 2, the group that has longer average LOS and experiences larger
effect by IT as component 1 patients does. Female patients are more likely to belong in
component 1.
Patients’ observable health indicators also play important role in these regressions. Those
who were admitted through the ER are more likely to be in component 1, and patients with
more severe medical conditions are more likely to be component 2. More specifically, figure
2.5 shows the composition of comorbidity in each component. This graph provides a nice
visual explanation of how these two components of patients differ in medical severity.
In general, an image can be drawn from the significant variables, which shows that
component 2 patients have worse health conditions than component 1 patients. Not only
the comorbidity disparities send a clear signal, but also the demographic characteristic shows
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the consistent information. Older patients are generally less healthy than younger patients;
female patients tend to be healthier than males of the same age; black patients in general
suffer from more severe health conditions than do the other races.
However, hospital characteristics show almost no significant correlations in separating
the patients into two components. In other words, when controlled for other patient level
information, patients who are affected by EMRs differently have no significant variations in
the types of hospitals where they are staying. Therefore, this result implies that it is not the
observed hospital level characters except for “Critical Access Hospitals (CAHs)”, but rather
the patients demographic and comorbidity differences that are the reasons of heterogeneous
EMRs impacts. At the same time, it is reasonable to believe that “Critical Access Hospitals”
can be largely improved by EMRs due to the nature of CAHs, since they are required to
maintain an annual average LOS of no more than 96 hours for acute inpatient care.
In summary, the Finite Mixture Model supports Hypothesis 3, that there is an unobserv-
able latent variable that assigns patients as either the “less severe ones” or “more severe
ones”, and these groups are affected by EMRs differently. The model identifies two types
of EMRs effect on LOS for all patients in study sample: Component 1 patients have lower
comorbidity index, are more likely to be younger patients who stay in hospitals for relatively
shorter time periods, and on average experience a drop of 2 - 7% in LOS. Component 2
patients are in relatively worse medical conditions (high comorbidity index), more likely to
be of older age, stay in hospitals for a longer period of time, and on average experience a
drop of 12-21% in LOS after one year of EMRs implementation. The reason for this re-
sult could be that component 1 patients start with short Length of Stay, and any effort to
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shorten the days would have minimal effect. At the same time, for component 2 patients,
longer LOS may give them more space to improve (in terms of shortening stays) through
EMRs help. This may be accomplished either through faster process of paperwork, making
fewer medical errors during procedures, or improved ease and speed of decision making for
physicians. However these factors are not identifiable in this study.
2.5.3 More evidence on the Two Level Heterogeneous Treatment
Effect
In this section I review more evidence of the two levels of the heterogeneous treatment
effects. The sample is first divided into sub-samples based on each patient’s Major Diagnosis
Category (MDCs). The MDCs are formed by dividing all possible principle diagnoses (coded
in ICD-9-CM) into 25 mutually exclusive diagnosis areas6. Due to extremely low frequencies
(less than 1%) in some categories, I grouped similar categories in my analysis (e.g. Female
and Male Reproductive System are grouped together as the Reproductive System). Table
2.6 and its sub-tables show both the IV and FMM regressions results for each category.
Only eight out of 20 disease groups that are of large sample size are shown here and together
they cover 64% of the total sample. These are the diseases that affect the majority of the
population.
Table 2.6 reports both negative binomial regressions IV results and the FMM results.
The negative binomial results corresponds to figure 2.3 as discussed above. At the same
time, the FMM results show consistent patterns as in the analysis of patients with all diag-
nosis categories, which is in accordance with the hypothesis of the existence of second level
6MDCs is one of the most common ways of categorizing patients, although it has its limitations in
representing the disease type. For example, MDCs are coded with respond to organ systems or etiology, so
that there is no explicit category for neoplasms.
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heterogeneous treatment effects. Within each of the diagnosis group, component 2 patients
are always shown to be impacted more than component 1. And the component 2 in each
category consistently refers to the more severe patients within the diagnosis category, with
only the distribution of component 1 and 2 differing slightly across MDCs.
2.6 Conclusion
This paper examines how EMRs improve efficiency in timeliness by reducing LOS. By using
a seven-year period sample with detailed discharge level medical information, I am able
to identify the EMRs effect, which may take years to appear, and at the same time to
identify and control for patients’ medical conditions. The results show that on average,
for patients with all diagnoses, LOS is reduced by 11% to 16% under consistent estimation
due to the implementation of EMRs. Added CPOE can reduce LOS more than Enterprise
EMRs alone. One needs to notice that the consistent estimates of EMRs treatment effect
should be interpreted as the Local Average Treatment Effect (LATE) as discussed in Imbens
and Angrist (1994). The estimated coefficients represent the compliers of the instrument
variable. Although there are hospitals in sample that did not adopt any IT system at all
during the study period, it is not sufficient to believe they are the never-takers since their
future adoption behavior could change with more hospitals turning towards Information
System management.
Results also support the existence of two levels of heterogeneous treatment effect. The
source of first level comes from patients’ admission types and diagnostic groups. Within
each sub-group of patients lies the second level of heterogeneous effects based on health
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conditions of the patients. FMM results further show that this second level of heterogeneous
effect does not come from the variations in hospital types to which patients are admitted.
In other words, regardless of the observable hospital types, more severe patients are affected
more by the EMRs than those who are relatively less severe, in terms of shortening the
time spent inside the institution. By utilizing the FMM method, patients’ characteristics
and medical conditions together identify the underlying heterogeneity, even among each
stratified inpatient sample based on diagnoses, without putting dichotomy restrictions on
the sample prior to the analysis.
This study can shed light on the policy that encourages Health IT adoption and intends
to reduce health care costs across country, and especially addresses the potential benefit from
Stage I of Meaningful Use. The result shows that CPOE and other EMRs system can bring
benefit to hospitals by improving efficiency. Even though this study does not contain cost
information, the benefit of reducing LOS may be associated with reducing waste in medical
care. It may justify the large amount of Federal Health IT subsidies being provided in the
attempt to bring down total health care expenditures.
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Table 2.1: Summary Statistics
Enterprise EMRs No EMRs EMRs + CPOE No CPOE
Length of stay (cleaned) 4.540 4.459 4.560 4.474
Demographic
Age 51.936 52.007 51.614 52.114
Black 0.104 0.082 0.098 0.091
Hispanic 0.093 0.109 0.095 0.104
Asian and other race 0.311 0.321 0.323 0.314
Female 0.599 0.601 0.600 0.600
Low Income 0.208 0.215 0.204 0.215
Missing Income 0.031 0.023 0.036 0.023
Lower to Medium Income 0.237 0.240 0.243 0.237
Medium Income 0.245 0.239 0.250 0.239
Medicare 0.382 0.398 0.375 0.397
Medicaid 0.172 0.175 0.177 0.173
Other Insurance 0.085 0.091 0.089 0.088
Health Status
Charlson Score 1.046 1.018 1.042 1.028
Admitted through ER 0.422 0.444 0.410 0.443
N (Discharge × Year) 11,693,287 12,192,068 6,757,555 17,127,800
Hospital Characteristics
Ownership: Gov. 0.173 0.201 0.192 0.191
Ownership: Non Profit 0.757 0.637 0.776 0.657
Critical Access Hospital 0.063 0.244 0.055 0.208
System 0.631 0.570 0.653 0.577
Cancer program approved by ACS† 0.548 0.352 0.589 0.382
Residency training approved by GME† 0.341 0.166 0.401 0.188
AMA† Medical school affiliation 0.424 0.231 0.467 0.261
Accreditation by CARF† 0.180 0.086 0.185 0.104
Teaching 0.133 0.060 0.164 0.068
Rural Referral Center 0.098 0.067 0.087 0.076
Bed Size: less than 100 0.191 0.438 0.203 0.383
Bed Size: less than 300 0.491 0.381 0.444 0.415
Bed Size: less than 500 0.183 0.133 0.196 0.140
Bed Size: more than 500 0.136 0.048 0.156 0.061
N (Hospital × Year) 980 1,708 531 2,157
† Abbreviations:
ACS: American College of Surgeons
AMA: American Medical Association
CARF: Commision on Accreditation of Rehabilitation Facilities
CHAPTER 2. HEALTH IT ON EFFICIENCY 59
Table 2.2: First Stage Regressions
Enterprise EMRs Enterprise EMRs + CPOE
Lagged Competitors IT adoption 1.200 1.664
(0.201)*** (0.264)***
Ownership: Gov. 1.155 1.359
(0.160)*** (0.202)***
Ownership: Non Profit 1.176 1.341
(0.140)*** (0.172)***




Cancer program approved by ACS† -0.042 0.141
(0.100) (0.120)
Residency training approved by GME† -0.013 0.263
(0.155) (0.194)
AMA† Medical school affiliation 0.284 0.157
(0.142)** (0.176)




Rural Referral Center 0.390 -0.003
(0.125)*** (0.170)
N Hospital × Year 23,031 23,031
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes hospital size, year and state fixed effect.
Standard error clustered at hospital level.
† Abbreviations:
ACS: American College of Surgeons
AMA: American Medical Association
CARF: Commision on Accreditation of Rehabilitation Facilities
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Table 2.3: Effect of EMRs on LOS
(a) Effect of Enterprise EMRs on LOS
All Patients ER Admissions Non ER Admissions
(1) (2) (3) (4) (5) (6)
Enterprise EMRs -0.014* -0.112* -0.017* -0.089 -0.010 -0.096
(0.007) (0.061) (0.009) (0.078) (0.009) (0.075)
Residual from First Stage 0.101 0.073 0.089
(0.062) (0.081) (0.074)
Age 0.005*** 0.005*** 0.006*** 0.006*** 0.004*** 0.004***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.083*** 0.084*** 0.076*** 0.076*** 0.098*** 0.099***
(0.006) (0.006) (0.008) (0.007) (0.007) (0.007)
Hispanic -0.018** -0.017** -0.012 -0.012 -0.016** -0.015*
(0.008) (0.008) (0.011) (0.011) (0.008) (0.008)
Asian and other race 0.002 0.002 -0.001 -0.001 0.007 0.007
(0.007) (0.007) (0.009) (0.009) (0.008) (0.008)
Female -0.023*** -0.023*** -0.038*** -0.038*** -0.005** -0.005**
(0.002) (0.002) (0.003) (0.003) (0.002) (0.002)
Low Income 0.027*** 0.028*** 0.034*** 0.035*** 0.020** 0.020**
(0.007) (0.007) (0.009) (0.008) (0.008) (0.008)
Lower to Medium Income 0.017*** 0.017*** 0.022*** 0.022*** 0.011* 0.011*
(0.005) (0.005) (0.007) (0.006) (0.006) (0.006)
Medium Income 0.013*** 0.013*** 0.017*** 0.017*** 0.009* 0.009*
(0.004) (0.004) (0.006) (0.006) (0.005) (0.005)
Charlson Score 0.076*** 0.076*** 0.082*** 0.082*** 0.072*** 0.072***
(0.001) (0.001) (0.001) (0.001) (0.002) (0.002)
Admitted through ER 0.036*** 0.036***
(0.006) (0.006)
Medicare 0.129*** 0.129*** 0.146*** 0.146*** 0.120*** 0.120***
(0.004) (0.004) (0.005) (0.005) (0.005) (0.005)
Medicaid 0.135*** 0.135*** 0.208*** 0.208*** 0.076*** 0.076***
(0.005) (0.005) (0.007) (0.007) (0.007) (0.007)
Other Insurance 0.021*** 0.020*** 0.047*** 0.046*** 0.002 0.002
(0.008) (0.007) (0.008) (0.008) (0.012) (0.012)
ownership: Gov. 0.027* 0.048** 0.040** 0.055** 0.016 0.034
(0.015) (0.020) (0.018) (0.025) (0.018) (0.023)
ownership: non profit -0.017 0.004 -0.021* -0.006 -0.011 0.007
(0.011) (0.018) (0.013) (0.022) (0.013) (0.021)
critical access hospital -0.059*** -0.070*** -0.139*** -0.146*** -0.019 -0.029
(0.022) (0.023) (0.022) (0.023) (0.030) (0.032)
system 0.000 0.005 0.010 0.013 -0.013 -0.008
(0.008) (0.009) (0.010) (0.012) (0.010) (0.010)
Cancer program approved by ACS -0.003 -0.005 -0.009 -0.010 0.005 0.004
(0.009) (0.009) (0.012) (0.011) (0.010) (0.010)
Residency training approved by GME 0.035** 0.035** 0.019 0.019 0.044** 0.044**
(0.014) (0.014) (0.013) (0.013) (0.021) (0.021)
AMA Medical school affiliation -0.005 0.001 -0.001 0.004 -0.000 0.005
(0.013) (0.014) (0.012) (0.013) (0.020) (0.022)
Accreditation by CARF 0.011 0.016 0.010 0.013 0.013 0.017
(0.012) (0.012) (0.015) (0.016) (0.012) (0.012)
Teaching Hospital 0.056*** 0.062*** 0.042** 0.046** 0.072*** 0.077***
(0.015) (0.015) (0.019) (0.018) (0.017) (0.017)
Rural Referral Center -0.045*** -0.037*** -0.046*** -0.040*** -0.041*** -0.034**
(0.011) (0.012) (0.014) (0.015) (0.012) (0.014)
N 23,852,189 23,852,189 11,282,328 11,282,328 12,569,861 12,569,861
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(b) Effect of Enterprise EMRs + CPOE on LOS
All Patients ER Admissions Non ER Admissions
(1) (2) (3) (4) (5) (6)
EMRs + CPOE -0.019* -0.138*** -0.030** -0.102** -0.013 -0.158***
(0.010) (0.038) (0.013) (0.046) (0.011) (0.047)
Residual from First Stage 0.124*** 0.075 0.152***
(0.039) (0.046) (0.048)
Age 0.005*** 0.005*** 0.006*** 0.006*** 0.004*** 0.004***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.083*** 0.085*** 0.075*** 0.076*** 0.098*** 0.100***
(0.007) (0.006) (0.008) (0.008) (0.007) (0.007)
Hispanic -0.017** -0.015** -0.012 -0.011 -0.016* -0.013*
(0.008) (0.008) (0.011) (0.011) (0.008) (0.008)
Asian and other race 0.001 0.003 -0.001 -0.001 0.007 0.009
(0.007) (0.007) (0.009) (0.009) (0.008) (0.008)
Female -0.023*** -0.023*** -0.037*** -0.037*** -0.005** -0.005**
(0.002) (0.002) (0.003) (0.003) (0.002) (0.002)
Low Income 0.027*** 0.027*** 0.034*** 0.034*** 0.020** 0.020**
(0.007) (0.007) (0.008) (0.008) (0.008) (0.008)
Lower to Medium Income 0.017*** 0.017*** 0.022*** 0.022*** 0.011* 0.011*
(0.005) (0.005) (0.006) (0.006) (0.006) (0.006)
Medium Income 0.013*** 0.013*** 0.017*** 0.017*** 0.009* 0.009*
(0.004) (0.004) (0.006) (0.006) (0.005) (0.005)
Charlson Score 0.076*** 0.076*** 0.082*** 0.082*** 0.072*** 0.072***
(0.001) (0.001) (0.001) (0.001) (0.002) (0.002)
Admitted through ER 0.036*** 0.036***
(0.006) (0.006)
Medicare 0.129*** 0.129*** 0.146*** 0.146*** 0.120*** 0.120***
(0.004) (0.004) (0.005) (0.005) (0.005) (0.005)
Medicaid 0.135*** 0.135*** 0.208*** 0.208*** 0.077*** 0.077***
(0.005) (0.005) (0.007) (0.007) (0.007) (0.007)
Other Insurance 0.021*** 0.021*** 0.047*** 0.047*** 0.003 0.002
(0.007) (0.007) (0.008) (0.008) (0.012) (0.012)
ownership: Gov. 0.027* 0.042*** 0.040** 0.049*** 0.015 0.033*
(0.015) (0.015) (0.017) (0.019) (0.017) (0.018)
ownership: non profit -0.016 0.000 -0.020* -0.010 -0.010 0.009
(0.010) (0.011) (0.012) (0.013) (0.013) (0.015)
critical access hospital -0.060*** -0.072*** -0.140*** -0.146*** -0.020 -0.035
(0.022) (0.022) (0.022) (0.023) (0.030) (0.031)
system 0.001 0.009 0.011 0.016 -0.013 -0.002
(0.008) (0.009) (0.010) (0.011) (0.010) (0.010)
Cancer program approved by ACS -0.003 -0.002 -0.009 -0.008 0.005 0.007
(0.009) (0.009) (0.012) (0.012) (0.010) (0.010)
Residency training approved by GME 0.036** 0.042*** 0.020 0.024* 0.045** 0.051**
(0.014) (0.014) (0.014) (0.014) (0.021) (0.021)
AMA Medical school affiliation -0.006 -0.004 -0.001 -0.001 -0.000 0.002
(0.013) (0.013) (0.012) (0.012) (0.020) (0.019)
Accreditation by CARF 0.012 0.012 0.011 0.011 0.013 0.014
(0.012) (0.011) (0.014) (0.014) (0.012) (0.011)
Teaching Hospital 0.057*** 0.065*** 0.043** 0.048*** 0.073*** 0.082***
(0.015) (0.015) (0.018) (0.017) (0.017) (0.017)
Rural Referral Center -0.045*** -0.045*** -0.046*** -0.046*** -0.041*** -0.041***
(0.011) (0.011) (0.013) (0.013) (0.012) (0.012)
N 23,852,189 23,852,189 11,282,328 11,282,328 12,569,861 12,569,861
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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Table 2.4: Heterogeneous Effect of EMRs Adoption on LOS
(a) .Enterprise EMRs Adoption
All Discharges through ER Admissions through Non-ER Admissions
C 1 C 2 C 1 C 2 C 1 C 2
Enterprise EMRs -0.033 -0.182** -0.039 -0.120 -0.005 -0.183*
(0.049) (0.090) (0.057) (0.101) (0.072) (0.109)
Residual from 1st Stage 0.018 0.172* 0.020 0.107 -0.004 0.172
(0.049) (0.093) (0.058) (0.106) (0.072) (0.108)
Age 0.006*** 0.004*** 0.007*** 0.004*** 0.005*** 0.003***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.067*** 0.098*** 0.054*** 0.084*** 0.078*** 0.132***
(0.005) (0.009) (0.006) (0.009) (0.005) (0.011)
Hispanic 0.007 -0.037*** 0.001 -0.023* 0.017*** -0.046***
(0.006) (0.011) (0.007) (0.013) (0.007) (0.012)
Asian and other race -0.005 0.006 -0.018** 0.009 0.008 0.009
(0.005) (0.010) (0.008) (0.012) (0.005) (0.012)
Female 0.034*** -0.065*** 0.032*** -0.080*** 0.037*** -0.037***
(0.002) (0.003) (0.002) (0.003) (0.002) (0.003)
Low Income 0.032*** 0.025*** 0.049*** 0.027*** 0.016*** 0.029**
(0.005) (0.009) (0.007) (0.010) (0.006) (0.012)
Lower to Medium Income 0.019*** 0.014** 0.034*** 0.015* 0.007 0.015*
(0.004) (0.007) (0.006) (0.008) (0.005) (0.009)
Medium Income 0.014*** 0.012* 0.025*** 0.013* 0.006 0.011
(0.003) (0.006) (0.005) (0.007) (0.004) (0.007)
Charlson Score 0.061*** 0.073*** 0.063*** 0.079*** 0.057*** 0.074***
(0.001) (0.001) (0.001) (0.002) (0.001) (0.002)
Admitted through ER 0.047*** 0.043***
(0.007) (0.007)
Medicare 0.096*** 0.144*** 0.135*** 0.148*** 0.070*** 0.144***
(0.004) (0.005) (0.004) (0.006) (0.004) (0.006)
Medicaid 0.057*** 0.202*** 0.127*** 0.267*** 0.014*** 0.140***
(0.003) (0.008) (0.004) (0.009) (0.004) (0.011)
Other Insurance -0.031*** 0.074*** 0.014** 0.069*** -0.064*** 0.076***
(0.005) (0.011) (0.007) (0.010) (0.007) (0.015)
ownership: Gov. -0.003 0.082*** -0.013 0.093*** 0.001 0.061*
(0.015) (0.030) (0.017) (0.033) (0.020) (0.035)
ownership: non profit -0.004 0.018 -0.004 0.004 -0.010 0.023
(0.014) (0.027) (0.016) (0.029) (0.019) (0.031)
critical access hospital -0.057*** -0.043 -0.069*** -0.254*** -0.040** 0.095
(0.015) (0.056) (0.017) (0.043) (0.020) (0.081)
system -0.000 0.010 -0.000 0.020 -0.004 -0.004
(0.007) (0.013) (0.008) (0.016) (0.008) (0.015)
Residency approved by GME 0.016 0.054*** -0.016 0.041** 0.037* 0.060**
(0.015) (0.018) (0.013) (0.018) (0.019) (0.025)
AMA school affiliation -0.021 0.026 -0.004 0.013 -0.030 0.052**
(0.015) (0.018) (0.013) (0.017) (0.021) (0.026)
Accreditation by CARF 0.002 0.029 0.018* 0.014 -0.007 0.039**
(0.008) (0.019) (0.010) (0.022) (0.009) (0.018)
Teaching Hospital -0.021** 0.124*** -0.040*** 0.093*** -0.007 0.142***
(0.010) (0.021) (0.013) (0.025) (0.012) (0.025)
Rural Referral Center -0.017* -0.057*** -0.016 -0.056*** -0.014 -0.056**
(0.010) (0.019) (0.012) (0.020) (0.011) (0.023)
N 23,852,189 23,852,189 11,282,328 11,282,328 12,569,861 12,569,861
π (predicted share) 0.77 0.23 0.69 0.31 0.82 0.18
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
CHAPTER 2. HEALTH IT ON EFFICIENCY 63
(b) . EMRs + CPOE Adoption
All Discharges through ER Admissions through Non-ER Admissions
C 1 C 2 C 1 C 2 C 1 C 2
EMRs + CPOE -0.031 -0.205*** 0.020 -0.174*** -0.071* -0.198***
(0.030) (0.054) (0.042) (0.063) (0.039) (0.064)
Residual from First Stage 0.010 0.197*** -0.050 0.152** 0.058 0.202***
(0.031) (0.053) (0.043) (0.061) (0.039) (0.065)
Age 0.006*** 0.004*** 0.007*** 0.004*** 0.005*** 0.003***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.067*** 0.099*** 0.058*** 0.087*** 0.079*** 0.134***
(0.005) (0.009) (0.006) (0.009) (0.005) (0.011)
Hispanic 0.007 -0.035*** -0.000 -0.023 0.018*** -0.044***
(0.006) (0.011) (0.008) (0.014) (0.007) (0.012)
Asian and other race -0.005 0.008 -0.015* 0.010 0.008 0.012
(0.005) (0.010) (0.008) (0.012) (0.005) (0.012)
Female 0.034*** -0.065*** 0.023*** -0.088*** 0.037*** -0.037***
(0.002) (0.003) (0.002) (0.003) (0.002) (0.003)
Low Income 0.032*** 0.025*** 0.047*** 0.027** 0.016*** 0.029**
(0.005) (0.009) (0.007) (0.011) (0.006) (0.012)
Lower to Medium Income 0.019*** 0.014** 0.031*** 0.015* 0.007 0.016*
(0.004) (0.007) (0.006) (0.008) (0.005) (0.009)
Medium Income 0.014*** 0.012** 0.023*** 0.014* 0.006* 0.012*
(0.003) (0.006) (0.005) (0.007) (0.004) (0.007)
Charlson Score 0.061*** 0.073*** 0.069*** 0.079*** 0.057*** 0.074***
(0.001) (0.001) (0.001) (0.002) (0.001) (0.002)
Admitted through ER 0.047*** 0.043***
(0.007) (0.007)
Medicare 0.096*** 0.144*** 0.140*** 0.148*** 0.070*** 0.144***
(0.004) (0.005) (0.004) (0.006) (0.004) (0.006)
Medicaid 0.057*** 0.202*** 0.136*** 0.279*** 0.014*** 0.140***
(0.004) (0.008) (0.004) (0.010) (0.004) (0.011)
Other Insurance -0.031*** 0.074*** 0.021*** 0.073*** -0.064*** 0.076***
(0.005) (0.011) (0.007) (0.010) (0.007) (0.015)
ownership: Gov. -0.006 0.070*** -0.021 0.093*** 0.009 0.047*
(0.011) (0.023) (0.013) (0.027) (0.014) (0.027)
ownership: non profit -0.006 0.008 -0.018 0.006 -0.000 0.011
(0.010) (0.018) (0.011) (0.019) (0.012) (0.023)
critical access hospital -0.057*** -0.045 -0.077*** -0.283*** -0.047*** 0.095
(0.014) (0.056) (0.016) (0.050) (0.018) (0.081)
system 0.000 0.015 -0.003 0.026* 0.001 0.001
(0.007) (0.012) (0.008) (0.015) (0.008) (0.015)
Cancer program approved by ACS -0.004 0.004 -0.010 -0.001 0.001 0.016
(0.006) (0.013) (0.008) (0.016) (0.007) (0.015)
Residency approved by GME 0.017 0.064*** -0.013 0.053*** 0.040** 0.069***
(0.015) (0.018) (0.013) (0.019) (0.019) (0.025)
AMA school affiliation -0.022* 0.016 -0.006 0.008 -0.029* 0.043*
(0.013) (0.017) (0.012) (0.017) (0.018) (0.024)
Accreditation by CARF 0.001 0.021 0.018* 0.011 -0.006 0.030*
(0.007) (0.017) (0.009) (0.021) (0.008) (0.018)
Teaching Hospital -0.021** 0.129*** -0.034*** 0.103*** -0.002 0.147***
(0.010) (0.021) (0.013) (0.025) (0.012) (0.025)
Rural Referral Center -0.019** -0.071*** -0.020* -0.071*** -0.014 -0.071***
(0.008) (0.017) (0.011) (0.020) (0.009) (0.020)
N 23,852,189 23,852,189 11,282,328 11,282,328 12,569,861 12,569,861
π (predicted share) 0.77 0.23 0.69 0.31 0.82 0.18
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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Table 2.5: Posterior Probability of being Component 1











Low Income -0.001 -0.001
(0.001) (0.001)
Missing Income -0.003 -0.003
(0.002) (0.002)
Lower to Medium Income -0.001 -0.001
(0.001) (0.001)
Medium Income -0.001 -0.001
(0.001) (0.001)
Charlson Score -0.007*** -0.007***
(0.000) (0.000)
Admitted through ER 0.002 0.002
(0.001) (0.001)
ownership: Gov. 0.000 0.000
(0.003) (0.003)
ownership: non profit 0.003 0.003
(0.002) (0.002)




Cancer program approved by ACS 0.001 0.001
(0.002) (0.002)
Residency training approved by GME -0.001 -0.001
(0.003) (0.003)
AMA Medical school affiliation 0.000 -0.000
(0.003) (0.002)
Accreditation by CARF -0.002 -0.002
(0.003) (0.002)
Teaching Hospital -0.005 -0.005
(0.003) (0.003)












* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes hospital size, year and state fixed effect.
Standard error clustered at hospital level.
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Table 2.6: Impact of EMRs on Major Diagnosis Category
(a) .Respiratory System
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.135** -0.079 -0.141 -0.102** -0.006 -0.164**
(0.063) (0.053) (0.109) (0.046) (0.040) (0.072)
Residual from First Stage 0.126* 0.075 0.128 0.089* -0.007 0.163**
(0.066) (0.053) (0.113) (0.047) (0.043) (0.072)
Age 0.007*** 0.007*** 0.006*** 0.007*** 0.007*** 0.006***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black -0.009 -0.013* 0.022* -0.009 -0.013** 0.023*
(0.009) (0.007) (0.012) (0.009) (0.007) (0.013)
Hispanic -0.046*** -0.023** -0.045** -0.046*** -0.024** -0.043**
(0.012) (0.009) (0.017) (0.012) (0.010) (0.017)
Asian and other race -0.007 -0.013 0.012 -0.006 -0.014 0.013
(0.010) (0.009) (0.014) (0.010) (0.009) (0.014)
Female -0.021*** 0.038*** -0.088*** -0.021*** 0.038*** -0.088***
(0.003) (0.002) (0.004) (0.003) (0.002) (0.004)
Low Income 0.002 0.011 0.001 0.002 0.010 0.002
(0.009) (0.008) (0.012) (0.009) (0.008) (0.013)
Lower to Medium Income 0.004 0.008 -0.001 0.004 0.008 -0.001
(0.007) (0.006) (0.010) (0.007) (0.006) (0.010)
Medium Income 0.004 0.008 0.001 0.004 0.008 0.001
(0.006) (0.005) (0.009) (0.006) (0.005) (0.009)
Charlson Score 0.043*** 0.045*** 0.030*** 0.043*** 0.045*** 0.030***
(0.001) (0.001) (0.002) (0.001) (0.001) (0.002)
Admitted through ER -0.017** -0.019*** -0.006 -0.017** -0.019*** -0.006
(0.007) (0.005) (0.011) (0.007) (0.005) (0.011)
Medicare 0.083*** 0.090*** 0.072*** 0.083*** 0.090*** 0.072***
(0.005) (0.004) (0.007) (0.005) (0.005) (0.007)
Medicaid 0.124*** 0.060*** 0.203*** 0.124*** 0.059*** 0.202***
(0.007) (0.005) (0.011) (0.007) (0.005) (0.011)
Other Insurance 0.016** -0.030*** 0.071*** 0.016** -0.030*** 0.071***
(0.008) (0.006) (0.013) (0.008) (0.006) (0.013)
ownership: Gov. 0.006 -0.032* 0.051 -0.009 -0.047*** 0.041
(0.021) (0.018) (0.036) (0.018) (0.015) (0.027)
ownership: non profit -0.002 -0.010 0.012 -0.016 -0.025** 0.004
(0.019) (0.015) (0.033) (0.013) (0.012) (0.022)
critical access hospital -0.137*** -0.087*** -0.233*** -0.132*** -0.078*** -0.235***
(0.021) (0.016) (0.054) (0.020) (0.015) (0.054)
system -0.003 -0.000 -0.002 -0.003 -0.004 0.002
(0.011) (0.008) (0.016) (0.010) (0.009) (0.015)
Cancer program approved by ACS -0.005 0.001 -0.011 -0.002 0.002 -0.008
(0.011) (0.009) (0.016) (0.011) (0.009) (0.016)
Residency approved by GME 0.012 -0.021 0.058*** 0.017 -0.021 0.065***
(0.016) (0.018) (0.020) (0.016) (0.018) (0.020)
AMA school affiliation 0.001 -0.009 0.001 -0.006 -0.013 -0.007
(0.016) (0.016) (0.020) (0.015) (0.016) (0.019)
Teaching Hospital 0.027 -0.073*** 0.114*** 0.027 -0.077*** 0.119***
(0.018) (0.015) (0.028) (0.018) (0.015) (0.027)
Rural Referral Center -0.008 0.017 -0.044* -0.018 0.011 -0.055**
(0.016) (0.014) (0.027) (0.015) (0.013) (0.025)
N 2,362,632 2,362,632 2,362,632 2,362,632 2,362,632 2,362,632
π (predicted share) 0.81 0.19 0.81 0.19
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
CHAPTER 2. HEALTH IT ON EFFICIENCY 66
(b) .Circulatory System
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.128 -0.015 -0.172 -0.139** -0.036 -0.161**
(0.086) (0.079) (0.119) (0.055) (0.051) (0.069)
Residual from First Stage 0.093 -0.011 0.141 -0.139** -0.036 -0.161**
(0.088) (0.079) (0.122) (0.055) (0.051) (0.069)
Age 0.004*** 0.009*** 0.001*** 0.004*** 0.009*** 0.001***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.050*** 0.072*** 0.049*** 0.050*** 0.072*** 0.050***
(0.007) (0.008) (0.009) (0.007) (0.008) (0.009)
Hispanic -0.002 0.010 -0.003 -0.001 0.010 -0.001
(0.013) (0.013) (0.016) (0.013) (0.013) (0.016)
Asian and other race -0.008 -0.035*** 0.017 -0.008 -0.035*** 0.018
(0.010) (0.011) (0.012) (0.010) (0.011) (0.012)
Female 0.005* 0.040*** -0.019*** 0.005* 0.040*** -0.019***
(0.003) (0.003) (0.003) (0.003) (0.003) (0.003)
Low Income 0.039*** 0.074*** 0.023** 0.039*** 0.074*** 0.023**
(0.009) (0.009) (0.011) (0.009) (0.009) (0.011)
Lower to Medium Income 0.026*** 0.054*** 0.010 0.027*** 0.054*** 0.010
(0.008) (0.007) (0.010) (0.008) (0.007) (0.010)
Medium Income 0.023*** 0.041*** 0.013 0.023*** 0.041*** 0.013
(0.007) (0.006) (0.008) (0.007) (0.006) (0.009)
Charlson Score 0.154*** 0.123*** 0.156*** 0.154*** 0.123*** 0.156***
(0.002) (0.001) (0.003) (0.002) (0.001) (0.003)
Admitted through ER -0.038*** 0.101*** -0.110*** -0.038*** 0.101*** -0.110***
(0.009) (0.017) (0.008) (0.009) (0.017) (0.008)
Medicare 0.195*** 0.091*** 0.248*** 0.195*** 0.092*** 0.249***
(0.007) (0.006) (0.007) (0.007) (0.006) (0.007)
Medicaid 0.256*** 0.147*** 0.345*** 0.257*** 0.148*** 0.346***
(0.009) (0.008) (0.012) (0.009) (0.008) (0.013)
Other Insurance 0.066*** 0.042*** 0.099*** 0.067*** 0.042*** 0.100***
(0.010) (0.008) (0.013) (0.010) (0.008) (0.013)
ownership: Gov. 0.021 -0.017 0.043 0.011 -0.016 0.027
(0.026) (0.025) (0.035) (0.020) (0.019) (0.026)
ownership: non profit 0.022 0.008 0.027 0.017 0.011 0.015
(0.023) (0.022) (0.033) (0.015) (0.015) (0.020)
critical access hospital -0.070** -0.037 -0.085 -0.070** -0.039* -0.082
(0.034) (0.023) (0.076) (0.033) (0.021) (0.075)
system 0.013 0.004 0.025 0.015 0.005 0.028*
(0.012) (0.012) (0.015) (0.012) (0.011) (0.015)
Cancer program approved by ACS -0.025** -0.012 -0.032* -0.023* -0.012 -0.029
(0.013) (0.012) (0.017) (0.013) (0.012) (0.017)
Residency approved by GME 0.025 0.002 0.050** 0.031 0.004 0.058**
(0.021) (0.023) (0.024) (0.021) (0.023) (0.024)
AMA school affiliation 0.013 -0.016 0.025 0.006 -0.016 0.014
(0.020) (0.023) (0.023) (0.019) (0.021) (0.022)
Accreditation by CARF 0.027** 0.006 0.049*** 0.022 0.007 0.040**
(0.014) (0.016) (0.018) (0.013) (0.015) (0.017)
Teaching Hospital 0.042** -0.075*** 0.107*** 0.047** -0.072*** 0.111***
(0.019) (0.019) (0.023) (0.019) (0.020) (0.023)
Rural Referral Center -0.031* -0.014 -0.053** -0.039*** -0.013 -0.065***
(0.017) (0.015) (0.024) (0.015) (0.013) (0.022)
N 4,120,364 4,120,364 4,120,364 4,120,364 4,120,364 4,120,364
π (predicted share) 0.71 0.29 0.71 0.29
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(c) .Digestive, Hepatobiliary, Pancreas
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.064 -0.035 -0.089 -0.136*** -0.083* -0.169***
(0.091) (0.112) (0.090) (0.047) (0.045) (0.063)
Residual from First Stage 0.040 0.015 0.060 0.098** 0.040 0.142**
(0.089) (0.108) (0.091) (0.044) (0.040) (0.062)
Age 0.007*** 0.007*** 0.006*** 0.007*** 0.007*** 0.006***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.055*** 0.044*** 0.063*** 0.055*** 0.043*** 0.064***
(0.006) (0.006) (0.008) (0.006) (0.006) (0.008)
Hispanic -0.050*** -0.021*** -0.077*** -0.048*** -0.020*** -0.074***
(0.008) (0.007) (0.013) (0.008) (0.007) (0.013)
Asian and other race -0.042*** -0.038*** -0.039*** -0.042*** -0.039*** -0.038***
(0.008) (0.007) (0.013) (0.008) (0.007) (0.013)
Female -0.014*** 0.029*** -0.064*** -0.014*** 0.029*** -0.064***
(0.002) (0.002) (0.004) (0.002) (0.002) (0.004)
Low Income 0.033*** 0.044*** 0.021* 0.033*** 0.043*** 0.021*
(0.009) (0.009) (0.012) (0.009) (0.009) (0.012)
Lower to Medium Income 0.031*** 0.040*** 0.022** 0.031*** 0.040*** 0.022**
(0.008) (0.009) (0.009) (0.008) (0.009) (0.009)
Medium Income 0.023*** 0.030*** 0.017** 0.024*** 0.030*** 0.017**
(0.007) (0.007) (0.008) (0.007) (0.007) (0.008)
Charlson Score 0.077*** 0.074*** 0.068*** 0.077*** 0.074*** 0.068***
(0.001) (0.002) (0.001) (0.001) (0.002) (0.001)
Admitted through ER -0.031** -0.039*** -0.014 -0.031** -0.039*** -0.014
(0.012) (0.015) (0.010) (0.012) (0.015) (0.010)
Medicare 0.093*** 0.048*** 0.138*** 0.093*** 0.049*** 0.139***
(0.006) (0.006) (0.008) (0.006) (0.006) (0.008)
Medicaid 0.143*** 0.077*** 0.223*** 0.143*** 0.077*** 0.223***
(0.006) (0.005) (0.010) (0.006) (0.005) (0.010)
Other Insurance 0.029*** 0.021*** 0.034*** 0.029*** 0.022*** 0.034***
(0.007) (0.006) (0.009) (0.007) (0.007) (0.009)
ownership: Gov. 0.035 0.005 0.068** 0.038** 0.009 0.070***
(0.025) (0.026) (0.030) (0.017) (0.013) (0.026)
ownership: non profit 0.003 -0.005 0.021 0.010 0.001 0.025
(0.025) (0.027) (0.028) (0.013) (0.012) (0.019)
critical access hospital -0.185*** -0.130*** -0.274*** -0.191*** -0.134*** -0.281***
(0.024) (0.022) (0.043) (0.022) (0.017) (0.043)
system 0.010 0.018 0.008 0.015 0.021* 0.014
(0.012) (0.012) (0.015) (0.012) (0.012) (0.015)
Cancer program approved by ACS -0.002 -0.001 0.003 -0.001 -0.000 0.006
(0.010) (0.008) (0.014) (0.010) (0.008) (0.014)
Residency approved by GME 0.054 0.034 0.081*** 0.060* 0.038 0.090***
(0.033) (0.042) (0.026) (0.033) (0.042) (0.026)
AMA school affiliation -0.031 -0.049 -0.014 -0.033 -0.049 -0.018
(0.033) (0.041) (0.024) (0.029) (0.036) (0.022)
Accreditation by CARF 0.009 0.005 0.014 0.009 0.007 0.011
(0.014) (0.011) (0.021) (0.012) (0.009) (0.020)
Teaching Hospital 0.050*** -0.017 0.120*** 0.056*** -0.013 0.127***
(0.018) (0.015) (0.028) (0.018) (0.014) (0.027)
Rural Referral Center -0.051*** -0.033* -0.078*** -0.054*** -0.033*** -0.084***
(0.016) (0.017) (0.020) (0.013) (0.012) (0.018)
N 3,099,182 3,099,182 3,099,182 3,099,182 3,099,182 3,099,182
π (predicted share) 0.80 0.20 0.80 0.20
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(d) .Musculoskeletal
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.092 -0.084* -0.155 -0.096* -0.024 -0.169*
(0.076) (0.051) (0.133) (0.058) (0.041) (0.094)
Residual from First Stage 0.073 0.078 0.122 0.078 0.014 0.151
(0.077) (0.051) (0.135) (0.060) (0.044) (0.095)
Age 0.006*** 0.009*** 0.002*** 0.006*** 0.009*** 0.002***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.122*** 0.077*** 0.131*** 0.122*** 0.077*** 0.132***
(0.009) (0.006) (0.013) (0.009) (0.006) (0.013)
Hispanic 0.052*** 0.036*** 0.039** 0.053*** 0.036*** 0.042***
(0.012) (0.008) (0.016) (0.012) (0.008) (0.016)
Asian and other race 0.003 0.003 0.007 0.003 0.002 0.007
(0.010) (0.008) (0.020) (0.010) (0.008) (0.020)
Female -0.002 0.054*** -0.085*** -0.002 0.054*** -0.085***
(0.003) (0.002) (0.005) (0.003) (0.002) (0.005)
Low Income 0.055*** 0.023*** 0.098*** 0.055*** 0.023*** 0.098***
(0.009) (0.006) (0.016) (0.009) (0.006) (0.016)
Lower to Medium Income 0.020*** 0.006 0.041*** 0.020*** 0.006 0.041***
(0.007) (0.005) (0.012) (0.007) (0.005) (0.012)
Medium Income 0.015*** 0.008** 0.026*** 0.015*** 0.008** 0.026***
(0.005) (0.004) (0.009) (0.005) (0.004) (0.009)
Charlson Score 0.098*** 0.062*** 0.122*** 0.098*** 0.062*** 0.122***
(0.001) (0.001) (0.002) (0.001) (0.001) (0.002)
Admitted through ER 0.272*** 0.161*** 0.366*** 0.272*** 0.161*** 0.366***
(0.008) (0.006) (0.012) (0.008) (0.006) (0.012)
Medicare 0.097*** 0.053*** 0.170*** 0.097*** 0.053*** 0.170***
(0.005) (0.004) (0.010) (0.005) (0.004) (0.010)
Medicaid 0.262*** 0.120*** 0.418*** 0.263*** 0.120*** 0.419***
(0.009) (0.006) (0.015) (0.009) (0.006) (0.016)
Other Insurance 0.058*** -0.011 0.168*** 0.059*** -0.011 0.169***
(0.008) (0.007) (0.013) (0.008) (0.007) (0.013)
ownership: Gov. 0.056* 0.011 0.080* 0.049** -0.004 0.068*
(0.029) (0.019) (0.045) (0.024) (0.017) (0.036)
ownership: non profit 0.019 0.023 0.022 0.014 0.009 0.015
(0.022) (0.015) (0.040) (0.016) (0.012) (0.028)
critical access hospital 0.005 -0.090*** 0.307*** 0.005 -0.083*** 0.302***
(0.028) (0.020) (0.083) (0.028) (0.021) (0.082)
system -0.021 -0.014 -0.024 -0.019 -0.017* -0.020
(0.013) (0.009) (0.020) (0.013) (0.009) (0.019)
Cancer program approved by ACS -0.006 -0.003 -0.021 -0.004 -0.002 -0.017
(0.013) (0.009) (0.020) (0.013) (0.009) (0.020)
Residency approved by GME 0.026 0.008 0.061** 0.031* 0.009 0.068**
(0.017) (0.012) (0.028) (0.017) (0.012) (0.028)
AMA school affiliation 0.011 -0.004 0.027 0.006 -0.009 0.019
(0.016) (0.012) (0.028) (0.016) (0.011) (0.027)
Accreditation by CARF -0.010 -0.014 0.013 -0.014 -0.018* 0.006
(0.016) (0.010) (0.025) (0.015) (0.010) (0.024)
Teaching Hospital 0.081*** 0.020 0.148*** 0.083*** 0.018 0.153***
(0.022) (0.015) (0.035) (0.022) (0.015) (0.035)
Rural Referral Center -0.023 0.012 -0.080*** -0.029* 0.006 -0.090***
(0.017) (0.015) (0.028) (0.016) (0.014) (0.027)
N 2,175,878 2,177,042 2,177,042 2,175,878 2,177,042 2,177,042
π (predicted share) 0.84 0.16 0.84 0.16
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(e) .Skin, Breast
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.189** -0.041 -0.382** -0.162*** -0.010 -0.284***
(0.092) (0.077) (0.172) (0.061) (0.052) (0.103)
Residual from First Stage 0.178* 0.023 0.377** 0.161** -0.008 0.319***
(0.096) (0.078) (0.176) (0.065) (0.053) (0.108)
Age 0.005*** 0.005*** 0.005*** 0.005*** 0.005*** 0.005***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.098*** 0.051*** 0.142*** 0.099*** 0.051*** 0.143***
(0.011) (0.009) (0.020) (0.011) (0.009) (0.020)
Hispanic -0.036*** -0.018 -0.059*** -0.034*** -0.018 -0.056***
(0.011) (0.012) (0.021) (0.011) (0.012) (0.021)
Asian and other race -0.055*** -0.067*** -0.023 -0.054*** -0.068*** -0.022
(0.016) (0.010) (0.032) (0.016) (0.009) (0.031)
Female -0.144*** -0.117*** -0.140*** -0.143*** -0.117*** -0.140***
(0.005) (0.004) (0.010) (0.005) (0.004) (0.010)
Low Income 0.087*** 0.072*** 0.102*** 0.087*** 0.072*** 0.102***
(0.010) (0.010) (0.018) (0.010) (0.010) (0.018)
Lower to Medium Income 0.073*** 0.057*** 0.083*** 0.073*** 0.057*** 0.083***
(0.009) (0.008) (0.016) (0.009) (0.008) (0.016)
Medium Income 0.057*** 0.040*** 0.085*** 0.057*** 0.040*** 0.086***
(0.008) (0.006) (0.015) (0.008) (0.006) (0.015)
Charlson Score 0.029*** 0.008*** 0.063*** 0.029*** 0.008*** 0.063***
(0.002) (0.001) (0.003) (0.002) (0.001) (0.003)
Admitted through ER 0.127*** 0.182*** 0.004 0.127*** 0.182*** 0.005
(0.011) (0.010) (0.017) (0.011) (0.009) (0.017)
Medicare 0.238*** 0.167*** 0.301*** 0.238*** 0.167*** 0.301***
(0.008) (0.006) (0.015) (0.008) (0.006) (0.015)
Medicaid 0.270*** 0.156*** 0.413*** 0.270*** 0.156*** 0.413***
(0.009) (0.007) (0.018) (0.009) (0.007) (0.018)
Other Insurance 0.028** -0.039*** 0.128*** 0.028** -0.038*** 0.129***
(0.011) (0.012) (0.017) (0.011) (0.012) (0.017)
ownership: Gov. -0.003 -0.062** 0.091* -0.022 -0.069*** 0.049
(0.030) (0.025) (0.051) (0.022) (0.020) (0.035)
ownership: non profit 0.023 -0.013 0.082* 0.006 -0.020 0.041
(0.024) (0.022) (0.044) (0.017) (0.016) (0.028)
critical access hospital -0.067** -0.025 -0.119* -0.063** -0.022 -0.105
(0.027) (0.022) (0.072) (0.026) (0.021) (0.071)
system 0.006 -0.001 0.013 0.007 -0.003 0.013
(0.013) (0.011) (0.022) (0.013) (0.011) (0.022)
Cancer program approved by ACS -0.009 -0.006 -0.012 -0.004 -0.006 -0.002
(0.014) (0.012) (0.021) (0.014) (0.012) (0.021)
Residency approved by GME -0.023 -0.013 -0.028 -0.015 -0.013 -0.013
(0.019) (0.021) (0.029) (0.019) (0.021) (0.029)
AMA school affiliation 0.010 -0.027 0.061** 0.000 -0.029 0.039
(0.020) (0.019) (0.031) (0.019) (0.019) (0.028)
Accreditation by CARF 0.032** 0.018 0.055* 0.024 0.016 0.035
(0.016) (0.015) (0.028) (0.015) (0.015) (0.026)
Teaching Hospital -0.053** -0.101*** 0.007 -0.052** -0.102*** 0.008
(0.021) (0.020) (0.039) (0.021) (0.019) (0.039)
Rural Referral Center 0.011 -0.003 0.042 -0.005 -0.006 0.010
(0.022) (0.018) (0.039) (0.020) (0.017) (0.036)
N 615,856 615,856 615,856 615,856 615,856 615,856
π (predicted share) 0.82 0.18 0.82 0.18
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(f) .Endocrine, Nutritional, Metabolic
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.191** -0.111* -0.294** -0.123** -0.018 -0.287***
(0.086) (0.065) (0.139) (0.056) (0.046) (0.090)
Residual from First Stage 0.178** 0.106 0.270* 0.106* 0.001 0.281***
(0.089) (0.064) (0.145) (0.058) (0.048) (0.092)
Age 0.007*** 0.006*** 0.006*** 0.007*** 0.006*** 0.006***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.062*** 0.049*** 0.068*** 0.062*** 0.048*** 0.070***
(0.008) (0.007) (0.016) (0.008) (0.007) (0.016)
Hispanic 0.005 0.007 -0.003 0.005 0.006 -0.001
(0.011) (0.008) (0.019) (0.011) (0.008) (0.019)
Asian and other race -0.010 -0.021** 0.012 -0.010 -0.021** 0.014
(0.014) (0.009) (0.025) (0.014) (0.009) (0.025)
Female -0.071*** -0.008*** -0.124*** -0.070*** -0.008*** -0.123***
(0.004) (0.003) (0.008) (0.004) (0.003) (0.008)
Low Income 0.077*** 0.080*** 0.071*** 0.077*** 0.079*** 0.072***
(0.009) (0.008) (0.016) (0.010) (0.008) (0.016)
Lower to Medium Income 0.055*** 0.061*** 0.047*** 0.055*** 0.061*** 0.048***
(0.008) (0.007) (0.014) (0.008) (0.007) (0.014)
Medium Income 0.041*** 0.045*** 0.043*** 0.041*** 0.045*** 0.043***
(0.007) (0.006) (0.013) (0.007) (0.006) (0.013)
Charlson Score 0.061*** 0.044*** 0.066*** 0.061*** 0.044*** 0.066***
(0.001) (0.001) (0.002) (0.001) (0.001) (0.002)
Admitted through ER 0.060*** 0.076*** 0.016 0.060*** 0.076*** 0.017
(0.010) (0.009) (0.014) (0.010) (0.009) (0.014)
Medicare 0.185*** 0.129*** 0.210*** 0.185*** 0.129*** 0.210***
(0.009) (0.006) (0.014) (0.009) (0.006) (0.014)
Medicaid 0.266*** 0.139*** 0.401*** 0.266*** 0.138*** 0.402***
(0.010) (0.007) (0.017) (0.010) (0.007) (0.017)
Other Insurance 0.093*** 0.035*** 0.171*** 0.093*** 0.035*** 0.172***
(0.010) (0.007) (0.018) (0.010) (0.007) (0.018)
ownership: Gov. 0.049* -0.011 0.112*** 0.024 -0.032* 0.086***
(0.027) (0.020) (0.043) (0.021) (0.016) (0.033)
ownership: non profit 0.021 0.007 0.051 -0.002 -0.014 0.028
(0.022) (0.017) (0.037) (0.014) (0.013) (0.024)
critical access hospital -0.065 -0.058*** -0.004 -0.056 -0.048*** -0.000
(0.043) (0.018) (0.151) (0.042) (0.017) (0.151)
system 0.020 0.009 0.033* 0.018 0.004 0.037**
(0.014) (0.011) (0.020) (0.013) (0.011) (0.019)
Cancer program approved by ACS 0.010 -0.000 0.015 0.013 0.001 0.021
(0.013) (0.011) (0.019) (0.013) (0.011) (0.020)
Residency approved by GME 0.046** 0.033 0.062** 0.051** 0.034 0.075***
(0.021) (0.025) (0.024) (0.021) (0.025) (0.024)
AMA school affiliation -0.019 -0.044** 0.009 -0.030 -0.051** -0.008
(0.019) (0.020) (0.025) (0.018) (0.020) (0.023)
Accreditation by CARF 0.012 0.010 0.029 0.005 0.006 0.017
(0.016) (0.011) (0.026) (0.015) (0.010) (0.024)
Teaching Hospital 0.007 -0.047*** 0.097*** 0.006 -0.052*** 0.103***
(0.021) (0.016) (0.033) (0.021) (0.017) (0.032)
Rural Referral Center 0.001 0.012 -0.024 -0.014 0.004 -0.049*
(0.016) (0.013) (0.030) (0.015) (0.012) (0.026)
N 850,731 850,988 850,988 850,731 850,988 850,988
π (predicted share) 0.82 0.18 0.82 0.18
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(g) .Kidney and Urinary Tract
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.078 -0.075 -0.048 -0.118*** -0.065 -0.137*
(0.071) (0.060) (0.116) (0.045) (0.041) (0.071)
Residual from First Stage 0.064 0.065 0.030 0.106** 0.046 0.143**
(0.074) (0.060) (0.121) (0.048) (0.042) (0.072)
Age 0.004*** 0.004*** 0.004*** 0.004*** 0.004*** 0.004***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.130*** 0.084*** 0.165*** 0.130*** 0.084*** 0.167***
(0.009) (0.007) (0.016) (0.009) (0.007) (0.017)
Hispanic 0.018 0.030*** 0.002 0.020* 0.031*** 0.005
(0.012) (0.011) (0.017) (0.012) (0.011) (0.017)
Asian and other race 0.012 -0.001 0.029** 0.012 -0.001 0.031**
(0.010) (0.010) (0.015) (0.010) (0.010) (0.015)
Female 0.012*** 0.076*** -0.059*** 0.012*** 0.076*** -0.059***
(0.004) (0.004) (0.006) (0.004) (0.004) (0.006)
Low Income 0.045*** 0.040*** 0.059*** 0.045*** 0.039*** 0.060***
(0.009) (0.008) (0.014) (0.009) (0.008) (0.014)
Lower to Medium Income 0.031*** 0.028*** 0.038*** 0.032*** 0.028*** 0.038***
(0.008) (0.007) (0.011) (0.008) (0.007) (0.011)
Medium Income 0.024*** 0.025*** 0.027*** 0.024*** 0.025*** 0.028***
(0.006) (0.005) (0.010) (0.006) (0.005) (0.011)
Charlson Score 0.087*** 0.073*** 0.091*** 0.087*** 0.073*** 0.091***
(0.001) (0.001) (0.002) (0.001) (0.001) (0.002)
Admitted through ER 0.062*** 0.083*** 0.034*** 0.062*** 0.083*** 0.034***
(0.009) (0.009) (0.010) (0.009) (0.009) (0.010)
Medicare 0.211*** 0.185*** 0.224*** 0.211*** 0.185*** 0.224***
(0.006) (0.006) (0.010) (0.007) (0.006) (0.010)
Medicaid 0.241*** 0.156*** 0.352*** 0.241*** 0.156*** 0.352***
(0.009) (0.007) (0.017) (0.009) (0.007) (0.017)
Other Insurance 0.062*** 0.011 0.140*** 0.062*** 0.011 0.140***
(0.012) (0.010) (0.021) (0.012) (0.010) (0.021)
ownership: Gov. 0.037 0.019 0.043 0.035* 0.012 0.051*
(0.025) (0.021) (0.038) (0.020) (0.017) (0.030)
ownership: non profit 0.003 0.008 -0.004 0.003 0.002 0.005
(0.021) (0.018) (0.034) (0.015) (0.014) (0.022)
critical access hospital -0.071*** -0.043** -0.109 -0.074*** -0.042** -0.117
(0.025) (0.019) (0.077) (0.024) (0.019) (0.077)
system 0.003 0.006 0.002 0.007 0.006 0.009
(0.012) (0.009) (0.018) (0.011) (0.009) (0.016)
Cancer program approved by ACS 0.007 0.003 0.012 0.009 0.005 0.014
(0.012) (0.010) (0.018) (0.012) (0.010) (0.018)
Residency approved by GME 0.015 0.012 0.027 0.021 0.015 0.034
(0.016) (0.014) (0.025) (0.016) (0.014) (0.025)
AMA school affiliation -0.014 -0.023* -0.010 -0.018 -0.027** -0.012
(0.015) (0.014) (0.025) (0.014) (0.013) (0.023)
Accreditation by CARF 0.002 0.005 -0.004 -0.001 0.003 -0.006
(0.013) (0.011) (0.021) (0.013) (0.011) (0.020)
Teaching Hospital 0.024 -0.019 0.082*** 0.028* -0.018 0.090***
(0.016) (0.014) (0.025) (0.016) (0.014) (0.025)
Rural Referral Center -0.027 -0.013 -0.051* -0.033* -0.018 -0.056**
(0.018) (0.016) (0.027) (0.017) (0.015) (0.025)
N 970,319 970,319 970,319 970,319 970,319 970,319
π (predicted share) 0.79 0.21 0.79 0.21
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
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(h) .Injuries, Poison, Burns, Toxic, Trauma
Enterprise EMRs EMRs + CPOE
Neg. Binomial C 1 C 2 Neg. Binomial C 1 C 2
Health IT -0.097 -0.156 0.001 -0.454*** -0.223*** -0.402***
(0.187) (0.104) (0.197) (0.119) (0.076) (0.138)
Residual from First Stage 0.043 0.125 -0.054 .369*** 0.175** 0.332**
(0.191) (0.104) (0.201) (0.119) (0.077) (0.139)
Age 0.007*** 0.008*** 0.006*** 0.007*** 0.008*** 0.006***
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Black 0.018 0.002 0.029 0.021 0.002 0.034*
(0.018) (0.012) (0.020) (0.018) (0.011) (0.020)
Hispanic 0.037 0.022 0.032 0.043* 0.024 0.040
(0.027) (0.015) (0.027) (0.026) (0.015) (0.026)
Asian and other race 0.029 -0.014 0.047 0.033 -0.013 0.053*
(0.027) (0.016) (0.029) (0.027) (0.016) (0.029)
Female -0.145*** -0.018*** -0.166*** -0.144*** -0.018*** -0.164***
(0.007) (0.006) (0.009) (0.007) (0.006) (0.009)
Low Income 0.080*** 0.065*** 0.081*** 0.078*** 0.064*** 0.079***
(0.018) (0.013) (0.021) (0.018) (0.013) (0.020)
Lower to Medium Income 0.082*** 0.059*** 0.083*** 0.081*** 0.059*** 0.083***
(0.014) (0.010) (0.016) (0.014) (0.010) (0.016)
Medium Income 0.053*** 0.039*** 0.055*** 0.054*** 0.040*** 0.056***
(0.011) (0.009) (0.014) (0.011) (0.009) (0.014)
Charlson Score 0.051*** 0.059*** 0.040*** 0.051*** 0.059*** 0.040***
(0.004) (0.002) (0.004) (0.003) (0.002) (0.004)
Admitted through ER -0.054*** -0.096*** -0.047*** -0.057*** -0.096*** -0.051***
(0.016) (0.010) (0.018) (0.016) (0.010) (0.018)
Medicare -0.016 0.027*** -0.022 -0.015 0.027*** -0.020
(0.014) (0.010) (0.017) (0.014) (0.010) (0.017)
Medicaid 0.087*** 0.011 0.164*** 0.089*** 0.012 0.166***
(0.017) (0.012) (0.021) (0.016) (0.012) (0.021)
Other Insurance -0.069*** -0.062*** -0.064*** -0.069*** -0.062*** -0.063***
(0.016) (0.015) (0.018) (0.016) (0.015) (0.018)
ownership: Gov. 0.173** 0.105*** 0.166** 0.211*** 0.103*** 0.215***
(0.067) (0.035) (0.073) (0.053) (0.029) (0.060)
ownership: non profit 0.049 0.036 0.061 0.095** 0.037* 0.118**
(0.058) (0.029) (0.062) (0.041) (0.021) (0.047)
critical access hospital -0.010 -0.101** 0.133 -0.048 -0.104*** 0.085
(0.119) (0.039) (0.241) (0.115) (0.038) (0.236)
system -0.021 0.000 -0.012 0.006 0.008 0.014
(0.030) (0.016) (0.030) (0.030) (0.016) (0.030)
Cancer program approved by ACS 0.007 0.033* -0.006 0.012 0.036** -0.001
(0.033) (0.018) (0.034) (0.032) (0.018) (0.033)
Residency approved by GME 0.051 0.006 0.074* 0.072** 0.017 0.092**
(0.035) (0.027) (0.044) (0.035) (0.028) (0.044)
AMA school affiliation 0.015 0.009 0.012 0.013 0.002 0.015
(0.035) (0.027) (0.041) (0.033) (0.026) (0.040)
Accreditation by CARF 0.060 0.004 0.081* 0.061 0.001 0.084**
(0.043) (0.020) (0.043) (0.039) (0.018) (0.041)
Teaching Hospital 0.252*** 0.085*** 0.271*** 0.276*** 0.092*** 0.296***
(0.043) (0.027) (0.044) (0.040) (0.026) (0.042)
Rural Referral Center -0.101*** -0.058** -0.127*** -0.100*** -0.067*** -0.117***
(0.036) (0.023) (0.042) (0.034) (0.022) (0.040)
N 431,273 431,273 431,273 431,273 431,273 431,273
π (predicted share) 0.68 0.32 0.68 0.32
* p < 0.1; ** p < 0.05; *** p < 0.01
Standard error clustered at hospital level.
CHAPTER 2. HEALTH IT ON EFFICIENCY 73





















CHAPTER 2. HEALTH IT ON EFFICIENCY 74






2000 2002 2004 2006 2008
year
Enterprise EMR Enterprise EMR + CPOE
CHAPTER 2. HEALTH IT ON EFFICIENCY 75








KidneyUrinary Tract Circulatory Respiratory
DigestiveHepatobilaryPancreas Musculoskeletal Skin, Breast
EndocrineNutritionalMetabolic
Injuries, PoisonBurns, ToxicTrauma
Enterprise EMRs  EMRs + CPOE
CHAPTER 2. HEALTH IT ON EFFICIENCY 76









p1 = 0.77 ,  p2 = 0.23









p1 = 0.77 ,  p2 = 0.23







p1 = 0.69 ,  p2 = 0.31







p1 = 0.69 ,  p2 = 0.31









p1 = 0.82 ,  p2 = 0.18









p1 = 0.82 ,  p2 = 0.18
EMRs + CPOE; Non ER Admissions
f(LOS|x,c=1) f(LOS|x,c=2)
CHAPTER 2. HEALTH IT ON EFFICIENCY 77



















0 p1 =0.77 
p2 =0.23 






















































































0 p1 = 0.82
p2 = 0.18





















p1 = 0.82 
p2 = 0.18
EMRs + CPOE; Non ER Admissions
c=1 c=2
Chapter 3
Effects of Electronic Medical Records
on Hospital Readmission:
Evidence from Four States
3.1 Introduction
In the previous chapter I study the effect of Electronic Medical Records (EMRs) on Length
of Stay (LOS), where I find the Health IT system causes reduction in LOS particularly for
the more complex inpatient cases. While a shorter LOS may indicate an improvement in
hospital efficiency, there could be concerns that faster discharge may lead to more frequent
readmissions to hospitals. Common measures of hospital efficiency include both Length of
Stay and thirty-day readmissions. Thirty-day readmission to hospital is generally defined as
an admission to a hospital within 30 days of a discharge from the same or another hospital.
The research question in this chapter is to study the effect of EMRs on hospital readmission.
Chapter II analyzes the Health Information Technology’s impact based on nationally rep-
resentative dataset. However this national dataset does not contain readmission information.
Each observation in the national sample is one discharge record instead of one patient. To
identify multiple discharge records as one patient I need to use state level database. Due
to extremely large size of the datasets, I am only able to obtain and analyze the readmis-
sions from four states: California, Florida, New York and Washington state. The time frame
ranges from 2003 to 2008, except for Florida, where the collection of readmission information
only starts after 2004. Section 3.3 gives details of the databases as well as the coding and
measures of readmission variables.
Taking advantage of the panel structure in this study I adopt the fixed effect model in this
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analysis. This model is also in fact a difference-in-difference setting, and I conducted various
robustness checks for the validity of this setting. The IT systems are shown to reduce
the unplanned first readmission for Medicare patients of various conditions. I also study
the potential heterogeneity based on observable characteristics, and Charlson score is not
associated with the heterogeneity of the IT’s impact. Results show that EMRs decrease the
likelihood of having readmissions and having unplanned first readmissions, when considering
heterogeneous effects.
Next section introduces the background information of readmissions and some existing
literature that studies IT’s impact on readmissions to hospitals. Throughout this paper I
use the terms “revisits” and “readmissions” interchangeably, as well as the terms “advanced
EMRs” and “basic EMRs & CPOE” interchangeably. The definitions are given in section
3.3.
3.2 Background
While both LOS and hospital readmission are measures for hospital efficiency, there are
concerns that they may conflict with each other. Reducing LOS is often considered as an
improvement in efficiency because it can benefit both patients and hospitals, since unneces-
sary hospitalization may put patients at risk with potential infections and cost burdens. But
recently more researchers raise discussions about the balance between LOS and readmission,
as excessive LOS reduction may be harmful because discharge before medical stability may
result in increased hospital readmission (Kaboli et al.). For example, Schneider et al. (2012)
examined 20-year colorectal cancer patients’ sample from Surveillance, Epidemiology, and
End Results-Medicare dataset and found that hospital readmission after colectomies have
increased while LOS declined after the procedure.
According to the Medicare reports to Congress in 2007 and 2008, Medicare inpatient
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care accounts for 37 percent of hospitalization expenditure, and readmissions contribute
significantly to this cost with 18 percent of the Medicare patients discharged from the hospital
having a readmission within 30 days. These readmissions cost account for $15 billion in
spending. The HITECH Act of 2009 promotes adoption of Health Information Technology
(Health IT) with the “reduced hospital readmissions” as an expected outcome of improved
coordination of care.
There are two major phases of care that can affect readmissions to hospitals. The first
phase is during the initial hospital admission. In this phase, patients are exposed to risks
for adverse events such as potential medical errors, exposure to contagious illness or lack
of coordination that may lead to further re-hospitalization. The second phase is during the
transitions of care, such as being discharged from the hospital to home or another level of care.
Once discharged, the patient him/herself, other care-giving facilities or families are assumed
to be responsible for their daily activities, diet, medication and so on. The information
management during this phase is also of importance in order to receive appropriate level of
post-acute care.
The Health Information and Management Systems Society (HIMSS) in its recent report
presents several strategies of how information technology can be used to reduce readmis-
sions. These strategies include (a) Case Management, (b) Communication, (c) Analytics
and Modeling, (d) Post-acute Follow up, (d) Health Information Exchange (HIE), (e) Social
Media, (f) Cloud Technology and Mobility and other innovations. Some of these strategies
such as HIE and cloud mobility are still yet to be fully developed, especially during the study
period in this paper. Other strategies emphasize different phases that can affect the rate of
readmission. For example Case Management can refer majorly to the first phase (the initial
admission to hospitals), whereas the post-acute follow up focus more on the IT’s impact
during the second phase that is outside the hospital setting. Silow-Carroll et al. (2011) use
case studies to show that hospitals with Health IT system facilitates the patient assessment
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and discharge planning process since the first day of the patient’s admission, and therefore
promotes integrated care and results in lower readmission rates.
There is still lack of empirical evidence that Health IT reduces readmissions to hospi-
talsespecially outside of single hospital settings. Jones et al. (2011) find Health IT system is
correlated with about 20% reduction in readmission by using cross-section data analysis on
over 2000 hospitals in 2009. Lee et al. (2013a) analyze 708 hospitals from 2000 to 2007 and
find a positive correlation between EMRs adoption and readmission rate. That is, within
two-year’s of EMRs implementation, there is a 0.19 percent increase in 30-day readmission
rates. McCullough et al. (2016) find no significant changes in readmission due to EMRs
implementation by using MEDPAR data from 2002 to 2007.
3.3 Data
In the previous chapter I study the effect of Health IT on LOS using National Inpatient
Sample from HCUP, which unfortunately does not identify patients but rather discharge
records. To analyze readmission on disaggregated level, I need to use a dataset that can link
discharge records to individuals. Therefore in this chapter I examine readmissions using 2002
to 2008 State Inpatient Database (SID) from four states: CA, NY, FL, and WA1. The SID
database again is collected by Agency for Healthcare Research and Quality (AHRQ) for the
Healthcare Cost and Utilization Project (HCUP). In general the SID contains the universe
of that State’s hospital inpatient discharge records, that is patient-level hospital discharge
abstract data for 100 percent of discharges from hospitals in the States.
Health IT information is from the same source as in the previous chapter. Data come
from HIMSS Analytics in 2008, which is a national survey to hospitals in the US that are
part of integrated delivery system. A hospital is coded to be utilizing the basic Electronic
1Notice that for FL I am using data from 2004 to 2008 as readmission files do not exist before year 2003.
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Medical Records (basic EMRs) system if they report to have had the “Enterprise EMRs”, or
the combination of “Clinical Data Repository” and “Clinical Decision Support” for at least
one year, and the system is actively running. A hospital is coded to be utilizing an advanced
EMRs system if they report to have had the basic EMRs running, and at the same time
with Computerized Physician Order Entry (CPOE) running. Figure 3.1 shows the adoption
trend of both Basic and the advanced EMRs system in the four studied states. By the end
of 2008 more than 40% of the hospitals have adopted the basic EMRs system, while the
implementation rate for both EMRs and CPOE (the advanced EMRs) is only above 20%.
The control variables are categorized into four groups (plus year and hospital fixed ef-
fect). The first group is demographic information, including age, gender, race, and patients’
primary payer types. The second part is health status, which includes two variables: total
Charlson Comorbidity Index and an indicator of Emergency Room (ER) Admission. The
third group is patients’ Major Diagnoses Categories (MDCs). The fourth group is hospi-
tal characteristics, including hospital size, ownership types and other indicators. Summary
statistics are shown in table 3.1 to table 3.3. Notice that hospital characteristics are dropped
off due to collinearity with hospital fixed effect, but they are added in when analyzing het-
erogeneous effects using interaction terms. According to table 3.2, which shows the summary
statistics by adoption status, that patients from hospitals with EMRs adopted tend to be
older, less likely to be female, and less likely to be black. They generally have more co-
morbidities, and more unplanned revisits (defined in the following subsections) to hospitals.
Hospital-wise, adopters are less likely to be government owned, less likely to be non-profit
organizations, and more likely to be part of multiple hospital systems. And adopters tend
to be larger in terms of the number of beds.
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3.3.1 Definition of Various Readmission Measures
There are four definitions that I use as measures of readmissions, all on patient level: has at
least one readmission; has a first readmission that is within 30 days of discharge; unplanned
first readmission; unplanned 30-day first readmission. The first two indicate the existence of
readmission for each patient, while the latter two identifies the necessity of the first revisit,
if any.
As stated below, there are data restriction issues associated with the identification of
“initial visit” and readmissions across calendar years, therefore there are two parts of my
analysis. They use the same dependent variables but with the study sample changed. Details
are stated in the following subsections.
Measure 1: Has at least one readmission
This readmission variable is defined as one if the patient has at least one readmission to
hospitals after the initial visit during that calendar year, and zero if no readmission to
hospitals is observed during that calendar year. There is no restriction on the time period
between the visits. Patients are only identifiable within each calendar year therefore if the
readmissions happened across years I would be able to take that information into account.
Measure 2: Has a first readmission that is within 30 days
Thirty-day first readmission is defined as the readmission that happened within 30 days of
discharge from the initial visit in that calendar year. Again, not all 30-day first readmissions
were necessarily identified because patients cannot be linked across years.
This restriction on data availability also puts further limitation on identifying the “first
admission”. Patients whose first admission happened after December 2nd may be dropped
from analysis when using this measure, as these patients’ next admission may be in January
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the next year, which is not linked back to this record. On the other hand, the “first ad-
mission” in the next January may not necessarily be the true “first admission” either, as it
might be an readmission to the preceding December admission. For ease of analysis in the
first part of my analysis, I ignore such complications in my examination. In the second part
of analysis I restrict my sample by dropping January and December patients (as described
in “Measure 5”).
3.3.2 Measure 3: unplanned first readmission
Not all readmissions to hospitals should be considered as an inferior to the hospital efficiency,
as there can be readmissions that are scheduled ahead of time for necessary treatments and/or
procedures. Therefore the focus for Measure 3 and Measure 4 is to study the occurrence of
unplanned readmissions.
I adopt measure of unplanned first readmission for five condition as they are in the focus
of Center for Medicare and Medicaid Services (CMS) for the efforts of reducing readmis-
sions: Acute Myocardial Infarction (AMI), Heart Failure (HF), Pneumonia (PN), Chronic
Obstructive Pulmonary Disease (COPD) and Stroke. The measure is only conducted on
Medicare Fee-for-Service patients (primary payment type as appeared during their initial
visit). There are three steps to identify the unplanned readmissions. First, identify the
four condition by using ICD-9 codes on patients’ primary diagnoses. Second, identify types
of procedures that should always be considered as planned ones, by using patients’ pro-
cedure ICD-9 codes, diagnoses and procedure Clinical Classification codes (CCS). Third,
for patients whose initial admissions fall into the five conditions, measure whether the first
readmission is planned according the previous step. The detailed coding for the unplanned
first readmission is done according to a report prepared for CMS by Yale New Haven Health
Services Corporation/Center for Outcomes Research & Evaluation2. Figure 3.2 shows the
2YNHHSC/CORE, 2015 Condition-Specific Measures Updates and Specifications Report:Hospital-Level
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algorithm of measuring the unplanned readmissions.
3.3.3 Measure 4: unplanned first readmission within 30 days
Thirty-day readmission within 30 days measure follows the previous unplanned readmission
measure, but restricts it to be within 30 days of the discharge from initial admission, and
it is focused on the five conditions mentioned above. It should be noted again that this
restriction has the limitation that readmissions across calendar years cannot be identified.
Notice for all four types of re-hospitalization measure, I allow patients to be re-admitted
into different hospitals. Therefore for a patient, it is possible that he/she was identified to be
admitted to various hospitals during the same calendar year. As discussed above, all revisit
information is only identifiable within the same calendar year, therefore some observed “first
admission” may be a follow-up to previous year’s visit. However for ease of understanding,
I am using the term “first admission” and “initial admission” interchangeably throughout
this paper.
3.3.4 Measure 5: Redefined Sample
As stated in above subsections that patients in my sample are only identifiable within the
same calendar, and therefore there may be measurement errors when measuring patients
admitted during January and December, as an appeared to be initial visit in January may
be in fact a readmission following a December readmission from the previous calendar year.
In this second part of analysis, I restrict my sample including only patients whose initial visits
during a calendar year were between February and November. The same four measures of
dependent variables are used, as described in details in the previous subsections.
The purpose of redefining the sample is to make clear of the measurement of the depen-
dent variables. As the state of Florida does not report the admission month of the year in the
30-Day Risk-Standardized Readmission Measures, March 2015.
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SID database, in this part of analysis FL is droped, which reduces the number of hospitals
from 578 to 375. Results of this second part of analysis is shown in tables 3.14 to 3.23.
3.4 Identification Strategy
3.4.1 Model
I estimate the impact of EMRs and CPOE on patient outcomes, where patients vary in their
diagnoses and severities. Outcomes include four types of measure as described in the previous
section (section 3.3). I use linear models with hospital fixed effects including a rich set of
patient demographics, severity measure and illness controls. Hospital fixed effects control
for time-invariant differences in hospital quality that may be correlated with IT adoption.
This two-way fixed effect model is in fact using a difference-in-difference (DID) identifica-
tion strategy that relies on the variance in adoption timing for estimation. There are several
threats to this identification strategy that could bias the results and affect the causality
interpretation of the estimates. I employ a few robustness checks to test for these threats,
which will be discussed in more details in the subsection below (subsection 3.4.2).
The basic model uses hospital fixed effect to estimate the impact of EMRs on patient
outcomes. Since this SID dataset can identify multiple admissions for a patient, for each
patient there can be more than one observation stored. For analyzing purpose, the control
variables for severity and diagnoses I use come from the first visit. In other words, the model
identifies the EMRs effect, given the same observable status during the initial visit.
I model revisit information for patient i at time t within hospital j, and the outcome Yijt
as a function of patient and hospital characteristics. As the outcome is binomial, I use linear
probability model with hospital fixed effects. Patient demographic variables and diagnoses
categories are denoted using Xijt. Severity measures that include Charlson Comorbidity
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scores and an ER admission indicator are denoted by sijt. The variable of interest is Health
IT system, which is measured by basic EMRs and EMRs plus CPOE, denoted by Tj,t−1. For
analysis purpose, I am using the one-year lagged IT adoption information (subscript t− 1)
as it takes time to have care providers get used to new procedures and systems. Therefore
the empirical specification is :
E(Yijt) = αj + Tj,t−1γ1 +Xijtβ1 + β2sijt + τt, (3.1)
where αj is a time invariant hospital-specific outcome effect that may be correlated with
the other right-hand side variables. The coefficient of IT adoption (Tj,t−1), γ1 measures the
average change in the patient’s revisit outcome that corresponds to EMRs. The term τt is a
set of time indicators. When estimating equation (3.1) for the unplanned readmission and
unplanned 30-day outcomes, this equation is estimated separately for AMI, HF, PN, COPD
and Stroke patients.
Benefits from health IT implementation may be heterogeneous across hospital types
and patient characteristics, as have been discussed in details in last chapter. EMRs can
be used to provide clinical decision support, as the national provider organizations have
developed treatment protocols for a wide range of common conditions with widely accepted
standards of care. Therefore such decision support systems may automatically check for
known interactions and prevent random errors, and these support are most likely to be of
higher benefit for patients with higher medical complexity. At the same time, other hospital
facilities such as labor and IT support that are complementary to Health IT system can
also produce heterogeneity. Therefore I next study the heterogeneous effects of EMRs and
CPOE systems based on the basic model. The model follows:
E(Yijt) = αj + Tj,t−1γ2 + sijtTj,t−1θ1 +HjTj,t−1θ2 +Xijtβ3 + β4sijt + τt, (3.2)
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where Hj denotes observable hospital characteristics. In the interaction terms, continuous
variables (age and Charlson score) are coded as deviation from the median value for the
convenience of interpretation. The median values are reported in the summary statistics
table 3.1.
3.4.2 Identification
The estimation strategy used in this study is difference-in-difference, which relies on variation
in adoption decisions. It is the same strategy that has also been used in Bloom et al. (2007),
Miller and Tucker (2011b) and McCullough et al. (2016) that study the impact of EMRs
on organizations and patient outcomes. With the fixed effect model, I am controlling for
time-invariant information in the analysis. There are a few threats to this identification
strategy for causal implications, that may come from time-varying unobserved information.
The first one is the actions that are correlated with quality improvement that are not
observable in the data. It is possible that there are changes within the hospital to improve
quality of care or efficiency at the same time with EMRs implementation. If these processes
are successful in terms of improving efficiency and reducing medical errors, then the results
estimated from this model may not be interpreted as from IT’s impact alone. In other
words, there could be unobservable universal exogenous changes for better quality to bias the
estimates. Therefore I adopt a robustness check based on ST-elevated myocardial infarction
(STEMIs) patients alone, who are considered as a control group in this analysis. As pointed
out in Steg et al. (2002), AMI treatment procedures are with widely accepted guidelines,
which require to be implemented rapidly. Therefore the exposure time to EMRs for AMI
patients is limited, and it is reasonable to believe the EMRs impact is minimal for these
patients. STEMIs is a more severe type of AMI condition and requires rapid repercussion
therapy. According to McCullough et al. (2016), AMI patients may gain some benefits from
the IT system after initial stabilization, these benefits should be larger for patients with
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secondary diagnoses of Coronary atherosclerosis (CA) or congestive heart failure (CHF) and
for patients whose diagnoses require coordination with other clinical specialties. So I test on
STEMIs patients without secondary diagnoses for CA and CHF, and expect these patients
to receive minimal effect from EMRs. I find that STEMI patients without secondary CA or
CHF conditions receive insignificant impact from EMRs.
Another threat is that EMRs implementation may be correlated with some unobserv-
ables that affect the patients severity over time that will bias the estimation results. Such
behaviors could either come from upcoding patients’ severity, or changes through patients’
preference. This could result in a correlation between EMRs and CPOE adoptions and
patients’ comorbidity, but in the data these variations are insignificantly correlated over
time.
3.5 Results
3.5.1 Has at least one readmission
Table 3.4 shows the estimates from fixed effects models for “Has at least one revisit” and
“has 30-day first revisit”, for both the basic EMRs system and the EMRs plus CPOE (i.e.
advanced EMRs) systems. The model is conducted on all patients and controlling for hospi-
tal and year fixed effect, as well as major diagnostic categories. All coefficients of the Health
IT system show positive sign. Basic EMRs is shown to lead to significant 0.004 increase to
the “Has at least one revisit”, and significant 0.003 increase to “has 30-day first revisits”.
Patients of older age are more likely to have readmissions, regardless of whether the first
revisits are within 30 days after discharge. Female patients are less likely to have readmis-
sions, regardless of whether the first readmissions are within 30 days. Charlson score that is
used as a measure for patients’ severity is positively correlated with having revisits, which is
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not a surprise. At the same time, patients whose initial admission were through emergency
room tend to have revisits after their initial discharge, which may again be an indication of
their complexity of medical conditions.
When interacting the IT variable with all demographic, health and hospital character-
istics, as shown in table 3.5, the coefficients in front of the IT variable are all shown to be
negative which indicate on average a decrease in the likelihood of having readmissions and
first revisits within 30-days. Other variables are shown to have the same sign as in the previ-
ous non-interaction estimation. The interaction terms are to examine if heterogeneity exits
based on observable characteristics. Coefficients in front of these interaction terms show that
IT system can further decrease the likelihood of revisits for patients older than the median
age of the population (i.e. the negatively significant coefficients in front of the IT × Age
term). The fact that coefficient in front of the IT # Charlson score is insignificant suggest
that heterogeneity does not happen at the level of comorbidity. The result (first column for
example) reads that in a hospital with less than 100 bed size, the basic EMRs’ impact for a
typical white male patient, who is of the median age (51) with zero comorbidity score and
private insurance, is that the IT systems reduce the likelihood of having revisits by 0.026,
and reduce the likelihood of a 30-day first revisit by 0.024 (3rd column). IT interactions
with hospital sizes have positive coefficients, which suggests that the EMRs’ impact reduces
as a hospital gets larger. I report the joint tests for heterogeneity on the interaction terms
at the bottom of the table, and the test statistics show these terms are jointly significant.
3.5.2 Unplanned first revisit
In this section I discuss the results for IT’s impact on unplanned readmissions for Medicare
patients with five conditions (HF, PN, COPD, Stroke and AMI). Table 3.6 and table 3.7
reports the effect of EMRs on patients’ “unplanned readmission” to hospitals. Both Basic
and Advanced EMRs have insignificant impact on the unplanned revisits. Patients of older
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age, or minority race tend to be more likely to have a first unplanned readmission. Higher
Charlson score and ER admitted patients are also correlated with higher “unplanned” first
readmission.
The heterogeneous analysis that is done by interactions of the IT variable and all other
observables are shown in table 3.8 and 3.9. Coefficients in front of Health IT variables
are all negative regardless of whether the system is a basic or a advanced one, with a few
significant for different groups of patients (except for COPD and Stroke patients). Most of the
interaction terms have insignificant coefficients, but the joint tests of all interaction terms are
significant for HF, PN and COPD patients, suggesting the existence of heterogeneity along
the observable characteristics. The coefficients in front of the Health IT variable (without
interactions) can be understood as the IT systems’ effect in stand alone and private hospitals
with less than 100 bed size, for a white male patient of median age and median Charlson
scores (within that patient group). Median age and Charlson scores for each patient group
are reported in table 3.1. Under this interpretation, the EMRs system shows to significantly
decrease the likelihood of having an unplanned readmission, and its impace ranges from 4.8%
(for Pneumonia) to 14.2% (for AMI). For PN, COPD and AMI patients, as the patient get
older (older than the median age within that disease group), IT’s effect is getting smaller.
For PN, COPD and Stroke patients, the Health IT’s impact also decreases as the comorbidity
score increase. Coefficients in front of hospital sizes are positive (and significant for some
disease groups), which again says that IT’s impact reduces as hospital size gets larger.
3.5.3 Unplanned first revisit that is within 30 days of initial dis-
charge
In this section I show the result of IT’s impact on 30-day readmissions that are unplanned.
Notice this is the measure of readmission that is used by CMS as a tool for assessing the
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hospitals’ quality. Table 3.10 and 3.11 show the fixed effect model that estimate IT’s impact
on 30-day unplanned readmission, while table 3.12 and 3.13 show the heterogeneity analysis
by estimating the model with interaction terms. The first two tables with no interaction
terms show that for most of the conditions, neither basic nor advanced EMRs system can
significantly decrease the unplanned 30-day readmission, except for AMI patients. For AMI
patients, both basic and advanced EMRs reduce the likelihood of having an unplanned 30-
day readmission by 1% and 0.7%, respectively.
Under heterogeneous analysis, all of the conditions see reduction in unplanned 30-day
readmission with the IT system adopted, although with only the effect on AMI patients
being significant. For AMI patients, the reduction from basic EMRs is 9.4%, for a white
man with median age and comorbidity from a non-system, non-teaching hospital that has
less than 100 bed sizes. Similar as in the previous result, coefficients in front of hospital sizes
are positive (and significant for some disease groups), which again says that IT’s impact
reduces as hospital size gets larger. Compared to the results in “unplanned first revisit”,
results in previous subsection are also significant for HF, PN and patients. Although for
most the disease types, EMRs is not shown to significantly reduce the “unplanned first 30-
day readmission”, joint test of heterogeneous impact remains significant except for Stroke
patients.
3.5.4 Second part of analaysis: redefined sample
Tables 3.14 to 3.23 report the second part of analysis with redefined sample that drops initial
admission records in January and December. The results are virtually qualitatively identical
to the results in the first part of analysis shown in previous subsections, that the EMRs
systems reduce the likelihood of readmissions as well as unplanned first readmissions to some
disease types. The results are also consistent with the previous analysis that comorbidity
score is not shown to be a source of heterogeneous EMRs impact. Furthermore, the larger
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the hospitals get, the lower the IT’s effect is at reducing readmissions.
3.5.5 Falsification tests and robustness check
In section 3.4.2 I illustrate several threats to the identification of my Difference-in-Difference
setting in this study. As discussed in previous sections, STEMI patients without secondary
CHF or CA conditions are much less likely to be affected by IT system, as their procedures
and response time need to be rapid and thus short exposure to the IT system. Therefore
STEMI patients are studied as falsification checks for the validity of my identification strat-
egy. These falsification checks can be found in appendix tables C1 to C8, and they show
that EMRs does not have significant effect to these ST-AMI patients, either for unplanned
readmissions or for the likelihood of first readmissions.
Another threat to identification is the changes in patients’ medical conditions being
correlated with Health IT adoption behavior. To test for this threat I conduct robustness
checks by regressing patients’ comorbidity score on IT adoption. I check under both OLS
and fixed effect models. Results are shown in appendix tables C9 and C10, and Charlson
scores are not correlated with the EMRs adoption variations over time.
3.6 Conclusion
In this paper I examine EMRs impact on patients’ readmissions to hospitals using datasets
from CA, FL, NY and WA. EMRs show impact on reducing both the likelihood of having
readmissions, and the likelihood of having unplanned readmissions. For the studied five
conditions, EMRs reduce the likelihood of unplanned first readmission by various percentage
points, except for patients with stroke. The interaction terms identify very few heterogeneous
effects of the IT system based on observable characteristics. Generally speaking, the Charlson
score is not shown to be associated with the disparity of IT impact, while the larger the size
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of a hospital is shown to reduce the magnitude of the IT’s effect. Regardless of the few
significant coefficients in front of interaction terms, they appear to be jointly significant for
the likelihood of having readmissions, and for most of the disease cases on the likelihood of
having unplanned first readmissions.
There are a few things to be noted when interpreting the results from this analysis.
First, it is easy to notice that for most of results in this analysis, only basic EMRs sytems
are shown to have significant effect than the advanced EMRs. This does not suggest that
advanced EMRs (again, this means the basic EMRs plus CPOE) are inferior compared to
the basic ones. Notice that the advanced EMRs by definition is a subset of the basic EMRs.
Therefore the comparison group for advanced EMRs includes the hospitals who are adopting
only the basic EMRs. The fact that advanced EMRs does not have significant influence on
reducing the unplanned readmissions may indicate that the added-on CPOE system does
not generate more benefit than the clinical decision and repositories alone.
Second, in both parts of analysis (either using all patients information or redefining the
sample by dropping January and December patients), EMRs are shown to be more likely
to significantly reduce the likelihood of having unplanned first revisit are more, rather than
to reduce 30-day unplanned first revisit. In other words, the results reflect that EMRs can
drop unplanned readmissions, but this impact is less prominent for 30-day readmissions.
Third, the lack of more definite evidence that IT reduces total number of readmissions
in this study setting does not necessarily indicate a failure of the technology. The health
care delivery system consists of more than just hospitals, but with various care coordinators
working together for the patients. While hospitals’ quality of care can influence the read-
mission outcomes, it is reasonable to believe that post-acute care quality also performs an
important role in preventing unnecessary revisits to the acute-care settings. Due to data lim-
itation I am not able to identify the exact places to which patients are discharged; therefore
I cannot examine the situation for patients’ post-acute care quality, especially the utilization
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of IT system in these settings. More analysis should be conducted on the IT influence in
post-acute care facilities and home health.
Lastly, the heterogeneous analysis in this chapter only captured all observable character-
istics in data. As pointed out in the previous chapter, heterogeneity may happen on various
levels at the same time, and may be mixed or based on unobservables. Due to computation
limitation I am not able to further study the heterogeneous effect based on mixtures or
unobservables in this paper. Therefore the results presented here do not imply that there
are not other types of heterogeneity of the IT’s impact. At the same time, the unobservable
information of post-acute care could be another potential source of heterogeneity of IT’s
impact. It is reasonable to expect that any post-acute facility that can exchange health in-
formation with the hospital via EMRs system may help reduce the unplanned readmissions
to hospitals.
To my knowledge, this paper is among the first ones to identify Health IT’s impact
on reducing unplanned readmissions to hospitals. It contributes to literature of empirical
analyses of Health IT systems, in both the economics and health service research field.
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Table 3.1: Summary Statistics for Patients’ Characteristics
Variable All patient AMI HF PN COPD STROKE
Admissions 23,609,726 155,687 299,319 302,546 192,801 142,278
Age 49.815 78.934 80.494 80.332 77.150 79.666
(25.243) (8.185) (7.918) (7.987) (7.389) (7.821)
Age, median 51 79 81 81 77 80
Female 0.611 0.494 0.551 0.554 0.600 0.577
(0.487) (0.500) (0.497) (0.497) (0.490) (0.494)
Black 0.114 0.045 0.082 0.048 0.057 0.080
(0.317) (0.206) (0.275) (0.214) (0.231) (0.272)
Asian and Other 0.135 0.100 0.120 0.087 0.095 0.115
(0.342) (0.300) (0.315) (0.283) (0.293) (0.319)
Charlson Score 0.852 1.484 2.347 1.632 1.719 1.627
(1.572) (1.533) (1.416) (1.577) (1.311) (1.598)
Charlson Score, median 0 1 2 1 1 1
Through ER 0.531 0.754 0.759 0.813 0.783 0.864
(0.499) (0.430) (0.427) (0.390) (0.412) (0.342)
Has at least one revisits 0.233
(0.423)
First revisit is within 30 days 0.141
(0.348)
First revisit unplanned 0.284 0.396 0.314 0.381 0.226
(0.451) (0.489) (0.464) (0.258) (0.418)
First 30-day revisit unplanned 0.151 0.165 0.129 0.148 0.110
(0.358) (0.371) (0.335) (0.355) (0.312)
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Table 3.3: Summary Statistics for Hospital Characteristics
Variable All hospitals Adopters Non-Adopters
N (Hospital × Year) 3140 1156 1984
Government Owned 0.181 0.156 0.196
(0.385) (0.363) (0.397)
Non Profit 0.626 0.587 0.650
(0.484) (0.493) (0.477)
System 0.605 0.638 0.586
(0.490) (0.481) (0.493)
Bed Size below 100 0.178 0.119 0.212
(0.382) (0.323) (0.409)
Bed Size between 100 and 400 0.633 0.677 0.607
(0.482) (0.468) (0.489)
Beds Size above 400 0.189 0.204 0.181
(0.392) (0.403) (0.385)
Teaching Hospital 0.112 0.091 0.125
(0.316) (0.287) (0.331)
Cancer program approved by ACS 0.435 0.452 0.425
(0.496) (0.498) (0.494)
Residency training approved by GME 0.239 0.219 0.251
(0.427) (0.414) (0.433)
AMA Medical school affiliation 0.302 0.297 0.305
(0.459) (0.457) (0.460)
Accreditation by CARF 0.118 0.164 0.091
(0.322) (0.371) (0.287)
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Table 3.4: Health IT’s Impact on Readmission
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT 0.004 0.005 0.001 0.003
(0.002)* (0.002)*** (0.001) (0.001)**
Age 0.001 0.001 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.021 0.021 0.009 0.009
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Hispanic -0.009 -0.009 -0.010 -0.010
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Asian and other race -0.033 -0.033 -0.026 -0.026
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Female -0.007 -0.007 -0.010 -0.010
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Charlson Score 0.036 0.036 0.027 0.027
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Admitted through ER 0.038 0.038 0.030 0.030
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Medicare 0.081 0.081 0.051 0.051
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Medicaid 0.055 0.055 0.032 0.032
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Other Insurance -0.006 -0.006 -0.007 -0.007
(0.001)*** (0.001)*** (0.001)*** (0.001)***
N 23,609,726 23,609,726 23,609,726 23,609,726
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
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Table 3.5: Fixed Effect Model, Interaction
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.026 -0.011 -0.024 -0.010
(0.009)*** (0.008) (0.009)*** (0.009)
Age# 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.021 0.020 0.008 0.008
(0.002)*** (0.001)*** (0.001)*** (0.001)***
Hispanic -0.016 -0.015 -0.014 -0.014
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Asian and other race -0.035 -0.035 -0.028 -0.028
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Female -0.026 -0.025 -0.021 -0.020
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Charlson Score# 0.037 0.037 0.027 0.027
(0.001)*** (0.000)*** (0.000)*** (0.000)***
Admitted through ER 0.063 0.063 0.039 0.041
(0.002)*** (0.002)*** (0.002)*** (0.001)***
Medicare 0.085 0.085 0.053 0.052
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Medicaid 0.056 0.056 0.033 0.033
(0.002)*** (0.002)*** (0.002)*** (0.001)***
Other Insurance 0.001 0.001 -0.002 -0.002
(0.002) (0.002) (0.002) (0.001)
IT × AGE# (devided by 1000) -0.270 -0.233 -0.261 -0.202
(0.084)*** (0.099)** (0.067)*** (0.077)***
IT × Black 0.001 0.003 -0.000 0.001
(0.002) (0.003) (0.002) (0.002)
IT × Hispanic 0.004 0.005 0.003 0.004
(0.003) (0.003) (0.002) (0.002)*
IT × Other race 0.000 -0.002 0.002 0.001
(0.004) (0.004) (0.003) (0.003)
IT × Female 0.005 0.003 0.003 0.003
(0.002)*** (0.002) (0.001)** (0.001)**
IT × Charlson Score# 0.001 0.001 0.001 0.001
(0.001) (0.001) (0.001)* (0.001)
IT × ER Admitted 0.003 0.002 0.005 0.002
(0.003) (0.004) (0.002)** (0.003)
IT × Medicare 0.006 -0.006 0.002 -0.008
(0.006) (0.006) (0.005) (0.004)*
IT × Medicaid 0.007 0.000 0.002 -0.004
(0.003)** (0.004) (0.004) (0.003)
IT × Other Insurance -0.000 0.001 -0.000 0.001
(0.004) (0.004) (0.003) (0.003)
IT × Govn. 0.006 0.003 0.002 0.003
(0.005) (0.006) (0.003) (0.003)
IT × Non profit 0.001 0.001 -0.002 0.000
(0.003) (0.004) (0.003) (0.003)
IT × System 0.002 0.002 0.001 0.001
(0.003) (0.005) (0.002) (0.003)
IT × Teaching 0.004 0.007 0.003 0.005
(0.003) (0.003)** (0.002) (0.002)**
IT × 100-400 Bed size 0.019 0.009 0.019 0.011
(0.009)** (0.007) (0.008)** (0.008)
IT × 400+ Bed size 0.015 0.010 0.014 0.008
(0.010) (0.008) (0.009) (0.008)
Wald test of interactions 3.94 3.34 3.99 2.69
(p-value) (0.000)*** (0.000)*** (0.000)*** (0.000)***
N 23,609,726 23,609,726 23,609,726 23,609,726
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
# indicates deviation from median value.
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Table 3.6: Basic EMRs Impact on Unplanned First Revisit
HF PN COPD STROKE AMI
Basic EMRs 0.007 -0.001 0.006 -0.010 -0.003
(0.005) (0.005) (0.006) (0.007) (0.007)
Age 0.001 0.002 0.002 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.057 0.040 0.052 0.055 0.039
(0.005)*** (0.005)*** (0.006)*** (0.005)*** (0.006)***
Hispanic 0.041 0.018 0.012 0.022 0.023
(0.005)*** (0.004)*** (0.006)** (0.005)*** (0.006)***
Asian and other race -0.007 -0.021 -0.011 -0.009 -0.030
(0.006) (0.005)*** (0.008) (0.006) (0.006)***
Female 0.013 -0.002 0.005 0.010 0.023
(0.002)*** (0.002) (0.003)* (0.002)*** (0.002)***
Charlson Score 0.022 0.027 0.025 0.015 0.033
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.042 0.015 0.018 0.003 0.028
(0.003)*** (0.003)*** (0.003)*** (0.004) (0.004)***
N 299,319 302,546 192,801 142,278 155,687
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
Table 3.7: EMRs & CPOE (advanced EMRs) Impact on Unplanned First Revisit
HF PN COPD STROKE AMI
EMRs & CPOE 0.007 0.002 0.001 -0.003 0.000
(0.005) (0.005) (0.006) (0.007) (0.006)
Age 0.001 0.002 0.002 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.057 0.040 0.052 0.055 0.039
(0.005)*** (0.005)*** (0.006)*** (0.005)*** (0.006)***
Hispanic 0.041 0.018 0.012 0.022 0.023
(0.005)*** (0.004)*** (0.006)** (0.005)*** (0.006)***
Asian and other race -0.007 -0.021 -0.011 -0.009 -0.030
(0.006) (0.005)*** (0.008) (0.006) (0.006)***
Female 0.013 -0.002 0.005 0.010 0.023
(0.002)*** (0.002) (0.003)* (0.002)*** (0.002)***
Charlson Score 0.022 0.027 0.025 0.015 0.033
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.042 0.015 0.018 0.003 0.028
(0.003)*** (0.003)*** (0.003)*** (0.004) (0.004)***
N 299,319 302,546 192,801 142,278 155,687
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table 3.8: Heterogeneous Health IT’s Impact on Unplanned First Revisit, Part I
HF PN COPD
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.031 -0.057 -0.082 -0.048 -0.009 0.008
(0.026) (0.026)** (0.033)** (0.028)* (0.022) (0.037)
Age# 0.001 0.001 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.052 0.053 0.037 0.042 0.046 0.050
(0.006)*** (0.005)*** (0.006)*** (0.005)*** (0.008)*** (0.007)***
Hispanic 0.037 0.036 0.014 0.016 0.012 0.015
(0.006)*** (0.005)*** (0.004)*** (0.004)*** (0.007)* (0.006)**
Asian and other race -0.005 -0.007 -0.022 -0.022 -0.017 -0.017
(0.007) (0.006) (0.006)*** (0.006)*** (0.009)* (0.009)**
Female 0.010 0.013 -0.004 -0.002 0.002 0.004
(0.003)*** (0.002)*** (0.002)* (0.002) (0.003) (0.003)
Charlson Score# 0.021 0.022 0.026 0.026 0.023 0.024
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.044 0.040 0.014 0.015 0.017 0.016
(0.004)*** (0.003)*** (0.003)*** (0.003)*** (0.004)*** (0.003)***
IT × AGE# (divided by 1000) 0.342 0.067 0.387 0.815 0.664 1.057
(0.272) (0.327) (0.255) (0.309)*** (0.327)** (0.440)**
IT × Black 0.012 0.020 0.009 -0.007 0.014 0.008
(0.009) (0.010)** (0.009) (0.011) (0.011) (0.014)
IT × Hispanic 0.010 0.021 0.012 0.013 -0.003 -0.015
(0.009) (0.011)* (0.008) (0.009) (0.011) (0.011)
IT × Other race -0.005 0.003 0.004 0.004 0.013 0.023
(0.010) (0.011) (0.010) (0.010) (0.014) (0.016)
IT × Female 0.008 0.003 0.004 -0.002 0.007 0.004
(0.004)** (0.004) (0.004) (0.005) (0.005) (0.006)
IT × Charlson Score# 0.002 0.001 0.003 0.002 0.004 0.005
(0.001) (0.002) (0.001)** (0.001) (0.002)** (0.002)**
IT × Govn. -0.027 -0.006 -0.013 -0.018 -0.022 -0.034
(0.018) (0.021) (0.021) (0.019) (0.025) (0.025)
IT × Non profit -0.014 0.011 -0.017 -0.012 -0.004 -0.009
(0.013) (0.013) (0.015) (0.012) (0.017) (0.013)
IT × System 0.014 0.011 0.015 0.011 0.001 0.006
(0.012) (0.013) (0.013) (0.012) (0.012) (0.014)
IT × Teaching 0.005 0.012 0.003 -0.003 0.010 0.021
(0.013) (0.017) (0.013) (0.015) (0.014) (0.017)
IT × 100-400 Bed size 0.053 0.045 0.080 0.052 0.010 -0.025
(0.021)** (0.019)** (0.026)*** (0.022)** (0.015) (0.032)
IT × 400+ Bed size 0.030 0.017 0.081 0.054 0.026 -0.004
(0.021) (0.022) (0.028)*** (0.026)** (0.023) (0.036)
Wald test of interactions 7.17 4.93 1.80 1.52 1.69 2.34
(p-value) (0.000)*** (0.000)*** (0.029)** (0.086)* (0.044)** (0.002)***
N 299,319 302,546 192,801
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
CHAPTER 3. HEALTH IT ON REVISITS 103
Table 3.9: Heterogeneous Health IT’s Impact on Unplanned First Revisit, Part II
STROKE AMI
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.046 -0.027 -0.142 -0.091
(0.064) (0.051) (0.068)** (0.062)
Age# 0.003 0.003 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.054 0.059 0.048 0.042
(0.007)*** (0.006)*** (0.008)*** (0.007)***
Hispanic 0.019 0.020 0.021 0.021
(0.006)*** (0.005)*** (0.007)*** (0.006)***
Asian and other race -0.007 -0.009 -0.024 -0.030
(0.007) (0.006) (0.007)*** (0.006)***
Female 0.007 0.010 0.024 0.022
(0.003)** (0.003)*** (0.003)*** (0.003)***
Charlson Score# 0.013 0.014 0.033 0.033
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.008 0.003 0.029 0.028
(0.006) (0.005) (0.006)*** (0.005)***
IT × AGE# (divided by 1000) 0.416 0.374 0.929 0.537
(0.319) (0.378) (0.335)*** (0.377)
IT × Black 0.003 -0.019 -0.023 -0.017
(0.011) (0.013) (0.012)* (0.013)
IT × Hispanic 0.007 0.013 0.004 0.007
(0.010) (0.012) (0.011) (0.014)
IT × Other race -0.005 0.001 -0.013 -0.003
(0.010) (0.012) (0.009) (0.010)
IT × Female 0.006 0.000 -0.003 0.003
(0.005) (0.006) (0.005) (0.006)
IT × Charlson Score# 0.005 0.007 0.000 0.000
(0.002)*** (0.002)*** (0.002) (0.002)
IT × Govn. 0.032 0.021 0.001 -0.010
(0.036) (0.025) (0.031) (0.020)
IT × Non profit 0.031 0.008 0.009 -0.004
(0.030) (0.019) (0.022) (0.015)
IT × System -0.016 -0.000 0.008 0.013
(0.014) (0.015) (0.017) (0.014)
IT × Teaching -0.024 -0.008 0.009 0.014
(0.017) (0.021) (0.018) (0.018)
IT × 100-400 Bed size -0.021 -0.007 0.107 0.072
(0.051) (0.046) (0.062)* (0.059)
IT × 400+ Bed size -0.010 -0.023 0.098 0.072
(0.050) (0.050) (0.062) (0.060)
Wald test of interactions 1.52 0.60 1.21 0.82
(p-value) (0.088)* (0.600) (0.887) (0.667)
N 142,278 155,687
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table 3.10: Basic EMRs Impact on 30-day Unplanned First Revisit
HF PN COPD STROKE AMI
Basic EMRs 0.004 0.005 -0.001 -0.005 -0.010
(0.004) (0.004) (0.005) (0.006) (0.005)*
Age 0.001 0.001 0.001 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.015 0.016 0.005 0.027 0.005
(0.003)*** (0.004)*** (0.005) (0.004)*** (0.005)
Hispanic 0.011 0.000 -0.011 0.009 0.008
(0.004)*** (0.003) (0.004)*** (0.004)** (0.005)*
Asian and other race -0.021 -0.026 -0.020 -0.010 -0.021
(0.004)*** (0.003)*** (0.005)*** (0.004)** (0.004)***
Female 0.003 -0.002 -0.006 -0.002 0.009
(0.001)** (0.001) (0.002)*** (0.002) (0.002)***
Charlson Score 0.014 0.014 0.015 0.011 0.018
(0.001)*** (0.000)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.022 0.010 0.015 0.004 -0.003
(0.002)*** (0.002)*** (0.002)*** (0.003) (0.004)
N 299,319 302,546 192,801 142,278 155,687
Table 3.11: Advanced EMRs Impact on 30-day Unplanned First Revisit
HF PN COPD STROKE AMI
EMRs & CPOE 0.004 0.004 0.004 -0.004 -0.007
(0.004) (0.004) (0.005) (0.006) (0.004)*
Age 0.001 0.001 0.001 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.015 0.016 0.005 0.027 0.005
(0.003)*** (0.004)*** (0.005) (0.004)*** (0.005)
Hispanic 0.011 0.000 -0.011 0.009 0.008
(0.004)*** (0.003) (0.004)*** (0.004)** (0.005)*
Asian and other race -0.021 -0.026 -0.021 -0.010 -0.021
(0.004)*** (0.003)*** (0.005)*** (0.004)** (0.004)***
Female 0.003 -0.002 -0.006 -0.002 0.009
(0.001)** (0.001) (0.002)*** (0.002) (0.002)***
Charlson Score 0.014 0.014 0.015 0.011 0.018
(0.001)*** (0.000)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.022 0.010 0.015 0.004 -0.003
(0.002)*** (0.002)*** (0.002)*** (0.003) (0.004)
N 299,319 302,546 192,801 142,278 155,687
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table 3.12: Heterogeneous Health IT’s Impact on Unplanned 30-day First Revisit, Part I
HF PN COPD
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.060 -0.031 -0.028 -0.018 0.021 0.005
(0.037) (0.031) (0.022) (0.023) (0.023) (0.023)
Age# 0.001 0.001 0.001 0.001 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.014 0.014 0.015 0.018 -0.002 0.005
(0.004)*** (0.003)*** (0.004)*** (0.004)*** (0.006) (0.005)
Hispanic 0.007 0.008 -0.002 -0.002 -0.010 -0.008
(0.005) (0.004)** (0.004) (0.003) (0.005)** (0.004)**
Asian and other race -0.022 -0.021 -0.028 -0.028 -0.023 -0.021
(0.005)*** (0.004)*** (0.004)*** (0.004)*** (0.006)*** (0.006)***
Female 0.002 0.003 -0.003 -0.002 -0.008 -0.007
(0.002) (0.002)* (0.002)* (0.001) (0.002)*** (0.002)***
Charlson Score# 0.014 0.014 0.013 0.014 0.014 0.015
(0.001)*** (0.001)*** (0.001)*** (0.000)*** (0.001)*** (0.001)***
Admitted through ER 0.022 0.022 0.008 0.010 0.015 0.014
(0.002)*** (0.002)*** (0.002)*** (0.002)*** (0.003)*** (0.002)***
IT × AGE# (divided by 1000) -0.128 -0.276 -0.036 0.111 0.115 0.106
(0.193) (0.225) (0.172) (0.207) (0.224) (0.293)
IT × Black 0.003 0.006 0.002 -0.008 0.019 0.004
(0.006) (0.007) (0.007) (0.008) (0.008)** (0.010)
IT × Hispanic 0.010 0.012 0.005 0.010 -0.003 -0.010
(0.007) (0.008) (0.006) (0.006)* (0.007) (0.008)
IT × Other race 0.002 0.000 0.007 0.013 0.004 0.004
(0.007) (0.007) (0.006) (0.007)* (0.009) (0.010)
IT × Female 0.004 0.001 0.004 0.001 0.006 0.009
(0.003) (0.003) (0.003) (0.003) (0.003)* (0.004)**
IT × Charlson Score# 0.001 0.000 0.002 0.001 0.003 0.002
(0.001) (0.001) (0.001)** (0.001) (0.001)** (0.002)
IT × Govn. 0.004 -0.022 -0.024 -0.012 -0.044 -0.023
(0.021) (0.019) (0.015) (0.015) (0.020)** (0.019)
IT × Non profit 0.010 -0.005 -0.010 -0.004 0.000 0.013
(0.018) (0.010) (0.009) (0.009) (0.014) (0.011)
IT × System 0.001 -0.009 -0.010 -0.012 -0.008 -0.004
(0.008) (0.010) (0.010) (0.009) (0.011) (0.010)
IT × Teaching 0.002 0.006 -0.001 -0.002 0.014 0.005
(0.010) (0.014) (0.008) (0.009) (0.010) (0.012)
IT × 100-400 Bed size 0.063 0.046 0.039 0.029 -0.017 -0.016
(0.032)** (0.027)* (0.018)** (0.019) (0.017) (0.018)
IT × 400+ Bed size 0.053 0.040 0.047 0.036 -0.021 -0.025
(0.032) (0.030) (0.019)** (0.021)* (0.018) (0.020)
Wald test of interactions 1.00 0.72 2.67 1.55 2.44 1.36
(p-value) (0.458) (0.771) (0.000)*** (0.079)* (0.001)*** (0.156)
N 299,319 302,546 192,801
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
# indicates deviation from median value.
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Table 3.13: Heterogeneous Health IT’s Impact on Unplanned 30-day First Revisit, Part II
STROKE AMI
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.057 -0.020 -0.094 -0.044
(0.048) (0.049) (0.038)** (0.044)
Age# 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.026 0.028 0.013 0.009
(0.005)*** (0.005)*** (0.006)** (0.005)*
Hispanic 0.009 0.009 0.012 0.007
(0.005)** (0.004)** (0.006)** (0.005)
Asian and other race -0.008 -0.010 -0.023 -0.022
(0.006) (0.005)** (0.005)*** (0.005)***
Female -0.002 -0.002 0.012 0.011
(0.003) (0.002) (0.002)*** (0.002)***
Charlson Score# 0.009 0.010 0.017 0.018
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.005 0.006 -0.006 -0.004
(0.005) (0.004) (0.005) (0.004)
IT × AGE# (divided by 1000) -0.004 -0.156 0.190 0.169
(0.232) (0.264) (0.258) (0.287)
IT × Black 0.004 -0.002 -0.019 -0.017
(0.008) (0.010) (0.009)** (0.011)
IT × Hispanic -0.000 -0.000 -0.011 0.003
(0.008) (0.009) (0.009) (0.010)
IT × Other race -0.005 0.001 0.005 0.003
(0.007) (0.008) (0.008) (0.010)
IT × Female 0.002 0.004 -0.005 -0.005
(0.004) (0.004) (0.004) (0.004)
IT × Charlson Score# 0.003 0.004 0.001 0.002
(0.001)** (0.002)** (0.001) (0.002)
IT × Govn. -0.004 -0.015 -0.013 -0.018
(0.026) (0.019) (0.020) (0.013)
IT × Non profit -0.004 -0.014 -0.013 -0.013
(0.022) (0.014) (0.015) (0.011)
IT × System -0.016 -0.010 0.009 0.004
(0.014) (0.013) (0.011) (0.010)
IT × Teaching 0.005 0.026 -0.009 0.004
(0.015) (0.017) (0.013) (0.013)
IT × 100-400 Bed size 0.027 0.016 0.084 0.042
(0.041) (0.045) (0.034)** (0.042)
IT × 400+ Bed size 0.021 -0.007 0.086 0.038
(0.041) (0.047) (0.034)** (0.043)
Wald test of interactions 1.47 0.89 1.74 1.26
(p-value) (0.104) (0.577) (0.036)** (0.218)
N 142,278 155,687
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table 3.14: Redefined Sample: Health IT’s Impact on Readmission
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT 0.004 0.005 0.001 0.002
(0.002) (0.002)** (0.001) (0.001)
Age 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.018 0.018 0.007 0.007
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Hispanic -0.008 -0.008 -0.010 -0.010
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Asian and other race -0.031 -0.031 -0.026 -0.026
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Female -0.008 -0.008 -0.009 -0.009
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Charlson Score 0.035 0.035 0.025 0.025
(0.001)*** (0.001)*** (0.000)*** (0.000)***
Admitted through ER 0.038 0.038 0.029 0.029
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Medicare 0.076 0.076 0.049 0.049
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Medicaid 0.047 0.047 0.027 0.027
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Other Insurance -0.009 -0.009 -0.009 -0.009
(0.002)*** (0.002)*** (0.001)*** (0.001)***
N 15,313,915 15,313,915 15,313,915 15,313,915
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
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Table 3.15: Redefined Sample: Heterogeneous Health IT’s Impacts on Readmission
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.035 -0.020 -0.032 -0.017
(0.013)*** (0.010)* (0.012)*** (0.013)
Age# 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.018 0.018 0.006 0.006
(0.002)*** (0.002)*** (0.002)*** (0.001)***
Hispanic -0.015 -0.014 -0.014 -0.014
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Asian and other race -0.033 -0.033 -0.028 -0.027
(0.003)*** (0.002)*** (0.002)*** (0.002)***
Female -0.026 -0.025 -0.020 -0.020
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Charlson Score# 0.035 0.036 0.025 0.026
(0.001)*** (0.001)*** (0.000)*** (0.000)***
Admitted through ER 0.059 0.060 0.036 0.037
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Medicare 0.081 0.081 0.052 0.052
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Medicaid 0.050 0.050 0.029 0.028
(0.002)*** (0.002)*** (0.002)*** (0.001)***
IT × AGE# (divided by 1000) -0.204 -0.181 -0.191 -0.157
(0.092)** (0.110) (0.074)** (0.080)**
IT × Black 0.004 0.010 0.002 0.005
(0.003) (0.003)*** (0.003) (0.003)*
IT × Hispanic 0.007 0.008 0.005 0.006
(0.003)* (0.004)** (0.002)* (0.003)**
IT × Other race 0.003 0.002 0.003 0.002
(0.004) (0.004) (0.003) (0.003)
IT × Female 0.002 0.000 0.002 0.002
(0.002) (0.002) (0.001) (0.002)
IT × Charlson Score# 0.002 0.001 0.002 0.001
(0.001)** (0.001) (0.001)** (0.001)
IT × ER Admitted 0.005 0.002 0.005 0.002
(0.003) (0.005) (0.003)* (0.003)
IT × Medicare 0.001 0.001 -0.002 0.000
(0.003) (0.005) (0.004) (0.005)
IT × Medicaid 0.000 -0.001 -0.002 -0.002
(0.003) (0.005) (0.002) (0.003)
IT × Other Insurance -0.001 0.001 -0.000 -0.001
(0.003) (0.004) (0.003) (0.003)
IT × Govn. 0.009 0.002 0.003 -0.003
(0.007) (0.007) (0.006) (0.008)
IT × Non profit 0.009 0.005 0.005 0.001
(0.004)** (0.005) (0.005) (0.008)
IT × System 0.000 0.002 0.000 0.001
(0.005) (0.004) (0.003) (0.003)
IT × Teaching 0.004 0.000 0.003 0.002
(0.006) (0.005) (0.003) (0.003)
IT × 100-400 Bed size 0.029 0.013 0.028 0.013
(0.012)** (0.009) (0.011)** (0.010)
IT × 400+ Bed size 0.028 0.017 0.023 0.010
(0.013)** (0.010)* (0.011)** (0.010)
N 15,313,915 15,313,915 15,313,915 15,313,915
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
# indicates deviation from median value.
CHAPTER 3. HEALTH IT ON REVISITS 109
Table 3.16: Redefined Sample: Basic EMRs Impact on Unplanned First Revisit
HF PN COPD STROKE AMI
Basic EMRs 0.008 -0.005 0.008 0.002 -0.007
(0.007) (0.006) (0.009) (0.008) (0.009)
Age 0.001 0.002 0.001 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.052 0.036 0.032 0.040 0.038
(0.006)*** (0.007)*** (0.008)*** (0.006)*** (0.010)***
Hispanic 0.039 0.012 -0.004 0.018 0.023
(0.007)*** (0.005)** (0.008) (0.006)*** (0.008)***
Asian and other race 0.003 -0.019 -0.005 -0.004 -0.026
(0.007) (0.007)*** (0.010) (0.007) (0.008)***
Female 0.008 -0.006 -0.003 0.004 0.022
(0.003)*** (0.002)** (0.004) (0.003) (0.003)***
Charlson Score 0.021 0.025 0.023 0.012 0.031
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.040 0.013 0.026 0.005 0.027
(0.004)*** (0.003)*** (0.005)*** (0.005) (0.005)***
N 172,010 183,456 99,995 89,465 94,273
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Table 3.17: Redefined Sample: Advanced EMRs Impact on Unplanned First Revisit
HF PN COPD STROKE AMI
EMRs & CPOE 0.014 -0.003 0.007 0.011 0.001
(0.006)** (0.006) (0.009) (0.008) (0.008)
Age 0.001 0.002 0.001 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.052 0.036 0.032 0.040 0.038
(0.006)*** (0.007)*** (0.008)*** (0.006)*** (0.010)***
Hispanic 0.039 0.012 -0.004 0.018 0.023
(0.007)*** (0.005)** (0.008) (0.006)*** (0.008)***
Asian and other race 0.003 -0.019 -0.005 -0.004 -0.026
(0.007) (0.007)*** (0.010) (0.007) (0.008)***
Female 0.008 -0.006 -0.003 0.004 0.022
(0.003)*** (0.002)** (0.004) (0.003) (0.003)***
Charlson Score 0.021 0.025 0.023 0.012 0.031
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.040 0.013 0.027 0.005 0.027
(0.004)*** (0.003)*** (0.005)*** (0.005) (0.005)***
N 172,010 183,456 99,995 89,465 94,273
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table 3.18: Redefined Sample: Heterogeneous Health IT’s Impact on Unplanned First Re-
visit, Part I
HF PN COPD
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.076 -0.058 -0.059 -0.039 0.037 0.040
(0.044)* (0.034)* (0.045) (0.041) (0.055) (0.057)
Age# 0.001 0.001 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.049 0.048 0.030 0.035 0.035 0.035
(0.008)*** (0.007)*** (0.008)*** (0.007)*** (0.010)*** (0.009)***
Hispanic 0.037 0.036 0.010 0.011 0.001 -0.001
(0.008)*** (0.007)*** (0.006)* (0.005)* (0.009) (0.008)
Asian and other race 0.006 0.002 -0.023 -0.022 -0.013 -0.008
(0.008) (0.007) (0.007)*** (0.007)*** (0.010) (0.011)
Female 0.004 0.007 -0.004 -0.005 -0.006 -0.004
(0.003) (0.003)** (0.003) (0.003)* (0.005) (0.004)
Charlson Score# 0.021 0.021 0.024 0.025 0.022 0.022
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.002)*** (0.001)***
Admitted through ER 0.038 0.038 0.015 0.015 0.021 0.022
(0.005)*** (0.005)*** (0.004)*** (0.004)*** (0.006)*** (0.005)***
IT × AGE# (divided by 1000) -0.438 -0.654 -0.513 -0.052 0.157 -0.179
(0.395) (0.449) (0.355) (0.456) (0.488) (0.672)
IT × Black 0.009 0.026 0.017 0.003 -0.011 -0.022
(0.013) (0.016)* (0.013) (0.019) (0.016) (0.017)
IT × Hispanic 0.006 0.020 0.006 0.010 -0.016 -0.025
(0.014) (0.019) (0.012) (0.013) (0.015) (0.020)
IT × Other race -0.008 0.003 0.010 0.014 0.021 0.015
(0.012) (0.013) (0.012) (0.015) (0.015) (0.018)
IT × Female 0.012 0.007 -0.006 -0.004 0.007 0.005
(0.006)** (0.006) (0.006) (0.008) (0.007) (0.010)
IT × Charlson Score# 0.001 0.001 0.004 0.002 0.002 0.001
(0.002) (0.003) (0.002)*** (0.002) (0.003) (0.004)
IT × Govn. 0.016 -0.016 -0.010 -0.023 0.007 0.032
(0.032) (0.030) (0.029) (0.026) (0.047) (0.046)
IT × Non profit 0.004 -0.005 -0.019 -0.019 0.014 0.042
(0.023) (0.013) (0.018) (0.014) (0.032) (0.031)
IT × System 0.035 0.030 0.001 0.014 -0.018 0.005
(0.013)*** (0.014)** (0.015) (0.013) (0.018) (0.019)
IT × Teaching 0.001 0.004 0.002 -0.006 0.016 0.004
(0.018) (0.020) (0.015) (0.016) (0.018) (0.019)
IT × 100-400 Bed size 0.069 0.046 0.063 0.056 -0.053 -0.102
(0.034)** (0.029) (0.038)* (0.037) (0.043) (0.046)**
IT × 400+ Bed size 0.049 0.039 0.081 0.069 -0.044 -0.088
(0.035) (0.030) (0.038)** (0.038)* (0.049) (0.052)*
Wald test of interactions 5.98 20.91 1.80 1.30 1.83 2.55
(p-value) (0.000)*** (0.000)*** (0.193) (0.206) (0.026)** (0.001)***
N 172,010 183,456 99,995
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table 3.19: Redefined Sample: Heterogeneous Health IT’s Impact on Unplanned First Re-
visit, Part II
STROKE AMI
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT 0.003 0.041 -0.150 -0.124
(0.052) (0.045) (0.087)* (0.087)
Age# 0.003 0.003 0.003 0.003
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.035 0.042 0.045 0.039
(0.008)*** (0.007)*** (0.012)*** (0.011)***
Hispanic 0.016 0.014 0.024 0.022
(0.007)** (0.006)** (0.008)*** (0.007)***
Asian and other race -0.004 -0.006 -0.021 -0.027
(0.008) (0.007) (0.010)** (0.008)***
Female 0.005 0.007 0.023 0.021
(0.004) (0.003)** (0.004)*** (0.004)***
Charlson Score# 0.011 0.011 0.031 0.031
(0.001)*** (0.001)*** (0.002)*** (0.001)***
Admitted through ER 0.011 0.006 0.019 0.025
(0.007) (0.006) (0.006)*** (0.006)***
IT × AGE # (divided by 1000) 0.025 -0.022 0.851 1.164
(0.418) (0.513) (0.520) (0.632)*
IT × Black 0.016 -0.007 -0.022 -0.002
(0.015) (0.017) (0.018) (0.021)
IT × Hispanic 0.007 0.026 -0.005 0.000
(0.014) (0.017) (0.018) (0.027)
IT × Other race 0.004 0.014 -0.013 0.004
(0.011) (0.013) (0.013) (0.013)
IT × Female -0.003 -0.012 -0.000 0.008
(0.007) (0.010) (0.007) (0.008)
IT × Charlson Score# 0.002 0.003 -0.001 -0.000
(0.002) (0.003) (0.002) (0.003)
IT × Govn. 0.009 0.019 0.020 0.007
(0.038) (0.028) (0.039) (0.045)
IT × Non profit 0.028 0.025 0.040 0.032
(0.030) (0.021) (0.033) (0.041)
IT × System -0.008 -0.000 0.001 0.004
(0.015) (0.015) (0.027) (0.020)
IT × Teaching -0.029 -0.030 -0.010 -0.023
(0.020) (0.019) (0.024) (0.020)
IT × 100-400 Bed size -0.060 -0.089 0.095 0.073
(0.043) (0.041)** (0.079) (0.075)
IT × 400+ Bed size -0.047 -0.080 0.101 0.102
(0.046) (0.046)* (0.083) (0.079)
Wald test of interactions 1.90 2.50 1.30 2.34
(p-value) (0.019)** (0.001)*** (0.190) (0.003)
N 89,465 94,273
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table 3.20: Redefined Sample: Basic EMRs Impact on Unplanned 30-day First Revisit
HF PN COPD STROKE AMI
Basic EMRs 0.006 0.004 -0.003 0.001 -0.004
(0.005) (0.005) (0.007) (0.007) (0.005)
Age 0.001 0.001 0.001 0.002 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.017 0.018 -0.004 0.022 0.003
(0.004)*** (0.005)*** (0.006) (0.005)*** (0.007)
Hispanic 0.009 0.000 -0.018 0.009 0.011
(0.005)* (0.004) (0.005)*** (0.004)** (0.006)*
Asian and other race -0.016 -0.029 -0.019 -0.010 -0.023
(0.004)*** (0.004)*** (0.007)*** (0.005)** (0.006)***
Female 0.001 -0.001 -0.008 -0.003 0.012
(0.002) (0.002) (0.002)*** (0.002) (0.002)***
Charlson Score 0.013 0.013 0.014 0.009 0.016
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.019 0.007 0.014 0.001 -0.003
(0.003)*** (0.002)*** (0.003)*** (0.004) (0.005)
N 172,010 183,456 99,995 89,465 94,273
Table 3.21: Redefined Sample: Advanced EMRs Impact on Unplanned 30-day First Revisit
HF PN COPD STROKE AMI
EMRs & CPOE 0.002 0.003 0.005 0.004 -0.005
(0.005) (0.004) (0.007) (0.007) (0.005)
Age 0.001 0.001 0.001 0.002 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.017 0.018 -0.004 0.022 0.003
(0.004)*** (0.005)*** (0.006) (0.005)*** (0.007)
Hispanic 0.009 0.000 -0.018 0.009 0.011
(0.005)* (0.004) (0.005)*** (0.004)** (0.006)*
Asian and other race -0.016 -0.029 -0.019 -0.010 -0.023
(0.004)*** (0.004)*** (0.007)*** (0.005)** (0.006)***
Female 0.001 -0.001 -0.008 -0.003 0.012
(0.002) (0.002) (0.002)*** (0.002) (0.002)***
Charlson Score 0.013 0.013 0.014 0.009 0.016
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.019 0.007 0.014 0.001 -0.003
(0.003)*** (0.002)*** (0.003)*** (0.004) (0.005)
N 172,010 183,456 99,995 89,465 94,273
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table 3.22: Redefined Sample: Heterogeneous Health IT’s Impact on Unplanned 30-day
First Revisit, Part I
HF PN COPD
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.040 -0.005 -0.074 -0.051 0.024 0.008
(0.045) (0.034) (0.029)** (0.031) (0.032) (0.033)
Age# 0.001 0.001 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.014 0.015 0.018 0.021 -0.006 -0.001
(0.005)** (0.005)*** (0.005)*** (0.005)*** (0.008) (0.007)
Hispanic 0.005 0.005 0.001 -0.001 -0.019 -0.017
(0.005) (0.005) (0.004) (0.004) (0.007)*** (0.006)***
Asian and other race -0.016 -0.015 -0.032 -0.032 -0.022 -0.017
(0.005)*** (0.005)*** (0.005)*** (0.004)*** (0.008)*** (0.007)**
Female 0.000 0.000 -0.001 -0.001 -0.010 -0.010
(0.003) (0.002) (0.002) (0.002) (0.003)*** (0.003)***
Charlson Score# 0.013 0.013 0.012 0.013 0.014 0.014
(0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.019 0.020 0.007 0.008 0.015 0.013
(0.003)*** (0.003)*** (0.003)** (0.003)*** (0.004)*** (0.004)***
IT × AGE# (divided by 1000) -0.261 -0.482 -0.409 -0.208 -0.440 -1.175
(0.279) (0.336) (0.240)* (0.291) (0.393) (0.504)**
IT × Black 0.009 0.012 -0.001 -0.019 0.006 -0.021
(0.010) (0.013) (0.011) (0.014) (0.013) (0.016)
IT × Hispanic 0.014 0.024 -0.004 0.004 0.005 -0.004
(0.010) (0.012)* (0.008) (0.008) (0.011) (0.012)
IT × Other race 0.000 -0.005 0.007 0.014 0.005 -0.011
(0.008) (0.009) (0.007) (0.008)* (0.012) (0.015)
IT × Female 0.003 0.006 -0.000 0.000 0.008 0.017
(0.004) (0.005) (0.004) (0.005) (0.005) (0.006)***
IT × Charlson Score# 0.001 0.001 0.002 0.000 0.002 -0.001
(0.002) (0.002) (0.001)** (0.001) (0.002) (0.003)
IT × Govn. -0.013 -0.061 -0.019 -0.007 -0.037 0.013
(0.032) (0.024)** (0.018) (0.018) (0.031) (0.027)
IT × Non profit 0.003 -0.031 -0.015 -0.013 0.015 0.042
(0.026) (0.013)** (0.008)* (0.013) (0.020) (0.015)***
IT × System 0.017 0.001 -0.009 -0.007 -0.009 -0.008
(0.011) (0.011) (0.011) (0.010) (0.015) (0.015)
IT × Teaching -0.005 0.004 0.000 0.001 0.000 -0.004
(0.014) (0.015) (0.012) (0.010) (0.018) (0.014)
IT × 100-400 Bed size 0.047 0.035 0.095 0.079 -0.030 -0.046
(0.035) (0.031) (0.025)*** (0.027)*** (0.023) (0.028)
IT × 400+ Bed size 0.053 0.050 0.107 0.091 -0.029 -0.061
(0.037) (0.034) (0.027)*** (0.028)*** (0.027) (0.031)*
Wald test of interactions 1.06 1.86 2.27 2.26 1.89 2.75
(p-value) (0.395) (0.023)** (0.004)*** (0.004)*** (0.020)** (0.000)***
N 172,010 183,456 99,995
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table 3.23: Redefined Sample: Heterogeneous Health IT’s Impact on Unplanned 30-day
First Revisit, Part II
STROKE AMI
Variables Basic EMRs Adv EMRs Basic EMRs Adv EMRs
Health IT -0.056 -0.014 -0.098 -0.056
(0.043) (0.048) (0.052)* (0.055)
Age# 0.002 0.002 0.001 0.001
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.017 0.020 0.014 0.008
(0.006)*** (0.006)*** (0.009) (0.008)
Hispanic 0.009 0.007 0.015 0.009
(0.005) (0.005) (0.006)** (0.006)
Asian and other race -0.008 -0.010 -0.025 -0.024
(0.006) (0.006)* (0.006)*** (0.006)***
Female -0.003 -0.003 0.013 0.012
(0.003) (0.003) (0.003)*** (0.003)***
Charlson Score# 0.009 0.009 0.016 0.016
(0.001)*** (0.001)*** (0.001)*** (0.001)***
Admitted through ER 0.003 0.004 -0.011 -0.005
(0.005) (0.004) (0.006)* (0.005)
IT × AGE# (divided by 1000) -0.004 -0.462 -0.057 0.571
(0.346) (0.462) (0.387) (0.479)
IT × Black 0.017 0.011 -0.033 -0.025
(0.012) (0.016) (0.014)** (0.018)
IT × Hispanic 0.000 0.010 -0.014 0.009
(0.010) (0.011) (0.016) (0.020)
IT × Other race -0.004 0.005 0.005 0.007
(0.007) (0.008) (0.009) (0.011)
IT × Female 0.001 0.002 -0.003 -0.001
(0.005) (0.006) (0.006) (0.008)
IT × Charlson Score# -0.001 0.001 0.000 0.001
(0.002) (0.002) (0.002) (0.003)
IT × Govn. -0.031 -0.032 -0.010 -0.025
(0.028) (0.026) (0.023) (0.025)
IT × Non profit -0.010 -0.015 0.007 0.005
(0.021) (0.022) (0.018) (0.023)
IT × System -0.004 -0.009 0.013 -0.009
(0.014) (0.014) (0.011) (0.012)
IT × Teaching 0.003 0.009 -0.025 -0.015
(0.015) (0.015) (0.012)** (0.012)
IT × 100-400 Bed size 0.030 0.003 0.071 0.035
(0.039) (0.043) (0.047) (0.048)
IT × 400+ Bed size 0.024 -0.003 0.085 0.048
(0.040) (0.046) (0.049)* (0.049)
Wald test of interactions 1.10 0.94 3.46 4.31
(p-value) (0.350) (0.528) (0.000)*** (0.000)***
N 89,465 94,273
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Figure 3.2: Algorithm for Unplanned First Readmission
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Table A1: Summary Statistics for Patients’ Characteristics
Acronyms Explanation
Technologies
Health IT Health Information Technology
EMRs Electronic Medical Records
CPOE Computerized Physician Order Entry
Advanced EMRs Include both basic EMRs and CPOE systems.
Used interchangeably with “EMRs & CPOE”.
Diagnoses
AMI Acute Myocardial Infarction
STEMI ST-elevated Myocardial Infarction
HF Heart Failure
COPD Chronic Obstructive Pulmonary Disease
PN Pneumonia
Others
AHRQ Agency for Healthcare Research and Quality
CMS Center for Medicare and Medicaid Services
ER Emergency Room
MDCs Major Diagnosis Categories
118
Appendix B
Appendix for Chapter 2
119




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX B. APPENDIX FOR CHAPTER 2 122
Table B3: EMRs effect on AMI patients
Enterprise EMRs EMRs + CPOE
All AMI STEMIs All AMI STEMIs
Health IT -0.072 -0.076 -0.083 -0.088
(0.090) (0.088) (0.071) (0.071)
Residual from First Stage 0.039 0.043 0.056 0.061
(0.091) (0.089) (0.074) (0.074)
Age 0.002*** 0.002*** 0.002*** 0.002***
(0.000) (0.000) (0.000) (0.000)
Black 0.065*** 0.065*** 0.065*** 0.065***
(0.012) (0.012) (0.012) (0.012)
Hispanic -0.001 -0.000 0.001 0.001
(0.015) (0.015) (0.015) (0.015)
Asian and other race 0.008 0.005 0.007 0.005
(0.015) (0.015) (0.015) (0.015)
Female -0.019*** -0.019*** -0.019*** -0.019***
(0.006) (0.006) (0.006) (0.006)
Low inocme 0.034*** 0.035*** 0.035*** 0.035***
(0.011) (0.011) (0.011) (0.011)
Lower to Medium Income 0.013 0.013 0.014 0.013
(0.010) (0.010) (0.010) (0.010)
Medium Income 0.013 0.011 0.013 0.012
(0.009) (0.009) (0.009) (0.009)
Charlson Score 0.028*** 0.028*** 0.028*** 0.028***
(0.002) (0.002) (0.002) (0.002)
Admitted through ER -0.053*** -0.052*** -0.053*** -0.052***
(0.008) (0.008) (0.008) (0.009)
Medicare 0.037*** 0.035*** 0.037*** 0.036***
(0.009) (0.009) (0.009) (0.009)
Medicaid 0.137*** 0.136*** 0.137*** 0.136***
(0.012) (0.012) (0.012) (0.012)
Other Insurance 0.085*** 0.084*** 0.086*** 0.085***
(0.013) (0.013) (0.013) (0.013)
ownership: Gov. -0.006 -0.005 -0.011 -0.010
(0.035) (0.034) (0.028) (0.028)
ownership: non profit -0.035 -0.035 -0.038** -0.037**
(0.027) (0.027) (0.019) (0.019)
critical access hospital -0.107*** -0.109*** -0.109*** -0.111***
(0.035) (0.035) (0.035) (0.035)
system 0.027* 0.028** 0.028** 0.030**
(0.014) (0.014) (0.014) (0.014)
Cancer program approved by ACS 0.038** 0.038** 0.038*** 0.039***
(0.015) (0.015) (0.015) (0.015)
Residency training approved by GME 0.033* 0.033* 0.036* 0.037*
(0.020) (0.019) (0.020) (0.020)
AMA Medical school affiliation 0.022 0.024 0.019 0.020
(0.020) (0.020) (0.019) (0.019)
Accreditation by CARF -0.010 -0.010 -0.014 -0.014
(0.021) (0.021) (0.020) (0.020)
Teaching Hospital 0.068*** 0.067*** 0.071*** 0.070***
(0.021) (0.021) (0.021) (0.022)
Rural Referral Center -0.023 -0.023 -0.027 -0.027
(0.021) (0.021) (0.019) (0.020)
N 169,830 165,787 169,830 165,787
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, hospital size, year and state fixed effect.
Standard error clustered at hospital level.
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Table C1: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part I
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT 0.011 0.004 0.005 0.010
(0.008) (0.007) (0.008) (0.007)
Age 0.000 0.000 0.000 0.000
(0.000)*** (0.000)*** (0.000) (0.000)
Black 0.016 0.016 0.006 0.006
(0.007)** (0.007)** (0.006) (0.006)
Hispanic 0.008 0.008 0.004 0.004
(0.005)* (0.005)* (0.005) (0.005)
Asian and other race -0.036 -0.036 -0.027 -0.028
(0.006)*** (0.006)*** (0.005)*** (0.005)***
Female 0.019 0.019 0.009 0.009
(0.003)*** (0.003)*** (0.003)*** (0.003)***
Charlson Score 0.034 0.034 0.024 0.024
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.007 0.007 0.014 0.014
(0.004) (0.004) (0.004)*** (0.004)***
N 138,110 138,110 138,110 138,110
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
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Table C2: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part II
Has at least one Revisit Has 30-day First Revisit
Variables Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.063 0.000 -0.031 0.023
(0.083) (0.075) (0.083) (0.077)
Age# 0.000 0.000 0.000 0.000
(0.000) (0.000)* (0.000) (0.000)
Black 0.011 0.010 0.002 0.002
(0.008) (0.007) (0.007) (0.006)
Hispanic 0.007 0.007 0.002 0.003
(0.006) (0.005) (0.006) (0.005)
Asian and other race -0.039 -0.037 -0.032 -0.029
(0.007)*** (0.006)*** (0.005)*** (0.005)***
Female 0.021 0.019 0.011 0.010
(0.004)*** (0.004)*** (0.004)*** (0.003)***
Charlson Score# 0.033 0.033 0.023 0.023
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.013 0.011 0.016 0.015
(0.006)** (0.005)** (0.005)*** (0.004)***
Medicare 0.060 0.061 0.049 0.049
(0.006)*** (0.005)*** (0.005)*** (0.004)***
Medicaid 0.060 0.063 0.033 0.034
(0.008)*** (0.007)*** (0.008)*** (0.006)***
Other Insurance -0.016 -0.018 -0.011 -0.011
(0.006)*** (0.005)*** (0.005)* (0.005)**
IT × AGE# (divided by 1000) 0.172 0.435 0.400 0.877
(0.311) (0.367) (0.300) (0.833)
IT × Black 0.012 0.027 0.008 0.016
(0.013) (0.023) (0.011) (0.012)
IT × Hispanic 0.004 0.004 0.006 0.008
(0.009) (0.009) (0.009) (0.010)
IT × Other race 0.008 0.006 0.012 0.008
(0.009) (0.011) (0.008) (0.010)
IT × Female -0.006 -0.003 -0.006 -0.005
(0.006) (0.007) (0.006) (0.006)
IT × Charlson Score# 0.001 0.004 0.002 0.005
(0.003) (0.004) (0.003) (0.004)
IT × Medicare 0.041 -0.027 0.029 -0.031
(0.046) (0.032) (0.039) (0.032)
IT × Medicaid 0.009 -0.025 0.009 -0.011
(0.036) (0.015) (0.029) (0.017)
IT × Other Insurance 0.014 0.015 -0.002 -0.002
(0.016) (0.017) (0.015) (0.016)
IT × Govn. 0.012 0.014 0.004 0.011
(0.019) (0.023) (0.019) (0.022)
IT × Non profit -0.002 -0.009 -0.009 -0.017
(0.008) (0.009) (0.007) (0.018)
IT × System 0.015 0.012 0.012 0.016
(0.012) (0.014) (0.011) (0.012)
IT × Teaching 0.006 0.021 0.006 0.013
(0.009) (0.021) (0.008) (0.009)
IT × 100-400 Bed size 0.044 0.022 0.004 -0.006
(0.076) (0.072) (0.079) (0.073)
IT × 400+ Bed size 0.021 0.033 -0.011 0.012
(0.078) (0.074) (0.081) (0.075)
N 138,110 138,110 138,110 138,110
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
# indicates deviation from median value.
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Table C3: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part III
Unplanned 1st revisit Unplanned 1st 30-day revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.011 -0.006 -0.015 -0.006
(0.010) (0.010) (0.018) (0.008)
Age 0.004 0.004 0.002 0.002
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.032 0.032 0.014 0.014
(0.012)*** (0.012)*** (0.010) (0.010)
Hispanic 0.026 0.027 0.014 0.014
(0.009)*** (0.009)*** (0.008)* (0.008)*
Asian and other race -0.033 -0.033 -0.019 -0.019
(0.008)*** (0.008)*** (0.006)*** (0.006)***
Female 0.028 0.028 0.013 0.013
(0.004)*** (0.004)*** (0.003)*** (0.003)***
Charlson Score 0.037 0.037 0.022 0.022
(0.002)*** (0.002)*** (0.001)*** (0.001)***
Admitted through ER 0.005 0.005 -0.012 -0.012
(0.005) (0.005) (0.005)*** (0.005)***
N 45,458 45,458 45,458 45,458
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table C4: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part IV
Unplanned 1st revisit Unplanned 1st 30-day revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.122 -0.186 -0.159 -0.099
(0.126) (0.122) (0.118) (0.109)
Age# 0.003 0.004 0.002 0.002
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.032 0.033 0.026 0.020
(0.015)** (0.013)** (0.014)* (0.011)*
Hispanic 0.029 0.022 0.017 0.010
(0.011)*** (0.009)** (0.009)* (0.008)
Asian and other race -0.031 -0.034 -0.022 -0.020
(0.011)*** (0.009)*** (0.009)** (0.007)***
Female 0.030 0.028 0.015 0.015
(0.005)*** (0.005)*** (0.004)*** (0.004)***
Charlson Score# 0.039 0.038 0.023 0.023
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.005 0.004 -0.017 -0.015
(0.007) (0.006) (0.006)*** (0.005)***
IT × AGE# (divided by 1000) 1.545 0.787 0.776 0.598
(1.569) (0.635) (0.454) (0.516)
IT × Black -0.002 -0.010 -0.032 -0.035
(0.026) (0.034) (0.039) (0.022)
IT × Hispanic -0.009 0.019 -0.007 0.020
(0.019) (0.023) (0.017) (0.022)
IT × Other race -0.004 0.003 0.007 0.001
(0.014) (0.017) (0.012) (0.014)
IT × Female -0.004 -0.000 -0.004 -0.010
(0.008) (0.009) (0.006) (0.007)
IT × Charlson Score# -0.005 -0.003 -0.003 -0.002
(0.003) (0.004) (0.003) (0.003)
IT × ER Admitted -0.001 0.004 0.011 0.012
(0.011) (0.012) (0.009) (0.011)
IT × Govn. 0.019 -0.008 -0.026 -0.036
(0.048) (0.039) (0.054) (0.030)
IT × Non profit 0.027 -0.021 -0.034 -0.038
(0.033) (0.025) (0.042) (0.040)
IT × System 0.025 0.036 0.014 0.021
(0.022) (0.023) (0.016) (0.017)
IT × Teaching 0.002 -0.006 0.010 0.025
(0.023) (0.027) (0.021) (0.022)
IT × 100-400 Bed size 0.144 0.171 0.132 0.107
(0.117) (0.116) (0.108) (0.105)
IT × 400+ Bed size 0.157 0.184 0.145 0.095
(0.116) (0.118) (0.107) (0.106)
N 45,458 45,458 45,458 45,458
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table C5: Redefined Sample:
Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part I
Has at least one Revisit Has 30-day First Revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT 0.011 0.004 0.005 0.010
(0.008) (0.007) (0.008) (0.007)
Age 0.000 0.000 0.000 0.000
(0.000)*** (0.000)*** (0.000) (0.000)
Black 0.016 0.016 0.006 0.006
(0.007)** (0.007)** (0.006) (0.006)
Hispanic 0.008 0.008 0.004 0.004
(0.005)* (0.005)* (0.005) (0.005)
Asian and other race -0.036 -0.036 -0.027 -0.028
(0.006)*** (0.006)*** (0.005)*** (0.005)***
Female 0.019 0.019 0.009 0.009
(0.003)*** (0.003)*** (0.003)*** (0.003)***
Charlson Score 0.034 0.034 0.024 0.024
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.007 0.007 0.014 0.014
(0.004) (0.004) (0.004)*** (0.004)***
N 138,110 138,110 138,110 138,110
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
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Table C6: Redefined Sample: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part
II
Has at least one Revisit Has 30-day First Revisit
Variables Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.063 0.000 -0.031 0.023
(0.083) (0.075) (0.083) (0.077)
Age# 0.000 0.000 0.000 0.000
(0.000) (0.000)* (0.000) (0.000)
Black 0.011 0.010 0.002 0.002
(0.008) (0.007) (0.007) (0.006)
Hispanic 0.007 0.007 0.002 0.003
(0.006) (0.005) (0.006) (0.005)
Asian and other race -0.039 -0.037 -0.032 -0.029
(0.007)*** (0.006)*** (0.005)*** (0.005)***
Female 0.021 0.019 0.011 0.010
(0.004)*** (0.004)*** (0.004)*** (0.003)***
Charlson Score# 0.033 0.033 0.023 0.023
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.013 0.011 0.016 0.015
(0.006)** (0.005)** (0.005)*** (0.004)***
Medicare 0.060 0.061 0.049 0.049
(0.006)*** (0.005)*** (0.005)*** (0.004)***
Medicaid 0.060 0.063 0.033 0.034
(0.008)*** (0.007)*** (0.008)*** (0.006)***
Other Insurance -0.016 -0.018 -0.011 -0.011
(0.006)*** (0.005)*** (0.005)* (0.005)**
IT × AGE# (divided by 1000) 0.172 0.435 0.401 0.377
(0.311) (0.367) (0.300) (0.330)
IT × Black 0.012 0.014 0.008 0.016
(0.013) (0.013) (0.011) (0.012)
IT × Hispanic 0.004 0.004 0.006 0.008
(0.009) (0.009) (0.009) (0.010)
IT × Other race 0.008 0.006 0.012 0.008
(0.009) (0.011) (0.008) (0.010)
IT × Female -0.006 -0.003 -0.006 -0.005
(0.006) (0.007) (0.006) (0.006)
IT × Charlson Score# 0.001 0.004 0.002 0.005
(0.003) (0.004) (0.003) (0.004)
IT × Medicare -0.002 -0.009 -0.009 -0.007
(0.008) (0.009) (0.007) (0.008)
IT × Medicaid 0.015 0.012 0.012 0.016
(0.012) (0.014) (0.011) (0.012)
IT × Other Insurance 0.006 0.021 0.006 0.013
(0.009) (0.021) (0.008) (0.009)
IT × Govn. 0.041 -0.027 0.029 -0.031
(0.046) (0.032) (0.039) (0.032)
IT × Non profit 0.009 -0.025 0.009 -0.031
(0.036) (0.015) (0.029) (0.037)
IT × System 0.014 0.015 -0.002 -0.002
(0.016) (0.017) (0.015) (0.016)
IT × Teaching 0.012 0.014 0.004 0.011
(0.019) (0.023) (0.019) (0.022)
IT × 100-400 Bed size 0.044 0.022 0.004 -0.006
(0.076) (0.072) (0.079) (0.073)
IT × 400+ Bed size 0.021 0.033 -0.011 0.012
(0.078) (0.074) (0.081) (0.075)
N 138,110 138,110 138,110 138,110
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
# indicates deviation from median value.
APPENDIX C. APPENDIX FOR CHAPTER 3 130
Table C7: Redefined Sample: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part
III
Unplanned 1st revisit Unplanned 1st 30-day revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.033 -0.016 -0.011 -0.016
(0.031) (0.021) (0.009) (0.018)
Age 0.004 0.004 0.002 0.002
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.031 0.031 0.020 0.019
(0.017)* (0.017)* (0.014) (0.014)
Hispanic 0.029 0.029 0.017 0.017
(0.011)** (0.011)*** (0.010)* (0.010)*
Asian and other race -0.029 -0.029 -0.025 -0.025
(0.011)*** (0.011)*** (0.008)*** (0.008)***
Female 0.031 0.031 0.018 0.018
(0.006)*** (0.006)*** (0.004)*** (0.004)***
Charlson Score 0.034 0.034 0.020 0.020
(0.002)*** (0.002)*** (0.002)*** (0.002)***
Admitted through ER 0.014 0.013 -0.004 -0.004
(0.007)* (0.007)* (0.006) (0.006)
N 29,448 29,448 29,448 29,448
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients
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Table C8: Redefined Sample: Health IT’s Impact on Acute ST-AMI (STEMI) patients, Part
IV
Unplanned 1st revisit Unplanned 1st 30-day revisit
Basic EMRs EMRs & CPOE Basic EMRs EMRs & CPOE
Health IT -0.103 -0.118 -0.010 0.037
(0.123) (0.121) (0.117) (0.111)
Age# 0.003 0.004 0.002 0.002
(0.000)*** (0.000)*** (0.000)*** (0.000)***
Black 0.041 0.037 0.034 0.031
(0.020)** (0.018)** (0.018)* (0.016)*
Hispanic 0.031 0.029 0.021 0.014
(0.012)*** (0.011)*** (0.011)** (0.010)
Asian and other race -0.023 -0.028 -0.027 -0.024
(0.014) (0.012)** (0.010)** (0.009)***
Female 0.029 0.030 0.018 0.020
(0.007)*** (0.006)*** (0.005)*** (0.005)***
Charlson Score# 0.039 0.036 0.023 0.021
(0.003)*** (0.003)*** (0.002)*** (0.002)***
Admitted through ER 0.008 0.010 -0.013 -0.009
(0.009) (0.008) (0.008)* (0.006)
IT × AGE# (divided by 1000) 1.634 2.069 0.625 1.669
(1.778) (1.838) (0.597) (1.598)
IT × Black -0.034 -0.045 -0.028 -0.073
(0.037) (0.054) (0.027) (0.072)
IT × Hispanic -0.008 -0.002 -0.016 0.017
(0.028) (0.041) (0.027) (0.038)
IT × Other race -0.015 -0.008 0.004 -0.004
(0.017) (0.020) (0.014) (0.016)
IT × Female 0.005 0.007 0.002 -0.009
(0.012) (0.016) (0.009) (0.012)
IT × Charlson Score# -0.014 -0.009 -0.008 -0.005
(0.015) (0.006) (0.008) (0.005)
IT × ER Admitted 0.016 0.016 0.024 0.025
(0.015) (0.021) (0.022) (0.017)
IT × Govn. 0.070 0.058 -0.060 -0.051
(0.056) (0.055) (0.047) (0.053)
IT × System 0.012 0.036 0.011 -0.005
(0.029) (0.026) (0.017) (0.020)
IT × Teaching -0.025 -0.077 -0.026 -0.027
(0.035) (0.072) (0.024) (0.025)
IT × 100-400 Bed size -0.038 -0.030 -0.039 -0.074
(0.111) (0.112) (0.108) (0.100)
IT × 400+ Bed size -0.015 0.019 0.005 -0.040
(0.113) (0.114) (0.108) (0.101)
N 29,448 29,448 29,448 29,448
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes year and hospital fixed effect.
Standard error clustered at hospital level.
All Medicare patients.
# indicates deviation from median value.
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Table C9: Robustness check: OLS Regression of Severity on Health IT Adoption
Full Sample HF PN COPD STROKE AMI
Basic EMRs -0.027 0.001 -0.013 0.003 -0.029 -0.000
(0.018) (0.022) (0.026) (0.024) (0.031) (0.031)
EMRs & CPOE -0.036 0.040 -0.063 0.003 -0.020 -0.014
(0.019) (0.025) (0.060) (0.030) (0.021) (0.032)
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level.
Table C10: Robustness check: Fixed Effect Regression of Severity on Health IT Adoption
Full Sample HF PN COPD STROKE AMI
Basic EMRs -0.003 -0.088 -0.019 -0.073 -0.003 0.067
(0.008) (0.084) (0.043) (0.045) (0.045) (0.048)
EMRs & CPOE 0.002 -0.053 -0.031 0.068 -0.036 -0.013
(0.007) (0.038) (0.049) (0.051) (0.052) (0.052)
* p < 0.1; ** p < 0.05; *** p < 0.01
Model also includes Major Diagnosis Category, year and hospital fixed effect.
Standard error clustered at hospital level. Diff-in-Diff setting
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